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Summary 
 
Polymersomes (synthetic polymeric vesicles), formed by the self-assembly of 
amphiphilic block copolymers in water attract great attention as drug delivery systems 
and as diagnostic/imaging tools. Our group has shown that 2-(methacryloyloxy)ethyl 
phosphorylcholine-block-2-(diisopropylamino)ethyl methacrylate (PMPC-PDPA) 
polymersomes are of special interest due to their ability to encapsulate a wide range of 
therapeutic molecules including anticancer compounds, antibiotics, antibodies, and 
nucleic acids,  and their capacity to deliver their cargo intracellularly, both in vitro and 
in vivo, without promoting cellular toxicity or stress.  
The favourable uptake kinetics and toxicological profile of PMPC-PDPA 
polymersomes justify a thorough study on the cellular interactions and mechanisms 
underlying their uptake, which was the aim of this thesis. 
 
Exploring different polymersome production methods we studied the impact that the 
physical properties of PMPC-PDPA polymersomes (nanoparticle size and shape) have 
on their cellular uptake. Using flow cytometry and fluorescence microscopy we 
demonstrated that both spherical and tubular polymersomes could be used as 
intracellular delivery vectors. In addition, spherical and tubular polymersomes presented 
different uptake kinetic profiles, opening new avenues to modulate the temporal 
delivery of a cargo. 
In a parallel line of work we identified receptor-mediated endocytosis as a common 
pathway for the internalisation of PMPC-PDPA polymersome in mammalian cells. 
Studying polymersome uptake in the presence of antagonists and neutralising 
antibodies, we identified two families of transmembrane proteins mediating PMPC-
PDPA polymersome endocytosis and the specific receptors facilitating polymersome 
uptake. In addition, different endocytic pathways and molecules (i.e. dynamin, BAR 
domain proteins) were investigated in relation with polymersome internalisation by 
means of chemical inhibitors, dominant negative proteins and siRNA knockdown. 
Polymersome endocytosis seems to be dominated by a high level of promiscuity and the 
ability of PMPC-PDPA polymersome to induce their uptake, which could be translated 
in new therapeutic applications with a great clinical impact.   
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Chapter 1: Introduction 
 
1.1 Nanotechnology for drug delivery 
 
Advances in biomedicine and medicinal chemistry have produced state-of-the-art 
therapeutic biomolecules and drugs with great potential for diagnosis and patient 
treatment that are highly specific towards their target (i.e.. antibodies and nucleic acids). 
Nonetheless, these molecules often present undesirable properties that can hamper their 
clinical use, such as poor solubility in water, which is a major problem since biological 
fluids are aqueous fluids3. In addition, therapeutic molecules can be unstable in certain 
biological environments. For example therapeutic proteins, which are quite sensitive to 
pH changes and the presence of proteases, or may be rapidly cleared from the body 
circulation by the immune system4. Moreover, some molecules with high therapeutic 
value, such as nucleic acids, act in the cell cytoplasm and are impermeable to the cell 
membrane and so cannot reach their target site by themselves5,6. Finally, some drugs are 
quite cytotoxic (i.e. anticancer chemicals) and therefore only the target tissue or group 
of cells should come in contact with them. Consequently, there is the need to engineer 
drug delivery systems able to protect the active compound within a biological 
environment and at the same time to limit its interactions with off-target sites, to 
transport it to the desired biological target and to efficiently release it at that site. 
Furthermore, no collateral toxicity must be derived from the use of such vector. 
Traditional drug formulations are frequently associated with poor protection of the 
compound of interest from the biological environment and lack of controlled release, 
spatially or temporally. This is translated in the need for frequent doses to reach a 
therapeutic effect, which in turn can result in unwanted side effects including drug 
resistance. Along these lines, nanotechnology has emerged as a promising way to 
improve drug delivery7. Nanotechnology (understanding and controlling matter at the 
nanoscale, where at least one dimension is between 1-100 nm) takes a multi-disciplinary 
approach to engineer nanoscopic devices that offer enhanced protection and transport of 
bioactive cargoes, increasing the ability to overcome biological barriers in order to 
release this cargo at the cellular or subcellular level, which are the sites of action for 
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most drugs and therapeutic biomolecules. In fact, several nanoparticles formulations are 
currently commercialised for the treatment of different diseases (table 1.1). 	  
To deliver a cargo intracellularly is not an easy task, evolution has placed several 
barriers within the human body to protect it from external sources of danger, and to 
maintain the specific local conditions that the different biological processes need to 
operate. Nevertheless, there is communication between these compartments (i.e. plasma 
and interstitial fluid or cytoplasm and nucleus), and although the transport at their 
interface is strictly regulated it opens a window for the use of nanotechnology for 
enhanced drug delivery8. Nature itself is an example of nanotechnology at work, with 
viruses being the most effective intracellular nanoscopic delivery vectors described. 
Viruses rely in their ability to overcome all the biological barriers to be able to replicate, 
therefore, evolution has equipped them with a set of tools to evade the immune system, 
avoid rapid renal and hepatic clearance, and target a specific group of cells, sometimes 
beyond extremely tightly regulated barriers such as the blood brain barrier9,10. Finally, 
viruses are able to penetrate the cell membrane, to escape from endo-lysosomal 
intracellular vesicles and to cross the nuclear membrane, which comprise the main 
barriers to be overcome at the cellular level11. In the in-depth knowledge of the barriers 
mentioned and the examples of natural particles with the ability to cross them, 
nanoscientists have an invaluable source of inspiration that they can turn to in order to 
engineer better intracellular delivery systems12. 
 
This thesis focuses on the study of nanoparticle transport across the plasma membrane, 
hence, the ways to move across this barrier will be described below. 
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1.2 Transport across the plasma membrane  
 
1.2.1 Diffusion 
 
The plasma membrane of mammalian cells is semi-permeable, therefore only a selected 
group of molecules can passively diffuse across it. This group include small (< 1kDa) 
lipophilic particles, such as fatty acids and steroids, gases, such as oxygen or carbon 
dioxide, and small non-charged polar molecules like water, ethanol, and urea. On the 
other hand, larger polar/apolar macromolecules such as glucose, amino acids, or 
nucleotides, and strongly charged molecules such as ions (K+, Na+, Ca2+, Cl-) require 
ion channels or small molecule transporters embedded within the membrane, which are 
highly specific towards the cargo transported, to diffuse through it. Facilitated 
diffusion does not require energy to operate when molecules move from areas of high 
concentration to areas of low concentration (i.e. glucose). Instead, energy, often in form 
of ATP, is needed to fuel facilitated diffusion against a concentration or electrochemical 
gradient (i.e. K+ / Na+ pump)13. 	  
Passive and facilitated diffusion are non-compatible with the cellular uptake and release 
of high volume of fluids and macromolecules (i.e. proteins) very different in nature. 
These cargoes cross the plasma membrane through endocytosis (cellular uptake) or 
exocytosis (cellular release). These are energy-dependent processes associated with 
high rates of membrane remodelling in which cargoes are transported in and out the cell 
in membrane-enclosed vesicles. 
 
1.2.2 Endocytosis 
 
The term endocytosis was first coined in 1963 by de Duve, to name the cellular 
internalisation of particles and fluids through plasma membrane invaginations, resulting 
in intracellular vesicles containing the material endocytosed14. Therefore, endocytosis is 
best known as the energy-dependent process by which cells uptake fluids, molecules 
and macromolecules by the controlled deformation of the plasma membrane. However, 
its role in the biology of the cell is far more extensive. It regulates the lipo-protein 
composition of the plasma membrane, participates in the presentation of receptors in the 
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plasma membrane, cell signalling, cell motility and division15. Numerous diseases are 
related to defective endocytosis, and bacteria and viruses often exploit this pathway to 
enter cells16,17. Mechanisms of nanoparticle cellular internalisation have mostly been 
found  to be energy-dependent processes, rather than passive diffusion through the 
membrane or membrane pores18. In addition, endocytosis has been identified as the 
primary cellular internalisation pathway for many nanoparticles formulations19. 
Endocytosis and its consequent subcellular sorting is a complex process with multiple 
cellular pathways often overlapping. Furthermore, the lack of enough specific markers 
and inhibitors for distinctive pathways, and the technical limitations to its in-depth 
study (i.e. imaging resolution thresholds, experimental protocols perturbing cell 
homeostasis) are responsible for the fact that only a small, although extremely 
significant part, of this important biological process has been decoded so far. 	  
Endocytosis is traditionally divided into phagocytosis and pinocytosis. Phagocytosis, 
typically exclusive of specialised cells of the immune system such as macrophages and 
neutrophils, is normally associated with the internalisation of large solid particles. 
Membrane protrusions, driven by the rearrangement of the actin cytoskeleton, are 
usually projected to engulf the extracellular particle in vesicles called phagosomes. 
Phagosomes bypass early endosomes and fuse directly with lysosomes to form 
phagolysosomes20 (figure 1.1). On the other hand, pinocytosis is a process present in 
almost all eukaryotic cells and it is regularly used for the uptake of fluids and particles 
smaller than 1 µm. Pinocytosis can be further subdivided into several mechanisms 
defined by the specific lipids and proteins involved in each of them. The precise 
boundary between different pathways is an area of much debate, and the particular 
uptake mechanisms remain highly dependent on the cargo and the cell type. Figure 1.1 
is a schematic representation of the currently identified endocytic routes, while table 1.2 
lists different endocytic pathways, together with the vesicular morphology observed and 
a examples of cellular molecules involved in each of them. Table 1.2 does not include 
non-lysosomal pathways (and hence non-degradative pathways). However, it is 
important to mention that transcytosis has a central role in the transport of 
macromolecular nutrients across endothelial and epithelial barriers. Transcytosis allows 
the effective intracellular transport of macromolecules such as folate, chemokines and 
immunoglobulins, maintaining biologically active cargo from one side to the opposite 
side of a cell21.  
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Due to the relatively big diameter of the endocytic vesicles formed, macropinocytosis 
was one of the first pinocytic events observed22. Macropinocytosis involves the 
internalisation of a large quantity of external fluids by the extension of the plasma 
membrane, usually upon stimulation by growth factor receptors, bacteria, apoptotic 
bodies, necrotic cells or viruses, to form > 200 nm organelles known as 
macropinosomes. Macropinocytosis provides an effective uptake route for the non-
selective endocytosis of macromolecules up to 1 µm23. In addition, it is associated with 
high cell surface ruffling (lamellipodia-like extensions, circular ruffles and blebs) and 
therefore with high rates of actin cytoskeleton reorganisation. Nonetheless, it is not 
macropinocytosis, but clathrin-mediated endocytosis (CME), discovered by Roth and 
Porter in 196424, that is the most-studied and best-characterised endocytic pathway to 
date. CME is initiated at membrane sites enriched in phosphatidyl-4,5-bisphosphate 
(PI(4,5)P2), where adaptor proteins trigger the assembly of clathrin and accessory 
proteins into polygonal lattices that will grow to form clathrin coated pits (CCPs) upon 
cargo stimulation25,26. Clathrin coated vesicles are subsequently detached from the 
plasma membrane in a dynamin-dependent way and lose their clathrin coat before 
localising to early endosomes. At a given time CCPs occupy approximately 2% of the 
plasma membrane surface27,28, and the rate of plasma membrane internalisation through 
CME is close to 1–5% per minute29.  
The first clathrin-independent pathway described, caveolae-mediated endocytosis, was 
originally observed in the early 1950’s at the surface of endothelial cells30,31. It was 
named after the transmembrane cholesterol-binding protein coating the invaginations: 
caveolin. Three isoforms of caveolin have been identified, caveolin 1, caveolin 2 and 
caveolin 332. Caveolin 1 and caveolin 3, the last one only present in muscle cells, are 
indispensable for the formation of the caveolae. The main function of caveolin 2 
remains unclear. Caveolae are 50-80 nm flask-shaped invaginations (20-40 nm at the 
neck) displayed by the plasma membrane of many cells, except hepatocytes, neuronal 
cells and lymphocytes33. Caveolae present limited motility and dynamics33 and are 
characterised by the presence of cholesterol and sphingolipid-rich domains (lipid-rafts 
domains). Actually, caveolae are important in cholesterol homeostasis regulation34. 
Although traditionally it has been considered that the main role of caveolae were to 
define a clathrin-independent endocytic pathway, as well as being important signalling 
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platforms, nowadays the hypothesis in which the main role of caveolae is to act as 
membrane tension regulators is gaining strength35,22. Nonetheless, it is clear that 
different cargoes can take advantage of caveolae to be internalised through endocytosis, 
especially by transcytosis36.  
 
Advances in microscopy (sample preparation protocols and instrumentation) and 
molecular techniques, have permitted, in the last decade, the discovery of novel 
endocytic pathways, different from clathrin and caveolae-mediated endocytosis. 
Although these new routes remain largely unexplored, it seems that they could account 
for a high percentage of the total cellular endocytosis and plasma membrane turnover37. 
In addition, many of these pathways appear to be highly sensitive to cholesterol levels at 
the plasma membrane and be related to the uptake of glycosylphosphatidylinositol-
anchored proteins (GPI-Aps) and glycosphingolipids. One of these pathways is defined 
by the presence of the ubiquitously expressed mammalian transmembrane proteins 
known as flotillins (flotilin 1, flotilin 2). Flotillins, associated with lipid rafts at the 
plasma membrane, define specific microdomains that resemble caveolae but that are 
different from them, as well as negative for the presence of clathrin38. Flotillin-positive 
domains are associated with the endocytosis of plasma membrane components such 
CD59 (GPI-Ap)39,40. In addition, and similar to caveolae, they seem to function as 
signal transduction platforms and more importantly, as regulators of the cortical 
cytoskeleton41.  
Cell division cycle 42 (Cdc42), a small GTPase enzyme of the Ras superfamily of 
GTP-binding proteins, seems to define a specific endocytic route, first identified during 
the study of GPI-APs internalisation42. Cdc42 binding and hydrolysis of GTP 
(nucleotide guanine triphosphate) is crucial for cell growth regulation, cellular 
differentiation, and apoptosis, mostly through the rearrangement of the actin 
cytoskeleton. It directly binds to Neural Wiskott-Aldrich syndrome protein (N-WASP), 
which activates Arp2/3, which in turn nucleates new F-actin. Therefore Cdc42 
endocytosis is very sensitive to inhibitors of actin polymerisation. Cdc42 interacts with 
multiple partners, among them Arf1 and GRAF1, a GTPase in which different domains 
associated with membrane deformation and vesicle scission can be identified. Cdc42 is 
one of the few dynamin-independent endocytic mechanisms identified so far together 
with Arf6-dependent endocytosis. ADP-ribosylation factor 6 (Arf6), another small 
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GTPase ubiquitously expressed in mammalian cells43, is normally found in membrane 
ruffles. It contains a BAR domain which allows this protein to sense and promote 
membrane curvature44. Endocytosis of the GPI-linked protein CD59 and proteins from 
the major histocompatibility complex (MHC) class I occurs in an Arf6-dependent 
fashion. Finally, the internalisation mechanism followed by the interleukin-2 cytokine 
receptor (IL-2R) appears to outline a novel endocytic route. The involvement of the 
small G proteins rhoA and rac1, and the kinases PAK1, PAK2, and 
phosphatidylinositol-3-kinase are hallmarks of this pathway45. Vesicle scission from the 
plasma membrane is regulated by dynamin. N-WASP regulation of actin is also 
important for membrane remodelling associated with IL-2R endocytosis46. As pointed 
out above, the small GTPase RhoA (Ras homolog gene family) is closely related to IL-
2R internalisation47. Moreover, both RhoA and IL-2R define γc-cytokine receptor 
endocytosis. RhoA has a main role in actin cytoskeleton dynamics and therefore it is 
also found regulating other endocytic routes (table 1.2).  
 
1.2.2.1 Detachment of the endocytic vesicle from the plasma membrane. 
Membrane fission 
 
1.2.2.1.1 Dynamin 
 
Dynamin is a large GTPase belonging to the dynamin superfamily48. It was discovered 
in the last decade of the 20th century and soon related to endocytosis through genetic 
loss-of-function studies in Drosophila melanogaster49,50. Three dynamins have been 
described in mammals. Dynamins 1 and 3 are mostly expressed in the nervous system 
and dynamin 2 is almost ubiquitously expressed.  In addition to the GTPase domain that 
binds and hydrolyses GTP, dynamin has 4 more domains: the middle domain, the 
pleckstrin-homology domain (PH), the GTPase effector domain (GED) and the 
proline/arginine-rich domain (PRD). The middle and the GED domains are involved in 
oligomerization and regulation of the GTPase activity. The PH domain targets dynamin 
to the plasma membrane, and it is through the PRD domain that dynamin establishes 
direct interactions with other proteins involved in membrane remodelling and scission26. 
These domains are expected to fold into a hairpin-like three-dimensional structure 
where the G domain lies on a helical bundle, known as the bundle signalling element 51 
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52. The helices of the middle and the GED domains form a stalk that connects the 
GTPase region and the PH domain53,54. The PH domain constitutes the ‘foot’ of the 
hairpin that interacts with the lipidic membrane55-57. The PRD domain is predicted to be 
unfolded and to get projected in opposite direction to the membrane at the conjunction 
between the BSE and the G domain58. Dynamin polymerisation is central to dynamin 
function. The stalks of two dynamin monomers dimerise in a cross-like fashion53,54. 
Dynamin dimers further polymerise and self-assemble as rings and spirals around the 
neck of endocytic buds59,60. G domain dimerisation, which is crucial for GTP 
hydrolysis, occurs between adjacent rungs of the dynamin helix52,61. 	  
Dynamin is an important protein with a mechano-enzymatic activity mediating pinching 
off of endocytic membranes from the plasma membrane in mammalian cells48. 
Accordingly, it has been found driving the fission of endocytic vesicles in some of the 
best characterised endocytic pathways described to date62,63 (table 1.2). Although there 
is extensive evidence of the ability of dynamin to tubulate membranes and generate 
membrane fission both in vitro and in vivo64-66 the exact mechanism through which 
dynamin promotes membrane fission is still the subject of much debate57,67,68. Bridging 
the gap, a general consensus exists that dynamin polymerises around the neck of the 
spherical or tubular invagination in the form of short spirals, and that it undergoes a 
structural change following GTP hydrolysis which ultimately results in the scission of 
the endocytic vesicle from the plasma membrane25,69. Whilst dynamin is often 
indispensable for the scission of endocytic vesicles in vivo, it does not work alone, quite 
the opposite, it directly interacts with different proteins with the special mention of 
actin70,71 and BAR domain proteins72,73	  that contribute to dynamin-mediated membrane 
fission74.  
 
1.2.2.1.2 BAR domain proteins 
 
As the name indicates, proteins belonging to the super family of BAR domain proteins 
contain a BAR domain within their structure that allow them to sense and/or induce 
membrane curvature, mainly through electrostatic interactions75. The first BAR domain 
protein identified was amphiphysin in 2004 by the McMahon group76, since then dozens 
of new members have been recognised77-83. Different subtypes have been identified 
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depending on their ability to bind to membrane with diverse curvatures. BAR/N-BAR 
proteins bind to membranes with high positive curvature (towards the cell cytoplasm, 
i.e. amphiphysin and arfaptin). F-BAR members bind to positive curved membranes, 
although flatter than the previous group (i.e. FCHo2)81, while I-BAR domain proteins 
recognise and bind to membranes with negative curvature  (towards the extracellular 
space, i.e. IRSp53)84. The dimeric α-helical coiled coils that constitute the BAR domain 
function as a rigid scaffold for the stabilisation or generation of curved membrane 
domains76,85. BAR domain dimers recruited to the membrane can interact among them 
to form higher-order assemblies, which tend to be more flexible structures in 
comparison to the isolated dimers, and offer new opportunities for the deformation of 
the membrane86. For example, CIP4 or FBP17 generate helical oligomers through 
lateral contacts, and contacts at the ends of their BAR domains85,87. Another example is 
the crosslinking of endophilin through the amphipathic helices present at the N-
terminus of the dimers88. 	  
BAR domain proteins have, in some cases, other domains within their structure that 
allow them to directly interact with different endocytic molecules. A well-studied 
example is amphiphysin that has an internal clathrin and adaptor-binding domain 
(CLAP) to bind to clathrin and the AP2 adaptor complex, and a C-terminal SH3 domain 
through which it binds to dynamin. It has been demonstrated that inhibiting dynamin-
amphiphysin interaction inhibits clathrin-mediated endocytosis89. BAR domain proteins 
also serve as bridges between the plasma membrane and the cytoskeleton at different 
endocytic sites65,75,90, and they are implicated in actin polymerization and the 
intracellular trafficking of a cargo after scission from the plasma membrane via 
interaction with nucleation promoting factors (i.e. N-WASP)75 and Rho-family 
GTPases90 (i.e. Cdc4291, Arf692).  
Interestingly, it has been recently demonstrated, in a liposome vesiculation assay, the 
ability of BAR domain proteins containing amphipathic helices (N-BAR proteins such 
as endophilin and amphiphysin) to directly promote membrane scission93. This is in 
addition to their well-known capacity to generate membrane curvature through the same 
mechanism94.  According to the published study, the ability of these proteins to promote 
membrane fission resides on their amphipathic helices, and it is proportional to the 
hydrophobicity and number of those helices.  In line with this, they showed that Epsin, 
which although it is not a BAR domain protein, has an amphipathic helix (ENTH 
	  	  	   30	  
domain) that inserts in the plasma membrane, can also generate membrane fission at the 
neck of clathrin coated vesicles in the absence of dynamin93.  
 
1.2.2.1.3 Actin, lipid-phase separation and the energy-state of the plasma 
membrane 
 
Actin is an ATPase highly abundant in most eukaryotic cells, where it can be found as 
monomeric globular G-actin and as polymeric filamentous F-actin. Actin filaments are 
formed by polymerisation of G-actin giving rise to the actin cytoskeleton. Therefore 
actin is crucial to preserve the cell shape. In addition, actin polymerisation and the 
growth of actin filaments in a polarised fashion generate a force needed to maintain cell 
polarity and to drive cell remodelling when necessary (i.e. motility, division, muscle 
contraction and endocytosis)95. Actin is an important player in endocytosis in 
mammalian cells, where it is involved at different stages of the internalisation process, 
from early invagination, to movement of the endocytosed vesicle away from the plasma 
membrane, being able to drive membrane fission in some types of clathrin-independent 
endocytosis96. Actin is crucial in phagocytosis97 and macropinocytosis98, it is involved 
in the generation of caveolae and their endocytosis99,100, and it is also implicated in 
CME, and clathrin and caveolae-independent endocytosis101 (table 1.2).  
The specific role of actin is especially controversial in CME in mammalian cells102, and 
therefore much research has been committed to study actin in this pathway. In yeast, 
actin is essential for early plasma membrane invagination in CME103. Actin is also 
important in the successive endocytic stages including the scission of the CCP, which 
seems to be driven by Vps1 and amphiphysins104,105. Vsp1 is the yeast homologue of the 
human dynamin, the main molecule responsible for the detachement of CCPs in 
mammalian cells48. Thanks to the extensive investigation on this field we now know 
that dynamin interacts directly and indirectly with actin at the endocytic site106-108 and 
that actin is important, although the level of importance seems to be quite cell-type 
dependent, in dynamin-mediated fission of the endocytic vesicle70,109. The current 
understanding, inspired by the fact that actin may be essential in yeast CME to 
overcome the turgor pressure103, is that actin is needed for the successful internalisation 
of clathrin coated vesicles at endocytic sites under high local membrane tension 
providing the extra force required in such situations110. This could be easily extended to 
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other endocytic routes, complementing the fact that actin could be facilitating 
membrane fission by actively driving lipid phase separation96,111. In line with this, not 
only proteins, but also lipids seem to have a decisive role in membrane invagination and 
membrane scission through lipid-phase separation at the plasma membrane. Phase 
separation, also known as formation of lipids domains or lipid clustering, creates a 
repulsive tension at the boundary of the domain with the surrounding membrane, which 
is known as line tension. A way to minimise this tension is to bud the domain out of the 
membrane, providing the line tension is higher than the energy necessary to bend the 
membrane (bending energy). Theoretical models and in vitro studies raise the idea that 
in extreme cases, when the line tension is high and the radius at the bud neck smaller 
than a threshold (approx. 5 nm) the vesicle could undergo spontaneous fission67,112,113. 
Otherwise, the bud might be detached with the help of the proteins mentioned above or 
it could remain connected to the plasma membrane helping to minimise line tension.  As 
follows from this argument, the local energy-state of the plasma membrane, which in 
turn is influenced by the arrangement of lipids, transmembrane and peripheral proteins, 
is a key parameter to have in consideration, and it could be indicating the essential 
requirements for effective membrane fission in each situation. Scission has to be overall 
an energetically favourable process. The scission of an endocytic vesicle is a way to 
relax the tension built up in a membrane under high local curvature and therefore it 
should be accompanied by a relaxation of the free energy of the system114,115. 	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Figure	  1.1:	  Mechanisms	  of	  endocytosis	   identified	   in	  mammalian	  cells	   together	  with	  
the	  approximated	  size	  of	  the	  endocytic	  vesicles	  formed.	  	  
Adapted	   from	   Canton	   and	   Battaglia	   2012	   with	   permission	   of	   The	   Royal	   Society	   of	  
Chemistry(http://dx.doi.org/10.1039/C2CS15309B).	  	  
This journal is c The Royal Society of Chemistry 2012 Chem. Soc. Rev., 2012, 41, 2718–2739 2719
self-assembly into a membrane made of a hydrophobic layer
stabilised by two hydrophilic layers. The ability to compart-
mentalise is due to the phospholipid membrane impermeability
to molecules such as ions, proteins and other polar compounds.
This allows the formation of confined aqueous volumes with
controlled concentrations and compositions, necessary to create
the appropriate conditions for housing biochemical processes.
Subcellular compartmentalisation is not a static but a dynamic
condition, since the phospholipid membrane plays an important
role in biological communication; allowing for trafficking of
molecules either through passive diffusion (i.e. Fickian diffusion
of small molecule across the membrane) or by lodging protein
channels that actively control the molecular flow. In multi-
compartmented eukaryotic cells, trafficking is also controlled by
the exchange of small membrane-enclosed sacs known as vesicles.
They are formed from ‘‘pinching off’’ segments of the membrane
that comprises the organelle of origin. The resulting vesicles
encapsulate some of the material from the organelle and through
selective, often protein-controlled interactions, they deliver the
contents by fusing membranes with the target organelle. This
continuous fission and fusion ensures the exchange of an isolated
but considerable amount of biochemical information. Material is
continuously exchanged between the extracellular space and the cell
interior (e.g. cytosol) via endocytosis (in) and exocytosis (out).
Although endocytosis and exocytosis processes are strictly
connected between each other to maintain cell homeostasis,3 we
will focus the attention of this review on the former process.
Endocytosis is a fundamental process that is used by cells to
internalise molecules and macromolecules. Its function is not
only limited to uptake of nutrients, it plays a primary role in
surface receptor regulation (including antigen presentation), cell
motility and mitosis, as well as the control of several signalling
cascades.4,5 Furthermore, endocytosis is also the primary route
exploited by bacteria and viruses to enter cells.6–11 With the
advent of nanotechnology and the ability to modulate the design
of nanoparticles, unravelling the role of endocytosis in nano-
particle internalisation is becoming crucial. This would be key to
understand the fate of the nanoparticles once internalised, their
toxicological profile and the effect on the biological activity of the
cargo transported inside the cells. Herein, we discuss the mechan-
isms of endocytosis. How internalised materials are sorted within
the cell, and the strategies to escape the endocytic pathway and
deliver cargoes intracellularly.
2. Endocytotic pathways
Cellular and molecular biologists are still trying to understand
the mechanisms that regulate endocytosis. This is a very
difficult task to achieve because of: (i) a lack of generally
accepted markers/inhibitors to elucidate the pathways, (ii)
technical limitations such as imaging resolution and toxicity/
cell homeostasis perturbation, and (iii) cross-talking between
the different pathways. The traditional classification divides
uptaken cargoes by size into two categories: phagocytosis
(i.e. cell eating) and pinocytosis (i.e. cell drinking). While the
former is typical of only few specialised cells, the latter is
ubiquitous to almost any eukaryotic cell. Pinocytosis is further
sub-classified in several other mechanisms depending on the
different proteins and lipids involved. In Fig. 1, the main
endocytic mechanisms are depicted together with the intra-
cellular fate of internalised materials. All of these mechanisms
generally share four fundamental steps: (i) specific binding
event at the cell surface; (ii) plasma membrane budding and
pinching off; (iii) tethering of the resulting trafficking vesicle
and finally (iv) trafficking of the vesicle to a specific subcellular
organelle. In this section, we discuss the latest insights into the
Fig. 1 Mechanisms of extracellular uptake by endocytosis in a typical eukaryotic cell.
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1.3 Soft nanoparticles as intracellular delivery vectors 
 
Nanotechnology has already provided different examples of nanoparticles (NPs) able to 
deliver their cargo intracellularly both in cell cultures and in vivo animal models, some 
of which are currently marketed products (table 1.1). Depending on the material that the 
nanoparticle is comprised and on the methods of assembly we can distinguish between 
hard metal nanoparticles (gold, silver, iron, quantum dots) and carbon-based NPs 
(fullerene, carbon nanotubes), characterised by the strong ionic, metallic or covalent 
bonds holding the particle together, and soft nanoparticles, such as lipid-based 
nanoparticles (micelles, liposomes) and polymer-based nanoparticles (micelles, 
dendrimers, polymersomes) supported by weak interactions including  hydrogen bonds, 
hydrophobic effect or columbic forces116. This thesis focuses on polymersomes, and 
therefore the main characteristics of different colloidal soft nanoparticles with great 
potential to improve the intracellular delivery of diagnostic and therapeutic molecules 
will be introduced below.  
 
Liposomes, vesicles made by natural amphiphilic molecules known as phospholipids, 
were first produced in the early 60s by Bangham and Horn117, and have remained as the 
gold standard in synthetic biology for the intracellular delivery of different compounds 
since then. Liposomes have the ability to encapsulate hydrophilic and hydrophobic 
cargoes while self-assembling in physiological solutions, they are relatively easy to 
size-tune and composed of well-characterised building blocks. However, these 
nanoparticles present short shelf-life during storage due to their reduced chemical and 
physical stability, and poor biostability as they present very reduced blood circulation 
times. Polymeric science at the nanoscale allows for the creation of similar delivery 
systems to liposomes but from a completely synthetic nature, the polymersome, which 
will be described in detail in the next section. Another interesting alternative to 
liposomes is the exosome. Exosomes are endocytic-derived vesicles, ≈ 40–100 nm in 
diameter, firstly observed in 1983118, which are secreted by most cell types in vitro. 
Exosomes present high stability in blood and shielding from immunogenicity due to 
their self-origin. Interestingly, exosomes derived from dendritic cells carry on their 
surface tetraspanins including CD9, which has been found to facilitate direct membrane 
fusion with the target cell and cargo release bypassing lysosomal degradation119. 
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Although the use of exosomes as intracellular delivery vectors is recent, there are 
interesting reports showing exosome-mediated delivery of a small anti-inflammatory 
drug120 and interfering siRNA121.  
 
Dendrimers are spherical hyperbranched macromolecules formed by repeated 
polymerisation around a central synthetic polymeric core. Since the synthesis of the first 
dendrimers in 1978122 various generations of these polymeric nanoparticles have been 
produced. Dendrimer generation refers to the number of repeated branching cycles 
performed during particle synthesis, with the molecular weight of the nanoparticle 
nearly doubling in each new generation. High generation dendrimers present many 
cavities that can be used to accommodate therapeutic molecules123, at the same time 
they boast a higher number of functional groups on their surface allowing further 
dendrimer customisation124. Synthesis of dendrimers is a laborious process with 
numerous steps, however, this is rewarded by obtaining nanoparticle populations with 
narrow size and shape distributions.   
 
It is important to highlight that in order to improve specificity towards the target site 
and to promote or enhance the cellular uptake of the nanocarrier, many nanoparticles 
are currently conjugated on their surface with ligands for the targeting of cellular 
markers. These ligands include small molecules, proteins and peptides, antibodies or 
antibody fragments, and aptamers. Among them, conjugation of nanoparticles with cell-
penetrating peptide (CPP) has emerged as a promising technology to cross the plasma 
membrane by direct translocation or endocytosis125. CPPs derive from proteins able to 
translocate across cellular membranes. The most common CPP used in intracellular 
delivery derives from the HIV-1 Tat protein126. Novel CPP delivery vectors have been 
engineered for the transmembrane delivery of oligonucleotides, peptides, peptide 
nucleic acids, proteins, low-molecular-mass drugs, and nanoparticles such as 
liposomes127. The association of CPPs to nanocarriers has also been used for the 
development of new cellular imaging tools or biosensors128. 
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1.3.1 Polymersomes 
 
The first self-assembly of block copolymer chains into polymeric vesicles (a.k.a 
polymersome) was reported in 1995 by Zhang and Eisenberg129. Since then much 
research has been conducted in polymersome design and production, and directed 
towards polymersome biomedical applications, especially as intracellular delivery 
nanovectors. Polymersomes are considered as the biomimetic analogues of natural 
phospholipid vesicles since they are formed from the self-assembly in water of synthetic 
polymeric amphiphiles.  Therefore, they are able to entrap hydrophilic molecules within 
the aqueous core, hydrophobic compounds within the membrane, and amphiphilic 
substances across the membrane. Their high molecular weight entangled polymeric 
membranes provide them with enhanced mechanical properties (i.e. stability, flexibility 
and lower permeability) in comparison with liposomes130,131. As an example 
poly(ethylene oxide)-poly(ethyl ethylene) (PEO-b-PEE) membranes are around 5–50 
times tougher than phosphatidylcholine membranes130. In addition, polymersome 
membranes thickness varies between 2 to 50 nm while lipid membranes are 3-5 nm 
thick132,133, and the diffusion coefficient of polymeric membranes is at least one order of 
magnitude inferior to that of lipidic membranes134. The soft nature of polymersomes 
equips them with a liquid-liquid interface, meaning that their interactions with the 
biological surroundings are characterised by surface energies with orders of magnitude 
comparable to those of biological systems116,135. Finally, their synthetic nature allows 
modification of their chemical composition relatively easily136, decoration of their 
external surface with biomolecules for active targeting, or making them stimuli-
responsive134.   
 
1.3.1.1 Molecular fundamentals in polymersome self-assembly 
 
An amphiphile is a molecule where two domains that behave in an opposite way in 
contact with water can be identified, with one part being hydrophilic and the other one 
hydrophobic. Therefore, in an aqueous solution the hydrophilic segment tends to 
maximise its contact with the surrounding water molecules while the hydrophobic part 
of the amphiphile tries to limit the contact with the water by staying in close proximity 
to other hydrophobic regions. This phenomenon is known as the hydrophobic effect137 
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and drives the self-assembly of block copolymers in aqueous solution into polymeric 
aggregates of different architectures when the copolymer concentration overcome the 
critical aggregation concentration (CAC). CAC corresponds to the minimum 
amphiphile concentration to form an aggregate. For high molecular weight amphiphilic 
copolymers CAC is virtually zero. This is translated in slow chain exchange and 
therefore high stability of the nanostructure formed. The most likely self-assembled 
morphology formed is dictated by the dimensionless molecular packing parameter p138 
(equation 1 and figure 1.2): 
Equation 1 
	  
	  
Where v is the volume of the hydrophobic chains, lc is the length of the hydrophobic 
tail, and ao is the optimal surface area per molecule at the interface between the 
hydrophobic and hydrophilic domains.  	  
Spherical micelles, monolayered particles consisting of a hydrophobic core surrounded 
by a soluble corona, are formed when p ≤ 1/3; when the hydrophobic fraction increases 
being p a value between 1/3 and 1/2 (1/3 < p ≤ 1⁄2) cylindrical micelles are formed 
instead. Finally, p values between 1⁄2 < p ≤ 1 associate with the formation of bilayers 
with hydrophilic brushes at both sides and a thick hydrophobic core of interdigitated 
polymers. In order to protect the hydrophobic edges of the bilayer from the contact with 
the water the membrane rounds itself into a vesicle with an aqueous core, the 
polymersome139.  
Self-Assembled Block Copolymer Aggregates:
From Micelles to Vesicles and
their Biological Applications
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Introduction
Polymer chemists have exploited the wide range of
controlled polymerization techniques now available in
order to design macromolecular analogues of nature’s
simple amphiphiles. In particular, advances in living
radical polymerization[1–3] have enabled a much broader
range of functional groups to be incorporated into
copolymer structures than was previously possible using
anionic polymerization.[4] Well-defined block copolymer
amphiphiles undergo self-assembly in aqueous solution in
order to minimize energetically unfavourable hydro-
phobe–water interactions. The various reported morphol-
ogies are primarily a result of the inherent molecular
curvature and how this influences the packing f the
copolymer chains: specific self-assembled nanostructures
can be targeted according to a dimensionless ‘packing
parameter’, p, which is defined in Equation (1):
p ¼ v
aolc
(1)
where v is the volume of the hydrophobic chains, ao is the
optimal area of the head group, and lc is the length of the
hydrophobic tail. Therefore, the packing parameter of a
given molecule usually dictates its most likely self-
asse bled morphology. As a general rule,[5] spherical
micelles are favoured when p " 1=3, cylindrical micelles
when 1=3 " p " 1=2, and enclosed membrane structures
(vesicles, also known as polymersomes) when 1=2 " p " 1
(Figure 1).
Conventional micelles and vesicles ba ed on hydro-
philic–hydrophobic AB diblock copolymers have been
extensively reported.[6] However, a ‘Pandora’s Box’ of
possible morphologies has recently been opened because
of the remarkably diverse and growing range of block
copolymer architectures that are now available, including
Review
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E-mail: s.p.armes@sheffield.ac.uk; tony.ryan@sheffield.ac.uk
The ability of amphiphilic block copolymers to self-assemble in selective solvents has been
widely studied in academia and utilized for various commercial products. The self-assembled
polymer vesicle is at the forefront of this nanotechnological revolution with seemingly
endless possible uses, ranging from biomedical to nanometer-scale enzymatic reactors. This
review is focused on the inherent
advantages in using polymer vesicles
over their small molecule lipid
counterparts and the potential appli-
cations in biology for both drug
delivery and synthetic cellular reac-
tors.
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Figure	   1.2:	   Molecular	   packing	   factor	   and	   associated	   geometries	   of	   self-­‐assembled	  
block	  copolymers	  
Hydrophilic	  regions	  are	  represented	  in	  blue	  while	  hydrophobic	  segments	  are	  shown	  in	  
red.	   Polymersome	   representation	   is	   reproduced	   from	   LoPresti	   et	   al.,	   2009	   with	  
permission	   of	   The	   Royal	   Society	   of	   Chemistry	   (http://dx.doi.org/10.1039/B818869F).	  
Spherical	  micelle,	  cylindrical	  micelle	  and	  bilayer	  representations	  are	  courtesy	  of	  Prof.	  
Battaglia.	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we explore the latest developments in block copolymer nanoparticles 
and nanostructures formed in solution. We also look into the 
applications lined up for them, both immediate and in the near future.
Dispersed nanoparticles versus ordered 
nanostructures
Amphiphilic molecules in water are the most studied example of self-
assembling molecules in selective solvents. A selective solvent, water 
in this case, will preferentially dissolve one part of a molecule over 
another. Molecules such as natural phospholipids, detergents, and soap 
comprise both hydrophobic (water insoluble) and hydrophilic (water 
soluble) parts. The hydrophobic segments become packed together 
in aggregates as it is more entropically favorable for the hydrophobic 
parts to pack together than for water to order itself around each one 
separately in solution (this is know as the hydrophobic effect11–13). 
The hydrophilic parts, however, preferentially dissolve in water. There 
is a bigger enthalpic compensation from forming hydrogen bonds with 
water molecules than if the hydrophilic parts interacted with each 
other, leading to short range repulsion between adjacent hydrophilic 
blocks. The balance between these forces drives the formation of many 
nanostructures and mesophases14–16. 
Similarly, block copolymers can be made of hydrophilic and 
hydrophobic blocks and form similar structures in water17. Such an 
effect can be easily expanded into any selective solvent condition and 
thus, as long as the block copolymers are made of soluble and insoluble 
blocks, they can assemble into defined architectures18. 
The geometry and degree of order of these architectures depends 
on the concentration and the volume ratio between insoluble and 
soluble blocks – the insoluble soluble ratio (ISR). At very dilute 
concentrations, the soluble block compatibility with the host solvent is 
sufficient to maintain the copolymer as dissolved molecules (unimers). 
At a certain concentration called the critical aggregation concentration 
(CAC), block copolymers start to self-assemble so as to separate the 
insoluble blocks from the solvent. As the molecular mass and the ISR 
increase, the CAC decreases19. At concentrations higher than CAC, 
block copolymers self-assemble into dispersed isotropic phases. 
The structures are determined by the enforced curvature in the 
assembly arising from the relative sizes of soluble and insoluble 
domains, or from the ISR. The dimensionless packing parameter, 
p, originally developed for small amphiphiles in water14,15, can be 
generalized and used to define the relative size of the nonsoluble region 
of a copolymer20,21. The balance between solvent-phobic and solvent-
philic interactions gives rise to an optimal surface area of the solvent-
phobic block at the interface between the solvent-phobic and solvent-
philic blocks (a0). This, together with the length and the volume of 
the nonsoluble domain, contributes to the packing parameter, defined 
as14,15:
=p
v
a0d
Where v is the volume and d is the length of the solvent-phobic 
block. The packing parameter is the ratio between the insoluble chain 
molecular volume and the volume actually occupied by the copolymer 
in the assembly. As a general rule, spherical micelles are formed when 
p ≤ 1 3 , cylindrical micelles are formed at 1 3  < p ≤ ½ and membranes 
arise when ½ < p ≤ 1. As shown in Fig. 1, both cylindrical and spherical 
micelles consist of a nonsoluble core surrounded by a soluble corona. 
Fig.1 Different geometries formed by block copolymers in selective solvent conditions.
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another. Molecules such as natural phospholipids, detergents, and soap 
comprise both hydrophobic (water insoluble) and hydrophilic (water 
soluble) parts. The hydrophobic segments become packed together 
in aggregates as it is more entropically favorable for the hydrophobic 
parts to pack together than for water to order itself around each one 
separately in solution (this is know as the hydrophobic effect11–13). 
The hydrophilic parts, however, preferentially dissolve in water. There 
is a bigger enthalpic compensation from forming hydrogen bonds with 
water molecules than if the hydrophilic parts interacted with each 
other, leading to short range repulsion between adjacent hydrophilic 
blocks. The balance between these forces drives the formation of many 
nanostructures and mesophases14–16. 
Similarly, block copolymers can be made of hydrophilic and 
hydrophobic blocks and form similar structures in water17. Such an 
effect can be easily expanded into any selective solvent condition and 
thus, as long as the block copolymers are made of soluble and insoluble 
blocks, they can assemble into defined architectures18. 
The geometry and degree of order of these architectures depends 
on the concentration and the volume ratio between insoluble and 
soluble blocks – the insoluble soluble ratio (ISR). At very dilute 
concentrations, the soluble block compatibility with the host solvent is 
sufficient to maintain the copolymer as dissolved molecules (unimers). 
At a certain concentration called the critical aggregation concentration 
(CAC), block copolymers start to self-assemble so as to separate the 
insoluble blocks from the solv nt. As the molecular mass and the ISR 
increase, the CAC decreases19. At concentrations higher than CAC, 
block copolymers self-assemble into dispersed isotropic phases. 
The structures are determined by the enforced curvature in the 
assembly arising from the relative sizes of soluble and insoluble 
domains, or from the ISR. The dimensionless packing parameter, 
p, originally developed for small amphiphiles in water14,15, can be 
generalized and used to define the relative size of the nonsoluble region 
of a copolymer20,21. The balance between solvent-phobic and solvent-
philic interactions gives rise to an optimal surface area of the solvent-
phobic block at the interface between the solvent-phobic and solvent-
philic blocks (a0). This, together with the length and the volume of 
the nonsoluble domain, contributes to the packing parameter, defined 
as14,15:
=p
v
a0d
Where v is the volume and d is the length of the solvent-phobic 
block. The packing parameter is the ratio between the insoluble chain 
molecular volume and the volume actually occupied by the copolymer 
in the assembly. As a general rule, spherical micelles are formed when 
p ≤ 1 3 , cylindrical micelles are formed at 1 3  < p ≤ ½ and membranes 
arise when ½ < p ≤ 1. As shown in Fig. 1, both cylindrical and spherical 
micelles consist of a nonsoluble core surrounded by a soluble corona. 
Fig.1 Different geometries formed by block copolymers in selective solvent conditions.
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1.3.1.2 Polymersome-Cell interactions  
 
Nanoparticles are characterised by a large surface area, through which they can 
establish multiple interactions with the surrounding biomolecules and cells. Therefore, 
small changes in their physicochemical properties (i.e. size, shape, surface topology and 
charge) could strongly affect their interactions with the cell membranes. Different 
groups have been interested in studying soft nanoparticle-cell interactions and how the 
physicochemical properties of the nanoparticle influence them. The information 
gathered has proved very useful to guide the design of improved formulations.  
 
One of the most-studied parameters influencing the rate and mechanism of nanoparticle 
internalisation is nanoparticle size. Nowadays, a general agreement exists in that 
nanoparticles ≤ 100 nm in diameter tend to be internalised faster than  particles >100 
nm140,141. Alongside size, nanoparticle shape greatly impacts nanoparticle-cell 
communication. Several studies have concluded that spherical nanoparticles are more 
efficiently internalised than their rod-shaped or cylindrical counterparts across a variety 
of cell cultures19,142-145. A reason for this behaviour can be found in the fact that 
spherical particles are characterised by an aspect ratio of one, meaning that particle 
orientation has no effect on their physical interaction with the cell. Ferrari and 
Decuzzi19 found the fastest internalisation time for nanoparticles with aspect ratios close 
to one. Moreover, they observed that particles with large aspect ratios lead to 
‘‘frustrated endocytosis’’, where the particles become partially wrapped by the 
membrane but not successfully internalised. Previously, Champion and Mitragotri145 
had arrived at an interesting conclusion when studying the effect of particle shape on 
cellular internalisation. The angle created between the particle and the cell at the initial 
contact point, alongside with the volume of the particle, determines the internalisation 
efficiency. Spherical particles are characterised by a cellular contact angle of 45 
degrees. Particles with smaller angles correspond to a more elliptical morphology, with 
the smaller edge oriented towards the cell. This interaction was easily internalised by 
phagocytes. On the other hand, phagocytes were unable to internalise elongated 
particles lying parallel to the cell (contact angles larger than 45 degrees) and would 
simply spread around them. Nonetheless, studies by DeSimone group146 contradict this 
trend of less efficient internalisation at increasing aspect ratio. They found higher rates 
of endocytosis for rod-like nanoparticles compared with cubic-shaped particles, 
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highlighting the importance of particle curvature in nanoparticle cellular uptake. To our 
knowledge, there are no published studies that specifically address the effects of shape 
on the cellular polymersome internalisation. However, Discher and coworkers have 
studied the effect of nanoparticle shape in cellular uptake using block copolymer 
micelles, finding that spherical micelles and short ‘‘rod-like’’ filomicelles were taken 
up more readily by cells than highly elongated filomicelles144. 
 
The plasma membrane of mammalian cells is covered by anionic polysaccharides 
(proteoglycans), which are responsible for its negative charge147. Therefore, cationic 
nanoparticles show a stronger affinity than anionic or neutral particles towards cell 
membranes. This has driven the design of cationic nanoparticles with the aim to 
enhance cellular uptake. However, cationic formulations have been related to cytotoxic 
effects more often than their anionic and neutral counterparts. This has been 
demonstrated for a diverse range of nanoparticle formulations including 
dendrimers148,149, gold nanoparticles150 and liposomes51,151-153. Our group have studied 
the effect of surface charge on the cellular uptake of polymersomes, with similar results 
to the aforementioned formulations. Triblock copolymer poly(ethylene oxide)-poly(2-
(diisopropylamino) ethyl methacrylate)-poly(2-(dimethylamino) ethyl methacrylate) 
(PEO-PDPA-PDMA) was used to produce polymersomes displaying either the neutral 
PEO or the cationic PDMA polymer on the outer surface. We observed that 
polymersomes with cationic corona were taken up faster than neutral polymersomes by 
primary cells in culture. However, the cationic formulation induced higher cellular 
toxicity154. The mechanism by which cationic nanoparticles cause this toxicity is not 
fully understood. It has been hypothesised that particles with a high density of positive 
charge would interact with phospholipids in the plasma membrane leading to severe 
membrane damage such as poration155,156. Nevertheless, there are also examples in the 
literature where the use of cationic polymeric nanoparticles was not related to 
cytotoxicity146,157,158. Although anionic formulations are generally associated with lower 
cytotoxicity than cationic ones, their negative charge favours the interaction with 
proteins and components of the extra-cellular matrix. Strong interactions with proteins 
can destabilise nanoparticle structure, promote particle aggregation and finally hinder 
their ability to be internalised. Strong interactions of both cationic and anionic 
nanoparticles with proteins have been observed159-163.  An additional particle surface 
feature that it is revealing crucial in nanoparticle-cell interactions is the arrangement of 
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domains of defined chemistry at the nanoparticle surface164. In line with this, our 
group has investigated the formation and internalisation of polymersomes with diverse 
surface topologies by blending PMPC-PDPA, and PEO-PDPA polymersome forming 
block copolymers165,166. It was observed that different surface topologies were related to 
drastic changes in the behaviour and rate of cellular internalisation. The uptake of 100% 
PEO-PDPA polymersomes was very moderate and relatively dependent on 
polymersome size with smaller particles internalised more rapidly than large ones, 
while the internalisation of 100% PMPC-PDPA polymersomes was more efficient and 
faster (polymersomes uptaken by the cell per hour) than in the former case, and strongly 
influenced by polymersome diameter. More interesting, blended polymersomes were 
more efficiently internalised by cells than formulations with uniform surfaces, and for 
the most efficiently internalised blended formulation, the uptake rates were hardly 
affected by polymersome diameter 165,166.  
 
1.3.1.3 PMPC-PDPA polymersomes 
 
Most of the research conducted in Prof. Battaglia laboratory has been devoted to 
investigate polymersome formation, and nanoparticle intracellular delivery, using 2-
(methacryloyloxy)ethyl phosphorylcholine-block-2-(diisopropylamino)ethyl 
methacrylate diblock copolymer, resulting in the formation of colloidally-stable 
nanometre-sized PMPC-PDPA polymersomes at physiological pH167. The 
characteristics of the two polymers in this formulation provide the final nanoparticle 
with some desirable properties for a vector intended for the intracellular delivery of 
different compounds in mammalian cells. In the last decade, there has been a movement 
in biomedical sciences towards bio-mimicking. This can be translated to the 
nanotechnology field in the production of biocompatible, phospholipid-like materials.  
One of those materials is the highly hydrophilic, phosphocholine-containing vinyl 
monomer 2-(methacryloyloxy)ethyl phosphorylcholine (MPC). The clinical use of 
MPC-based macromolecules is approved by the FDA (U.S Food and Drug 
Administration). As a result, it is currently used for the coating of several medical 
devices/implants such as soft contact lenses168, cardiovascular stents169, hip replacement 
joins170, and blood pumps for implants171. While the PMPC is biocompatible, the PDPA 
is pH sensitive, which drives the self-assembly of copolymer chains (unimers) in 
solution into polymersomes when the pH overcomes the pKa value of the PDPA, ≈6.4 
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at physiological conditions172. The logarithmic expression of the acid dissociation 
constant, the pKa, indicates the pH value at which half of the acid is dissociated. In the 
case of the weak cationic polyelectrolyte PDPA, at pH < 6.4 half of the tertiary amines 
are protonated making the copolymer hydrophilic, whilst at pH ≥ 6.4 the PDPA is 
mostly deprotonated becoming hydrophobic and turning the copolymer into an 
amphiphile that self-assembles into nanovesicles (figure 1.3). This pH sensitivity allows 
polymersome formation and encapsulation of compounds with different 
hydrophilic/hydrophobic behaviour. Furthermore, it is also behind the intracellular 
disassembly of the nanovesicle and the cargo release. Figure 1.4 shows how cells 
incubated with PMPC-PDPA polymersomes encapsulating a fluorescent dye have 
become fluorescent, as the dye has been effectively released into the cell cytoplasm. On 
the other hand, when the cells were incubated with a non-pH sensitive formulation 
where the PDPA is replaced by poly(butylene glycol) (PBG) the situation was markedly 
different. The dye-loaded polymersomes were confined in membrane-enclosed 
compartments within the cell. Most likely these compartments correspond to endo-
lysosomal vesicles, since the pH-sensitive formulation encounter in them the right 
stimulus for its disassembly, a low pH. In line with this, it is important to highlight that 
taking into account the pKa value of the PDPA polymer it is likely that polymersome 
disassembly occurs early in the endo-lysosomal route, presumably at the level of the 
early endosomes (figure 1.5). This is highly desirable for the intracellular delivery of 
functional biomolecules such as therapeutic proteins that are very sensitive to acidic pH 
and the presence of degradative enzymes and therefore they would be easily inactivated 
if released in the late endosomes or the lysosomes.  
We believe that the mechanism of cytosolic release is triggered by nanoparticle 
disassembly inside the endosomes, which will produce a sudden and strong increase in 
the endosomal osmotic pressure. As an example, a standard 200 nm PMPC-PDPA 
polymersome produced in 100 mM PBS aqueous solution would be disassembled into 
1.7 x 103 copolymer chains and 5 x 105 ionic species elevating the osmotic pressure to 
2.5 kPa (1 µm3 endocytic vesicle)173. In order to compensate for the high pressure built 
up in the endosomal lumen, part of its content would be released into the cell cytoplasm 
until homeostatic conditions are reached again, all this without a permanent disruption 
of the endosomal membrane (figure 1.6).  Although speculative, the proposed 
mechanism is in agreement with a couple of validated properties of PMPC-PDPA 
polymersomes. PMPC-PDPA polymersomes have excellent intracellular delivery 
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capability in mammalian cells. As figure 1.7 shows these polymersomes can 
encapsulate, and subsequently deliver, a wide range of different fluorescent compounds 
including hydrophilic propidium iodide, hydrophobic cholesterol and amphiphilic 
ceramides174. More interestingly, PMPC-PDPA polymersomes have been shown to be 
able to deliver in vitro and in vivo molecules with a high therapeutic profile such as 
antibiotics175, anticancer compounds176, DNA173,177, and antibodies177,178. Equally 
important, we have observed that the use of this polymersome formulation as a 
intracellular delivery vector does not promote cellular toxicity or stress, as incubation 
with PMPC-PDPA polymersomes did not significantly affect the normal mitochondrial 
metabolic activity or trigger NF-κB nuclear translocation166,173.  	  
Motivated by the excellent intracellular delivery abilities of PMPC-PDPA 
polymersomes and the lack of collateral toxicity observed, the cellular interactions 
established by this nanoparticle formulation have started to be studied. As previously 
mentioned, both nanoparticle surface topology and nanoparticle size affect 
polymersome-cell interactions. We have discovered that efficiency of PMPC-PDPA 
polymersome internalisation (polymersomes/cell) is strongly influenced by nanoparticle 
size, decreasing as particle size increases. Polymersomes of 100 nm diameter were 
internalised almost 100 times better than 200 nm polymersomes and near 3 orders of 
magnitude more than 400 nm polymersomes166. The effect of different nanoparticle 
surface topologies in PMPC-PDPA polymersomes internalisation has also been 
investigated by blending this chemistry with another block of copolymers. Interestingly, 
when PMPC distribution at the surface of the vesicles is not continuous but patched the 
overall nanoparticle size is less important in the uptake rates, up to the point that for 
certain formulations the internalisation efficiency is hardly affected by the polymersome 
diameter165,166 (figure 1.8). Our knowledge about the internalisation mechanism of 
PMPC-PDPA polymersomes is limited since the particular cellular uptake pathway for 
these nanoparticles is unknown. Nonetheless, it seems that PMPC-PDPA polymersomes 
enter the cell through an endocytic route. After general inhibition of endocytosis, both, 
by pre-incubating the cells at 4Cº or with chloroquine, polymersome internalisation was 
not detected166. In addition, PMPC-PDPA polymersomes were able to enter more than 
23 different cell types tested in the laboratory, of animal and human origin, including 
primary cell types and cell lines166,  except red blood cells166, which are known for not 
undergoing endocytosis179,180. 
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Figure	  1.3:	  Arrangement	  of	  PMPC-­‐PDPA	  block	  copolymers	  in	  aqueous	  solution	  above	  
and	  below	  the	  PDPA	  pKa	  	  
Upper	  panel	   shows	   the	  chemical	   structure	  of	  both	  copolymers	  when	   the	  pH	  <	  PDPA	  
pKa,	  with	  half	  of	  the	  tertiary	  amines	  in	  the	  PDPA	  polymer	  protonated.	  At	  this	  pH	  both	  
polymers	  are	  hydrophilic	  and	  therefore	  copolymer	  chains	  are	  dissolved,	  as	  shown	  by	  
the	  TEM	  micrograph	  on	  the	  right.	  The	  bottom	  panel	  displays	  the	  situation	  when	  the	  pH	  
≥	  PDPA	  pKa.	  As	   the	  PDPA	  becomes	  hydrophobic	   the	   copolymer	   chains	   self-­‐assemble	  
into	   bilayers	   that	   finally	   round	   up	   into	   vesicles,	   easily	   recognisable	   under	   the	   TEM.	  
TEM	   micrographs	   are	   reproduced	   from	   Lomas	   et	   al.,	   2008	   with	   permission	   of	   The	  
Royal	  Society	  of	  Chemistry	  (http://dx.doi.org/10.1039/B717431D).	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Figure	  1.4:	  Release	  of	   rhodamine	  octadecyl	  ester	  perchlorate	  B	  encapsulated	   in	  pH	  
sensitive	  or	  pH	  insensitive	  polymersomes	  	  
Confocal	  micrographs	   after	   24	   hours	   incubation	   of	   human	  dermal	   fibroblasts	   (HDFs)	  
with	   either	   pH	   sensitive	   PMPC-­‐PDPA	   polymersomes	   encapsulating	   a	   red	   fluorescent	  
dye	   a),	   or	   pH	   insensitive	   PEG-­‐PBG	   polymersomes	   encapsulating	   the	   same	   dye	   b).	  	  
Green	  channel:	  DNA	  staining	  SYTO®9.	  Reproduced	  with	  permission	  from	  Massignani	  et	  
al.,	   2009	   (http://dx.doi.org/10.1002/smll.200900578).	   KGaA	   Copyright	   Wiley-­‐VCH	  
Verlag	  GmbH	  &	  Co.	  KGaA.	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Figure	  1.5:	  Subcellular	  vesicular	   trafficking	  compartments,	  alongside	  their	   ionic	  and	  
enzymatic	  composition	  	  
Reproduced	  from	  Canton	  and	  Battaglia	  2012	  with	  permission	  of	  The	  Royal	  Society	  of	  
Chemistry	  (http://dx.doi.org/10.1039/C2CS15309B).	  	  
This journal is c The Royal Society of Chemistry 2012 Chem. Soc. Rev., 2012, 41, 2718–2739 2725
phosphoinositides and phosphatidylinositol-4,5-bisphosphate inter-
act with dynamin PH domains, triggering GTPase activity.126–128
In vitro studies using artificial phospholipid membranes also
showed that given the right mixture of phospholipids, phase
separation drives spontaneous fission129–132 as well as tubul-
ation.133,134 Regardless the mechanism of dynamin–membrane
interaction, both GTP driven protein conformational changes as
well as the right membrane composition are critical to drive the
vesicle severing.
Dynamin is involved in most endocytic pathways.67 However,
inhibition studies have demonstrated that both CDC42135 and
ARF6136 mediated endocytosis can occur without dynamin.
Both ARF6 and CDC42 are linked to tubular-like deformations
in the membrane, whereas vesicular-like deformations are often
dynamin dependant. It might be that the vesicular morphologies
require dynamin to a different extent than the tubular
morphologies.
2.2.3. Endocytic compartments. Following the complete
detachment from the plasma membrane, the resulting vesicle,
referred to as pinosome for macropinocytosis, phagosome for
phagocytosis, and trafficking vesicle (TV) for the other mechan-
isms, delivers its cargo to other subcellular compartments137,138
(see Fig. 7). The endocytic pathway is a spatiotemporal succes-
sion of different compartments, which continuously interchange
their content while undergoing structural transformation and
functional makeover. Such a dynamic nature makes its inter-
pretation extremely difficult. Several hypotheses have been
proposed to explain how the material is transported from one
endocytic compartment to another.139–142 For many years it was
thought that the internalised material is transported from one
compartment to another via a maturation process; with the first
step being the early endosome (EE), gradually maturing into a
late endosome (LE) and eventually a lysosome.143 However,
such model is no longer able to explain how most of the
endocytic compartments are recyclable and unique in nature.
Experiments in cell-free conditions showed that endosomes
and lysosomes could communicate via the exchange of small
vesicles.144 Other experiments have shown a continuous cycle of
temporary fusion between endosomes and lysosomes (kiss-and-
run theory).140,145 Researchers have also shown the complete
fusion between endosome and lysosomes, leading to a hybrid
compartment from which a lysosome buds out (fusion–fission
model).146,147 Live cell correlated light electron microscopy has
demonstrated a more complex and dynamic mechanism, where
the combination of coupling and direct fusion events lead to the
mixing of endosomes and lysosomes content.148 Even more
complex is the actual distinction between EEs and LEs, where
the molecular composition does not necessarily match the
organelle morphology.149 Very likely, the real scenario involves
the combination of all these above mechanisms in a succession
and synergy yet to be discovered.
As discussed above, each entry mechanism is related to a
specific cellular function. For example, material that is inter-
nalised by phagocytosis involves large volumes of membrane
and requires prompt and effective processing. The resulting
phagosomes by-pass the EEs and are directly fused with
lysosomes to accelerate the degradative process.107,108 All the
other entry mechanisms regulate cargo degradation as well as
receptor recycling. The internalised material is therefore trans-
ported to coordinating stations, where it is sorted depending
on whether it needs degradation or recycling back to the
plasma membrane. In caveolae-mediated endocytosis, the
resulting trafficking vesicle fuses with a compartment known
as caveosome (Fig. 1).150,151 This caveolin-1 rich organelle, in
contrast with all other types of endocytic compartments, has a
lumen with a neutral pH and lacks of the usual endosomal
markers.150,151 There, the material is further sorted to the EE
or to the trans-Golgi network (TGN).152 Such a non-acidic
intermediate step suggests also the association of caveolae-
mediated endocytosis, with endothelial cell transcytosis (see the
following section). Similarly, in ARF6, flotillin and CDC42
endocytosis the vesicles are first delivered to a GPI-AP enriched
early endosomal compartment (GEEC) where GPI-APs are
quickly recycled back to the plasma membrane (Fig. 1).153 As
for the other entry mechanisms, the vesicles are delivered
within 1 to 5 min into the early endosomes (EE). These are
pleomorphic compartments that comprise cisternae regions
with slender tubules (ca. 60–80 nm diameter) and large vesicles
(ca. 300–400 nm diameter). The latter ones are multivesicular in
nature with membrane invaginations either free in the lumen or
detaching from the limiting membrane. The EEs are responsible
of: (i) ensuring that housekeeping receptors are recycled back to
the plasma membrane (directly or indirectly via recycling
endosome); (ii) sorting material toward the TGN; and (iii)
shuttling receptors and internalised materials that require
downregulation/degradation to the LE. EEs are rich in GTPase
Rab5, phosphoinositide 3-kinase (PI3K) and phosphatidyl-
inositol-3-phosphate, indispensable for its physiological
function.154–156 The EE structure is directly correlated to its
function. The tubules regulate communication with the TGN
and the recycling endosome, as well as the entry of the trafficking
vesicles. However, the multivesicular parts lead to the formation
of multivesicular bodies (MVB). Endosomal membrane arrange-
ments are regulated by the ‘‘endosomal-sorting complex
Fig. 7 Schematics of the different endocytic compartments from
trafficking vesicle to early endosome, to multivesicular bodies, to late
endosome to lysosome. The time141 that the endocytosed material
tak s from its entry t each organelle is plotted alongside the organelle
internal pH, protease and several ions concentration.137
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Figure	  1.6:	  Proposed	  mechanism	  of	  endosomal	  escape,	  and	  polymersome-­‐mediated	  
cytosolic	  delivery,	  for	  PMPC-­‐PDPA	  polymersomes.	  	  
Adapted	  from	  LoPresti	  et	  al.,	  2009	  with	  permission	  of	  The	  Royal	  Society	  of	  Chemistry	  
(http://dx.doi.org/10.1039/B818869F).	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Figure	  1.7:	  PMPC-­‐PDPA	  mediated	  intracellular	  delivery	  of	  compounds	  with	  different	  
hydrophilic	  profiles	  	  
Reproduced	  from	  Massignani	  et	  al.,	  2010.	  	  
  
Effective Probes Delivery
PLoS ONE | www.plosone.org 4 May 2010 | Volume 5 | Issue 5 | e10459
Effective Probes Delivery
PLoS ONE | www.plosone.org 4 May 2010 | Volume 5 | Issue 5 | e10459
Effective Probes Delivery
PLoS ONE | www.plosone.org 4 May 2010 | Volume 5 | Issue 5 | e10459
a 
b 
c 
	   51	  
	  
Figure	  1.8:	  Effect	  of	  polymersome	  size	  (diameter)	  and	  polymersome	  surface	  topology	  
in	  PMPC-­‐PDPA	  polymersome	  internalisation	  	  
Polymersomes	   internalised	   per	   cell	   (HDFs)	   after	   24	   hours	   incubation	   with:	   a)	   100%	  
PMPC-­‐PDPA	   polymersomes	   b)	   75%	   PMPC-­‐PDPA	   25%	   PEG-­‐PDPA	   c)	   50%	   PMPC-­‐PDPA	  
50%	  PEG-­‐PDPA	  and	  d)	  25%	  PMPC-­‐PDPA	  75%	  PEG-­‐PDPA.	  Reproduced	  with	  permission	  
from	   Massignani	   et	   al.,	   2009	   (http://dx.doi.org/10.1002/smll.200900578).	   Copyright	  
Wiley-­‐VCH	  Verlag	  GmbH	  &	  Co.	  KGaA.	  
Controlling Cellular Uptake at the Nanoscale
Figure 4. TEMimagesshowingbothselectivestainingof thePMPCchainsatdifferentPMPC/PEGmolar ratiosandalsocelluptakeafter24 hincubation
asa functionof thepolymersomediameter.BinarymixturesofPMPC–PDPAandPEG–PDPAcopolymers formhybridpolymersomesthatdisplaysurface
domains due to microphase segregation. TEM images were analyzed using FFT filtering to minimize background noise. The resulting images are
displayedingrayscaleandusingacolorgradientsoastohighlight thenanoscaledomainsonthepolymersomesurface.a)TEManalysisofPMPC–PDPA
polymersomes.b)Numberofpolymersomes internalizedpercell after incubationofHDFcells for24 hwithPMPC–PDPApolymersomesasa functionof
polymersome dimensions. c) TEM analysis of 75:25 PMPC–PDPA/PEG–PDPA polymersomes. d) Number of polymersomes internalized per cell after
incubationofHDFcells for24 hwith75:25 PMPC–PDPA/PEG–PDPApolymersomesasa functionofpolymersomesize.e) TEManalysisof50:50PMPC–
PDPA/PEG–PDPApolymersomes. f)Numberofpolymersomes internalizedper cell after incubationofHDFcells for24 hwith50:50 PMPC–PDPA/PEG–
PDPApolymersomesasafunctionofpolymersomesize.g)TEManalysisof25:75PMPC–PDPA/PEG–PDPApolymersomes.h)Numberofpolymersomes
internalizedper cell after incubationofHDFcells for 24 hwith25:75 PMPC–PDPA/PEG–PDPApolymersomesasa functionofpolymersomesize. i) TEM
analysisof PEG–PDPApolymersomes. j)NumberofPEG–PDPApolymersomes internalizedpercell after incubationofHDFcells for24 hasa functionof
polymersome size. Scale bar¼ 50nm; error bar¼" standard deviation (n¼ 3).
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Chapter 2: Aim and objectives 
 
This thesis aims to elucidate and characterise the cellular internalisation mechanism, in 
mammalian cells, of PMPC-PDPA polymersomes developed in the group of Prof. 
Battaglia (Department of Chemistry, UCL; previously based in the Department of 
Biomedical Science, The University of Sheffield). According to the results reviewed in 
the previous chapter, PMPC-PDPA polymersomes have great potential as intracellular 
delivery vectors for a wide range of drugs and diagnostic compounds. The ultimate role 
of such vectors is to be internalised by the cells in order to deliver the encapsulated 
cargo at the appropriate subcellular compartment. Therefore, characterising nanovector-
cell interactions and nanoparticle internalisation becomes a crucial step in effective 
pharmacokinetics.  
 
Motivated by the early data obtained in our laboratory in the cellular uptake of PMPC-
PDPA polymersomes, the internalisation of the nanoparticles will be investigated from 
two complementary approaches. On one hand, the physicochemical properties of these 
polymersomes will be studied in relation with their ability to influence their own 
uptake. On the other hand, it is our objective to identify the cellular factors assisting 
nanoparticle internalisation.  
As previously presented, the size of the nanoparticles along with the surface chemistry, 
influences the cellular uptake of polymersomes. Subsequently, we hypothesise that the 
surface chemistry of the nanoparticle controls the binding to the cell surface. Once this 
binding is formed, there must be an optimal particle size in order to induce cell 
membrane deformation and polymersome endocytosis, in cooperation with the 
endocytic cellular machinery. In order to test this hypothesis the following points will 
be addressed:  
 
a) Identification of the cellular receptors or plasma membrane components 
mediating PMPC-PDPA polymersome binding to the plasma membrane. 
b) Further investigation of the effect that the nanoparticle size has in PMPC-PDPA 
polymersome uptake. Identification of the optimal size for the endocytosis of 
this formulation.  
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c) Examination of the influence that polymersome shape has in PMPC-PDPA 
polymersome internalisation. Studies in spherical and tubular PMPC-PDPA 
polymersomes.  
d) Identification of the intracellular cell factors mediating PMPC-PDPA 
endocytosis, with special attention to the involvement of endocytic molecules 
able to sense or induce membrane curvature, or to mediated detachment of 
invaginated vesicles from the cell surface, such as dynamin, actin and BAR 
domain proteins.  
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Chapter 3: Materials and Methods 
 
Unless otherwise specified all chemicals used were acquired from Sigma-Aldrich® and 
all the antibodies were purchased from Abcam. Polystyrene tissue cultured treated 24 
well plates and 6 well plates were purchased from Corning® Costar®. Tissue culture 
treated µ-dishes for high-resolution microscopy were obtained from Ibidi® (80136) and 
flat bottom 96 well plates for fluorescence microscopy from Greiner bio-one. PBS 
tablets were acquired from Oxoid (Thermo Scientific), and diluted in ultrapure water 
(Milli-Q® Integral Water Purification System, Merck Millipore) to prepare 100 mM 
PBS solution (pH 7.4).  
 
3.1 PMPC-PDPA polymersomes  
 
3.1.1 Polymersome preparation 
 
3.1.1.1 Copolymers 
 
 2-(Methacryloyloxy)ethyl phosphorylcholine (MPC) polymer was kindly donated by 
Biocompatibles UK Ltd. 2-(Diisopropylamino)ethyl methacrylate (DPA) polymer was 
purchased from Scientific Polymer Products, Inc.  
 
PMPCx-PDPAy and rhodamine 6G-labelled PMPCx-PDPAy (rho-PMPC-PDPA) 
copolymers were synthesized and kindly donated by Dr. J. Madsen and Dr. N. Warren 
in Prof. S. Armes group (Department of Chemistry, The University of Sheffield) and 
Dr. J. Gaitzsch from Prof. G. Battaglia group. The degree of polymerisation was 25 (x) 
and 62-70 (y) for PMPC-PDPA copolymers, depending on the batch, while a standard 
copolymer chain of rho-PMPC-PDPA was composed by 25 MPC monomers and 70 
DPA monomers. PMPC25-PDPA62-70 and rho-PMPC25-PDPA70 will be referred as 
PMPC-PDPA and rho-PMPC-PDPA in this thesis.  
PMPC-PDPA copolymers were obtained either by atom transfer radical polymerisation 
(ATRP)167 or by reversible addition fragmentation chain transfer polymerization181,182 
as previously described, whereas rho-PMPC-PDPA was always prepared by ATRP183. 
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Table	  3.1:	  Chemical	  composition	  of	  PMPC25-­‐PDPA70	  and	  rhodamine-­‐PMPC25-­‐
PDPA70	  copolymers	  	  Chemical	   structures	   and	   molecular	   weights,	   obtained	   by	   nuclear	   magnetic	  resonance,	  for	  two	  representative	  batches	  of	  block	  copolymers	  used	  on	  this	  thesis.	  	  
 
3.1.1.2 Methods of polymersome production 
 
Both unlabelled PMPC-PDPA and rhodamine-labelled PMPC-PDPA polymersomes 
were prepared and used in this thesis. When rhodamine-labelled polymersomes were 
required, they were produced by addition of 10 % (wt/wt) rho-PMPC-PDPA copolymer 
(equivalent to approx. 10% molar ratio) to already weighed PMPC-PDPA copolymer, 
unless otherwise specified.  
 
3.1.1.2.1 pH switch method 
 
3.1.1.2.1.1 Manual increase of the pH  
 
PMPC-PDPA and rho-PMPC-PDPA copolymers (if needed) were weighed in a glass 
vial and dissolved in a 2:1 mixture of analytical purity grade chloroform/methanol 
(Fisher Scientific) at a concentration of 3 mg/ml. The solvent mixture was evaporated in 
a vacuum oven at 60°C overnight, resulting in the formation of a copolymer film in the 
walls of the vial. The film was rehydrated using sterile PBS at pH 2 to give an acidic 10 
mg/ml polymer solution. The solution was then filtered into sterile vials using 0.2 µm 
- PMPC-PDPA Rho-PMPC-PDPA 
Structure 
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polyethersulfone filters (Minisart®, Sartorious). Polymersomes were formed at room 
temperature, by increasing the pH over the pKa of the DPA polymer (aprox.6.4) to a 
final pH of 7.4. This was done by manual dropwise addition of 1 M NaOH, mixing the 
solution by vortexing for 1 minute after every addition of NaOH. The polymersome 
dispersion obtained was finally sonicated for 30 minutes (Sonicor Instrument 
Corporation). Polymersome dispersion was characterised in terms of polymer 
concentration and polymersome size and shape, and stored at 4°C.  
 
3.1.1.2.1.2 Programmed increase of the pH  
 
PMPC-PDPA and rho-PMPC-PDPA copolymers (if needed) were weighed in a glass 
vial and dissolved in a 2:1 mixture of analytical purity grade chloroform/methanol 
(Fisher Scientific) at a concentration of 3 mg/ml. The solvent mixture was evaporated in 
a vacuum oven at 60°C overnight, resulting in the formation of a copolymer film in the 
walls of the vial. The film was rehydrated using sterile PBS at pH 2. The solution was 
then filtered into sterile vials using 0.2 µm polyethersulfone filters (Minisart®, 
Sartorious). Polymersomes were formed between 25-27°C, by increasing the pH over 
the pKa of the DPA polymer (aprox.6.4) to a final pH of 7.4. This was done with the 
help of a water bath and a heater/stirrer plate to monitor and control the temperature. In 
addition a LAMBDA VIT-FIT syringe pump (LAMBDA Laboratory Instruments) was 
programmed to standardise the dropwise addition of 0.5 M NaOH, to the polymer 
solution under continuous stirring. The polymersome dispersion obtained was finally 
sonicated for 30 minutes (Sonicor Instrument Corporation). Polymersome dispersion 
was characterised in terms of polymer concentration and polymersome size and shape, 
and stored at 4°C.  
 
3.1.1.2.2 Film rehydration method 
 
Tubular polymersomes used in chapter 4 were prepared by J. D. Robertson using the 
following method.  PMPC-PDPA and rho-PMPC-PDPA copolymers were dissolved in 
a 2:1 mixture of analytical purity grade chloroform/methanol (Fisher Scientific). The 
solution was subsequently filtered into a sterile glass vial using a 0.2 µm nylon filter 
(GE Healthcare). A sterilised 0.2µm membrane filter (Millipore) was placed and 
secured at the top of the vial to allow solvent evaporation, while preserving sterile 
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conditions inside the vial. The solvent mixture was consequently evaporated in a 
desiccator overnight. The resulting polymer film was rehydrated under stirring 
conditions for 4 weeks in sterile PBS (pH 7.4) for a final polymer concentration of 10 
mg/ml. The resultant nanoparticle dispersion was sonicated for 20 minutes at room 
temperature (Sonicor Instrument Corporation). Polymersome dispersion was 
characterised in terms of polymer concentration and polymersomes size and shape, and 
stored at 4°C.  
 
3.1.2 Polymersome purification 
 
3.1.2.1 Gel Permeation Chromatography 
 
Bulk polymersome dispersion, obtained by pH switch, was centrifuged at 500 RCF 
(rotational centrifugal force) in a 5424 microcentrifuge (Eppendorf). The resulting pellet 
was concentrated to 0.5 ml with the help of a sterilised hollow fiber module with 20 nm 
pores (MicroKros® Filter Modules   X1-500S-200-04P, Spectrum Laboratories, Inc.)  
The 0.5 µL polymersome dispersion was immediately placed on top of a size-exclusion 
column packed with sterile Sepharose 4B in endotoxin free PBS (pH 7.4), which was 
also used to elute the polymersomes. Nanoparticles were collected in sterile 96 well 
plates (2 drops/well) as they came out for the column. The content of each well was 
characterised in terms of nanoparticle size by dynamic light scattering (DLS). 
According to DLS measurements, wells containing nanoparticles of similar sizes were 
mixed and further characterised by DLS, transmission electron microscope 105 and UV-
Vis spectroscopy. Fractions of interest were stored at 10 mg/ml at 4°C.  
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3.1.2.2 Polymersome purification by centrifugation at increasing Relative 
Centrifugal Force 
 
3.1.2.2.1 Purification of spherical nanoparticles  
 
Bulk polymersome dispersion obtained by pH switch was circulated through a 
previously sterilised hollow fiber module with 50 nm pores using a KrosFlo® Research 
IIi Tangential Flow Filtration System (Spectrum Laboratories, Inc.) in order to remove 
the micelles from the dispersion (referred as fraction 6 in internalisation studies). The 
resulting dispersion was exposed to successive 20 minutes cycles of centrifugation at 
room temperature and increasing RCF in a 5424 microcentrifuge (eppendorf) to 
separate it into different fractions, each of them enriched in spherical nanoparticles 
within a specific nanometer-size range. The bulk dispersion was first centrifuged at 
2,000 RCF to pellet down any aggregates or big particles above the nm range. The 
remaining supernatant was then centrifuged at 5,000 RCF, the resulting pellet was 
resuspended in PBS and the sample was characterised in terms of nanoparticle size and 
shape and polymer concentration by DLS, TEM and UV-Vis spectroscopy, respectively. 
Characterised sample was stored at 4°C for subsequent internalisation experiments 
(fraction 1). The next centrifugation cycle was carried on the residual supernatant from 
the previous cycle, this time at 10,000 RCF. Pellet was processed as before (fraction 2) 
and the supernatant was centrifuged at 15,000 RCF. Pellet was resuspended, 
characterised and stored (fraction 3) while the supernatant was finally centrifuged at 
20,000 RCF. The resuspended pellet and the supernatant were characterised and stored 
as before (fraction 4 and fraction 5 respectively).  
 
3.1.2.2.2. Purification of tubular nanoparticles 
 
To isolate tubular polymersomes, of the desired diameter and length, from the bulk 
dispersion obtained after the rehydration method, the dispersion was centrifuged at 
2,000 RCF for 20 minutes. The remaining supernatant was then centrifuged at 15,000 
RCF for another 20 minutes. The resuspended pellet was characterised in the same way 
as described above and storage at 4°C for subsequent studies. 
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3.1.3 Polymersome physical characterisation 
 
3.1.3.1 Polymer concentration, UV-Vis Spectroscopy 
 
Polymersome samples were diluted in acidified PBS (standard PBS pH 7.4 acidified to 
pH 2 by dropwise adition of HCL 1M) to produce the disassembly of the nanoparticles 
into block copolymer chains. UV-Vis absorbance for each sample was measured in a 
Jasco UV-Vis V-630 Spectrophotometer between 190 nm and 600 nm, at a 400 nm/min 
scan speed, using a 10 mm quartz cuvette. Acidified PBS (pH 2) was used as a blank.  
Absorbance values at 540 nm (maximum absorbance for rho-PMPC-PDPA) and 217 
nm (maximum absorbance for PMPC-PDPA) were used to calculate total polymer 
concentration using equations 3.1 and 3.2, which were derived from Lambert-Beer’s 
Law (equation 2). 
Equation 2   
Where A is the absorption, ε is the molar extinction coefficient (M . cm)-1, l is the path 
length of the cuvette in which the sample is contained (cm) and C is the concentration 
of the sample (M). 
On this thesis we used the following modification of the formula in 2 (equation 3): 
Equation 3  
Where l was not represented since it is a constant value equal to 1 cm. C was measured 
in mg/ml and ε was measured in ml/mg (mass absorption coefficient). 
Mass absorption coefficients (ε) are specific for a polymer at an individual wavelength, 
and were extracted from the standard curves calculated for each polymer batch (figure 
3.1).  
Equation 3.1   
 
Equation 3.2   
 
NL refers to non-labelled polymer (PMPC-PDPA) and L refers to labelled polymer 
(rho-PMPC-PDPA). At 217 nm the final absorbance is influenced by the absorbance 
values of both labelled and unlabelled copolymers, while at 540 nm the final absorbance 
only depends on the rho-labelled polymer.  
ClA ⋅⋅= ε
A = ! !C
A217nm = A217nmNL + A217nmL = !217nmNL !cNL +!217nmL !cL
A540nm = A540nmL = !540nmL !cL
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Figure	   3.1:	   Absorption	   spectrums	   and	   standard	   curves	   for	   PMPC-­‐PDPA	   and	  
rhodamine	  6G-­‐PMPC-­‐PDPA	  block	  copolymers	  
a)	   Examples	  of	   absorption	   spectra,	   in	   aqueous	   solution	  at	  pH	  2,	   for	   rho-­‐PMPC-­‐PDPA	  
and	  PMPC-­‐PDPA	  copolymers	  synthetised	  by	  ARTP	  or	  by	  RAFT.	  PBS	  pH	  2	  was	  used	  as	  
blank.	  Vertical	  dashed	  lines	  at	  217	  nm	  and	  540	  nm	  represent	  absorbance	  maxima	  for	  
PMPC-­‐PDPA	   and	   rho-­‐PMPC-­‐PDPA	   copolymers.	   b)	   Examples	   of	   standard	   curves	  
produced	   for	  PMPC-­‐PDPA	  (at	  217	  nm)	  and	  rho-­‐PMPC-­‐PDPA	  (at	  217	  nm	  and	  540	  nm)	  
copolymers.	  The	  equations	   for	   the	   regression	   lines	  are	  embedded	  on	   the	  graph.	  n=3	  
experiments.	  Error	  bars:	  ±	  SD.	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3.1.3.2 Size and shape characterisation 
 
3.1.3.2.1 Dynamic Light Scattering  
 
Diluted polymersome samples in filtered PBS (pH 7.4) were placed in 1 ml polystyrene 
disposable cuvettes (Fisherbrand®) and their size distribution was measured in a 
Zetasizer Nano ZS (Malvern) at 25°C and at a scattering angle of 173°, using a 4mW 
He-Ne laser at 633 nm. Each sample was measured three times with a cycle consisting 
of 12-14 subcycles of 10 seconds duration each. Particle-size distributions were 
automatically provided by the Zetasizer.  
 
3.1.3.2.2 Transmission Electron Microscope 
 
Carbon-coated copper/palladium square mesh grids (Agar Scientific) were glow 
discharged by applying plasma to their surfaces for 30-40 seconds in a partly evacuated 
chamber. This procedure rendered their surfaces hydrophilic, facilitating the adsorption 
of aqueous nanoparticle suspensions. Subsequently, glow-discharged grids were treated 
with 5 µL of polymersomes dispersion (0.1 to 1 mg/ml) for 1 minute.  Excess of 
dispersion was blotted away with filter paper and grids were consecutively positively 
stained with a 0.75 % (wt/v) phosphotungstic acid solution in ultrapure water (pH 7) for 
5 seconds. Finally, grids were blotted with filter paper and dried using a vacuum 
system. Stained grids were imaged in a FEI Tecnai G2 Spirit electron microscope 
equipped with a high resolution Orius® CCD camera. Image analysis was performed 
using Gatan Digital Micrograph and Image J software packages. 
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3.2 Cell culture 
 
3.2.1 Mammalian cells 
 
Primary human dermofibroblasts (HDF), FaDu, HeLa, LADMAC and I-11.15 
macrophages were purchased from the American Type Culture Collection (Manassas, 
VA, USA). The hepatocyte-derived cellular carcinoma cell line Huh7 was a kind gift 
from Prof. J. McKeating (The University of Birmingham).  
FaDu, HeLa and HDF were cultured in Dulbecco's modiﬁed Eagle's medium (DMEM) 
supplemented with 10 % (v/v) fetal calf serum (FCS, Biosera), 2 mM L-glutamine, 100 
IU/ml penicillin, 100 mg/ml streptomycin, and 0.625 mg/ml amphotericin B. In the case 
of Huh7 cells the above media formulation was supplemented with 1 % (v/v) non-
essential amino acids and amphotericin B was not added to the media.  LADMAC were 
cultured in Eagle's minimal essential medium (EMEM) supplemented with 10 % (v/v) 
FCS and 2 mM L-glutamine. 20 % (v/v) of LADMAC conditioned medium together 
with 10 % (v/v) FCS and 2 mM L-glutamine was used to supplement DMEM medium 
for the culture of I-11.15 macrophages.  
 
Adherent FaDu, HeLa, HDF and Huh7 cells were detached using trypsin-EDTA and 
subcultured at ratios 1:5 to 1:10, 2 to 3 times per week. HDF were used for 
experimentation between passages 2-6 while HeLa, FaDu and Huh7 cells were used 
between passages 2-10. Before subculture, LADMAC cells were brought to suspension 
by tapping the sides of the flask. On the other hand, macrophages were gently detached 
with the help of a cell scraper.  
 
3.2.2 Insect cells 
  
Drosophila S2R+ cells supplied by the Sheffield RNAi Screening Facility (SRSF) were 
cultured in Schneider’s Drosophila medium (Gibco®, life technologiesTM) supplemented 
with 10 % (v/v) FCS and 1 % (v/v) penicillin/streptomycin, in a CO2-free incubator at 
25 °C. Cells were subcultured at a 1:4 ratio every 3 days. In order to do that, semi-
adherent cells were helped to come in suspension by carefully banging the culture flask 
and pipetting up and down the cellular suspension to separate cellular clumps.  
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3.3 Biological experimental procedures  
 
Incubation with PMPC-PDPA nanoparticle was always normalised by amount of 
polymer added per well, and concentration of polymer per well. Unlabelled or 10 % 
(wt/wt) rhodamine-labelled nanoparticles were normally diluted 10 times in media as 
they were added to the well or dish containing the cells. Cellular treatment, in terms of 
polymer concentration per well, ranged from 0.1 to 1 mg/ml depending on the 
experiment.  
 
3.3.1 Detection and analysis techniques  
 
3.3.1.1 Flow cytometry 
 
3.3.1.1.1 Relative quantification of polymersome internalisation 
 
Processing and evaluation of cellular samples  
 
Live cells were analysed by flow cytometry in order to determine relative polymersome 
internalisation were processed as follows: media was aspirated from the wells and cells 
were thoroughly washed with ice-cold PBS twice. Cells were then detached according 
to cell type (see page 63) and spun down at 153 RCF for 5 minutes. Cell pellets were 
carefully resuspended in ice-cold PBS (300-400 µL/pellet) and analysed either in a 
FacsArray (BD Biosciences) using a 532 nm laser and a 585-642 nm filter to record the 
red fluorescence emitted, or in a FacsAria analyser (BD Biosciences) using a 488 nm 
laser and a 575-626 nm filter. 10,000 cells were measured per sample.   
 
Data analysis 
 
The median fluorescence intensity (MFI) value, obtained from the viable cell population 
for each condition, was normalised against (divided by) the MFI value of the negative 
control (cells that were treated only with PBS, or the main diluent used in the 
experiment). A value of 1 was subsequently subtracted from the normalised data so that 
untreated cells are always represented by 0 normalised intensity ratios (a.u.).  
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In order to compare nanoparticle uptake under different conditions, or in the presence of 
diverse agents, data was represented as % of normalised intensity ratios. In this case the 
normalised intensity ratio for the positive control (cells treated only with 
polymersomes) was set to represent 100% uptake. The % of uptake for the rest of the 
conditions was calculated based on this. 
 
In addition to MFI values, the percentage of fluorescent cells retrieved by the flow 
cytometer, at a certain time point or under a specific condition, was also used to 
investigate polymersome uptake. The percentage of fluorescent cells in the negative 
control (typically a low value between 0.3-1 %) was deducted from the % of fluorescent 
cells in each condition under study.   
 
3.3.1.1.1.1 Titration of polymersomes uptake in mammalian cells 
  
To titrate the cellular response, in terms of cellular uptake, to different concentrations of 
polymersomes, FaDu cells were seeded in 24 well plates and allowed to grow for one 
day before incubating them with increasing concentrations of rhodamine-labelled 
polymersome dispersion (0.1-1 mg/ml) during 90 minutes. Afterwards, cells were 
processed for flow cytometry as described above. 
 
3.3.1.1.1.2 Uptake of polymersomes in serum+ vs. serum- conditions 
 
In order to investigate the effect that the presence of serum in the media has during the 
uptake of polymersomes different cells types were pre-incubated in serum free media or 
media with serum for 30 minutes. Afterwards rhodamine-labelled polymersomes were 
added to the cells for a final concentration of 1mg/ml polymer per well and incubation 
was maintained for 1 hour. Subsequently, cells were processed for flow cytometry as 
described above. MFI values associated with the cells and % of fluorescent cells were 
recorded and analysed.  
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3.3.1.1.1.3 Uptake kinetics of spherical nanoparticles with different sizes and tubular 
polymersomes  
 
FaDu cells were seeded in 24 well plates and allowed to grow for one day. The next day 
the cells were incubated, for different time points up to 24 hours, with 0.1 mg/ml (final 
concentration per well) rhodamine-labelled spherical polymersomes of diverse 
diameters, micelles or tubular polymersomes.  
 
In order to relate MFI values obtained by flow cytometry to the relative number of 
particles internalised, MFI values were normalised to mass of polymer per particle, in 
addition to the standard normalisation against the negative control described above. 
This specific value for each incubation condition was obtained by dividing the mass of 
polymer that the cells were treated with, by the number of particles that the cells were 
treated with. The number of particles was calculated based on the molecular weight of 
the copolymer, the number of polymer chains per particle, and the nanoparticle size 
distribution obtained by DLS in the case of spherical nanoparticles, or by manual 
analysis of multiple TEM micrographs, using ImageJ software in the case of tubular 
polymersomes. 
 
3.3.1.1.2 Immunolabeling of surface receptors 
 
Cells were harvested from T75 flasks using a 0.02% EDTA solution, and gently 
scraping when appropriate. Detached cells were pelleted at 106 RCF and 4°C for 5 
minutes, and resuspended in ice-cold 3% bovine serum albumin (BSA) in PBS 
(blocking buffer) at a cell density of 1x105
 
cells/aliquot. Cells were then incubated with 
3 µg (equivalent to 0.03 mg/ml) of anti SR-BI184 (PF-71, provided and used with the 
consent of Prof. McKeating at The University of Birmingham) or anti CD36 (ab80080), 
or 0.1 µg (equivalent to 0.006 mg/ml) of anti CD81184 (kindly donated by Prof. 
McKeating) for 30 minutes at 4°C. After washing off unbound primary antibody cells 
were incubated with fluorescently-labelled secondary antibody diluted in blocking 
buffer (ab97170 and ab6954 at 1:100 or ab97035 1:500) for another 30 minutes at 4°C. 
Finally, cells were washed to remove unbound secondary antibody and processed for 
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flow cytometry. Cells not treated with antibodies and cells treated only with secondary 
antibodies were used as controls. 
	  
3.3.1.2 Fluorescence microscopy 
 
Fluorescent micrographs were processed using either ImageJ on-line free software or 
Volocity 3D image analysis software (PerkinElmer). 
 
3.3.1.2.1 Polymersome internalisation 
 
3.3.1.2.1.1 Uptake of polymersomes at 37°C vs. 4°C 
 
Subconfluent HDF growing in 96 well plates were treated with 14 µg/ml (concentration 
per well) of Hoechst staining solution (InvitrogenTM, Life TechnologiesTM) for 20 
minutes. Subsequently cells were washed twice with PBS and they were either placed 
on the fridge at 4°C or in an incubator at 37°C for 15 minutes. Rhodamine-labelled 
polymersomes were then added to the cells (1 mg/ml per well) and incubation was 
maintained at either temperature for another 20 minutes. Finally, media was aspirated 
and cells were thoroughly washed 3 times using PBS. Live cells in culture media 
without phenol red were imaged in a Zeiss LSM510 Meta inverted confocal microscope 
using a 561 nm laser, a 575-615 nm filter to record the red fluorescence emitted and a 
40X water immersion lens.  
 
3.3.1.2.1.2 Internalisation of spherical polymersomes 
 
FaDu cells were seeded in a 96 well plate 24 hours prior to incubation with 0.5 mg/ml 
(concentration per well) rhodamine-labelled polymersomes for different time points up 
to 1 hour. Media was aspirated; cells were washed with PBS and left in culture media 
without phenol red for subsequent imaging. Live cells were imaged in a BD Pathway 
855 spinning disk confocal (BD biosciences) using a 20X lens. 
 
3.3.1.2.1.3 Internalisation of tubular polymersomes 
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FaDu cells were seeded in Ibidi® µ-dishes for fluorescence microscopy 24 hours to prior 
experimentation. On the following day, cells were incubated with 0.1 mg/ml (final 
concentration per dish) of 30 % (wt/wt) rhodamine-labelled tubular polymersomes for 
either 5 or 9 hours. Media was removed and cells were thoroughly washed with PBS. Z-
stacks of the cells were acquired in a Perkin-Elmer UltraVIEW VoX spinning disk 
confocal system running on an Olympus IX81 motorized microscope. A 514 nm laser 
and a 40X oil immersion lens were used to image the cells.  
 
3.3.1.2.2 Polymersome-mediated intracellular delivery 
 
3.3.1.2.2.1 Intracellular delivery by spherical polymersomes 
 
FaDu cells growing in Ibidi® µ-dishes, or HeLa cells growing in a 96 well plate, were 
treated with 1 mg/ml of PMPC-PDPA polymersomes encapsulating rhodamine B 
octadecyl ester perchlorate (CelLuminate®) for 1 hour. Afterwards, the media was 
aspirated and cells were thoroughly washed with PBS. Live cells in culture media 
without phenol red were imaged in a Zeiss LSM510 Meta inverted confocal microscope 
equipped with a 561 nm laser, a 575-615 nm filter, and a 60X oil immersion lens.  
 
3.3.1.2.2.2 Intracellular delivery by tubular polymersomes 
 
 BSA was fluorescently labelled with AlexaFluor®647 using a commercial kit from 
InvitrogenTM (Life TechnologiesTM) and encapsulated in tubular polymersomes by 
electroporation as previously described185. Encapsulation efficiency was determined to 
be 29% by fluorescence spectroscopy. Protein labelling and encapsulation was carried 
out by J. Robertson.  
FaDu cells were seeded in Ibidi® µ-dishes 24 hours prior to incubation with protein-
encapsulated polymersomes at a final concentration of 0.5 mg/ml of polymer/dish (0.15 
µg of fluorescent BSA/dish) for 9 hours. Media was aspirated and cells were washed 
with PBS before being imaged in a Perkin-Elmer UltraVIEW VoX spinning disk 
confocal system running on an Olympus IX81 motorized microscope, using a 514 nm 
laser and a 40X oil immersion lens. 
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3.3.1.2.3 Immunofluorescence of cellular receptors 
 
FaDu cells were seeded in sterile cover slides at a cell density of 9x104, and allowed to 
grow for either 1 or 2 days in order to reach 50% and 100% confluence respectively. 
Cells were fixed with 4 % paraformaldehyde at room temperature for 20 minutes. 
Fixation was then blocked during 3 cycles of 5 minutes incubation with 50 mM NH4Cl 
in PBS at room temperature. Subsequent steps were always carried out at room 
temperature. The blocking solution was washed off with PBS (3 cycles of 5 minutes 
each). Cells were then permeabilised with a 0.1 % (v/v) solution of Triton X-100 in 
PBS for 4 minutes. Fixed cells were incubated with a 0.2 % (wt/v) blocking solution of 
fish skin gelatine in PBS during 30 minutes. Cells on the cover slides were then 
incubated with diluted primary antibody in blocking solution, 1/500 for anti SR-BI/SR-
BII (ab36970) and anti CD81184 (kind gift form Prof. McKeating, The University of 
Birmingham), and 1/250 for anti CD36 (ab78054, ab80080) in a humidifier chamber for 
1 or 2 hours in the case of anti SR-BI/SR-BII (figures 5.5.b and 5.5.c-d respectively), 2 
hours or overnight for anti CD36 (figures 5.5.b and 5.5.c-d respectively), and 1 hour for 
CD81 (figures 5.5.b-d). Unbound primary antibody was washed off using blocking 
solution (3 cycles, 5 minutes each). Cells were then incubated with diluted secondary 
antibodies in blocking solution in a humidified chamber protected from light as follows: 
1/1000, 20 minutes or 40 minutes for anti SR-BI/SR-BII (ab6942, figures 5.5.b and 
5.5.c-d respectively), 1/500 or 1/1000 for 60 minutes for anti CD36 (ab6955, figures 
5.5.b and 5.5.c-d respectively), and 1/1000 during 20 minutes in the case of anti CD81 
(ab6947). Unbound antibody was removed as before and cells were briefly incubated 
with nuclear staining (DAPI, from Molecular probes®, Life TechnologiesTM) for 1 
minute. Nuclear staining in excess was removed in 3 cycles of 5 minutes each, with 
blocking solution, followed by 3 washing cycles of 5 minutes with ultrapure water to 
remove salts. Cells on cover slides were mounted using Prolong Gold Antifade 
(Molecular probes®, Life TechnologiesTM) and stored at -20°C, 24 hours after.  
Z stacks of the cells were acquired in a Delta Vision microscope equipped with a 100X 
Olympus lens. A 457 nm laser was used to image the cellular nucleus and a 685 nm 
laser to detect the fluorescently labelled receptors.  
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3.3.1.3 Western blotting 
 
To investigate protein levels of scavenger receptors B by western blotting, cells were 
first detached using either trypsin-EDTA (approx. 40 seconds) or a cell scraper.  
Subsequently they were spun down at 153 RCF for 5 minutes at 4°C and resuspended in 
lysis buffer (RIPA buffer form Sigma-Aldrich® complemented with fresh cOmplete 
protease inhibitor cocktail from Roche). Cells were then briefly vortexed (30s) and 
frozen down (-20°C) overnight. Defrosted pellets were briefly vortexed and spun down 
at high speed (20,000 RCF) for 10 minutes at 4°C, any pellet was discarded. Protein 
concentration was calculated by the Bradford protein dye-binding assay186. The cell 
pellet was mixed with diluted Bio-Rad Protein Assay reagent (Bio-Rad) and the 
absorbance of the mixture was measured in a spectrophotometer at 595 nm and 
compared to BSA standards. Denatured sample, containing 22 µg of protein, was mixed 
by vortex with Laemmli buffer (5X buffer: 1 M Tris-Cl pH 6.8, 2 g SDS, 10 ml 
glycerol, 2 ml β-mercaptoethanol, 50 mg bromophenol blue) and immediately denatured 
in a water bath at 37°C during 30 minutes. Denatured samples were loaded in 1 mm 
thick 8% acrylamide gels with a 20 % (wt/v) SDS content. Proteins in the gel were 
electrophoresed at 150 V for 40 minutes. Subsequently, they were transferred to a 
nitrocellulose membrane, either overnight at 22 V and room temperature, or during 75 
minutes at 400 mA and 4°C. The membrane was then blocked during 60 minutes using 
5 % (wt/v) dried milk in TBS (20 mM Tris-HCl pH 7.4, 137 mM NaCl). Next, it was 
incubated with anti SR-BI/SR-BII antibody (1:100, ab52629) or anti β-actin antibody 
(1:1000, A1778 Sigma-Aldrich®) diluted in blocking solution (5 % wt/v dried milk in 
TBS) for 90 minutes at room temperature. Unbound primary antibody was washed off 
using 0.05 % (v/v) Tween®20 in TBS (3 cycles of 5 minutes each). The membrane was 
then incubated with HRP-conjugated secondary antibodies (sc-2004 and sc-2006, Santa 
Cruz Biotechnology, Inc.) diluted 1:5000 in blocking solution for 60 minutes at room 
temperature. Unbound antibody was washed off as before. Finally, protein bands were 
revealed using either ECL, in the case of β-actin, or ECL prime for SR-BI/SR-BII (GE 
Healthcare Life Sciences) according to manufacturer instructions. Chemiluminescence 
was detected using an UVI-prochemi camera.  
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3.3.2 Cell viability 
 
3.3.2.1 MTT assay 
 
The MTT assay187 is based on the ability of living cells to reduce the yellow tetrazole 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to a purple 
formazan salt. Cellular metabolic activity can be determined by spectrophotometry 
following formazan solubilisation. The mitochondrial activity of a population of cells is 
an indirect indication of the cellular viability of those cells.  
 
Following cellular incubation with the compound, where its toxicity is to be determined, 
the media was aspirated and the cells were washed twice with PBS. Cells were then 
incubated with fresh 0.5 mg/ml MTT solution in PBS (1ml/well) at 37°C and 5% CO2 
for 50 minutes. After incubation, the MTT solution was carefully disposed of and the 
purple formazan crystals were solubilised with the help of 300 µL/well of acidified 
isopropanol (25 µL of concentrated HCL per 20 ml of isopropanol). Solubilised 
formazan was transferred to a 96 well plate (150 µL/well) and its absorbance at 540 nm 
was read in an ELx800 Absorbance Microplate Reader (BioTek Instruments, Inc.) using 
a 630 nm wavelength as a reference.  
 
Control cells were treated with PBS, or the main diluent used in the study. Absorbance 
at 540 nm associated with the control group was assigned to represent 100 % viable 
cells; percentages for the rest of the conditions were calculated accordingly.  
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Figure	   3.2:	  MTT	   assays	   performed	   in	   FaDu	   and	  HeLa	   cells	   treated	  with	   rho-­‐PMPC-­‐
PDPA	   polymersomes	   or	   the	   ligands	   for	   scavenger	   receptors,	   Fucoidan	   and	  
Polyinosinic	  acid	  
a-­‐b)	  Cell	  viability	  levels	  after	  24	  hours	  incubation	  with	  different	  concentrations	  of	  rho-­‐
PMPC-­‐PDPA	  polymersomes.	  In	  both	  cases	  the	  rho-­‐PMPC-­‐PDPA	  copolymer	  used	  for	  the	  
nanoparticle	  production	  was	  obtained	  by	  ARTP,	  while	  the	  PMPC-­‐PDPA	  copolymer	  was	  
produced	  by	  ARTP	  in	  a)	  and	  by	  RAFT	  in	  b).	  c)	  Cell	  viability	  after	  2	  hours	  incubation	  with	  
Fucoidan	   or	   Polyinosinic	   acid	   (see	   section	   3.3.3.2.1)	   n=3	   experiments.	   Error	   bars:	   ±	  
sem.	  No	  statistical	  difference	  was	  found	  between	  control	  cells	  (10	  %	  (v/v)	  PBS	  treated)	  
and	   treated	  cells	   (polymersomes	  or	   scavenger	   ligands)	  using	  one-­‐way	  ANOVA	   in	  a,	  b	  
and	  c.	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3.3.2.2 Live/Dead cell viability assay 
 
Propidium iodide (PI) (Ex/Em: 536 nm/617nm) and SYTO®9 (Ex/Em: 480 nm/500 
nm), acquired from InvitrogenTM (Life TechnologiesTM), were used to investigate 
cytotoxicity induced by different inhibitors of endocytosis in HeLa cells.  
 
3.3.2.2.1 Flow cytometry 
 
After incubation of subconfluent cells, growing in 24 well plates, with the compounds 
under study or the appropriated controls, media form the wells was aspirated and cells 
were thoroughly washed with PBS 3 times. Cells were then incubated with a solution 50 
µM of PI for 10 minutes at room temperature. PI solution was disposed of and cells 
were prepared for flow cytometry. Analysis was carried out in a FacsArray (BD 
Biosciences) using the 532 nm laser and a 585-642 nm bandpass filter to record the red 
fluorescence emitted.  
 
3.3.2.2.2 Fluorescence microscopy 
 
After incubation of subconfluent cells, growing in 96 well plates, with the compounds 
under study or the appropriate controls, media from the wells was aspirated and cells 
were thoroughly washed with PBS 3 times. Cells were then incubated with a solution 
containing 50 µM PI plus 2 µM SYTO®9, for 10 minutes at room temperature. The 
solution containing fluorescent dyes in excess was removed and cells were rinsed twice 
with PBS. Cells in culture media with out phenol red were imaged at 20X in a BD 
Pathway 855 spinning disk confocal (BD biosciences). 
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3.3.3 Perturbation of the cellular uptake of PMPC-PDPA 
polymersomes 
 
Different approaches were used to try to inhibit polymersome uptake in mammalian 
cells including the use of chemical compounds, ligands and small antagonists for 
scavenger receptors and antibodies targeting the extracellular loop of either CD36, SR-
BI/SR-BII scavenger receptors or tetraspanin CD81. 
 
3.3.3.1 Polymersome uptake in the presence of chemical inhibitors of 
endocytosis 
 
3.3.3.1.1 Preparation of stock solutions  
 
Inhibitors were dissolved in ultrapure water (chlorpromazine) or dimethyl sulfoxide 
(DMSO) (monodansylcadaverine, dynasore, sertraline, filipin, genistein, cytochalasin 
D, latrunculin B, IPA-3, EIPA, bafilomicin A1) to yield stock solutions 1mM to 16 µM 
(stock solution 1, Table 3.1). Stock solutions were filtered using sterile 0.20 µm filters 
(GE Healthcare) and stored according to manufacture instructions.  
 
For experiments involving the use of chemical inhibitors (MTTs, live-dead cell viability 
assays and experiments looking at polymersome uptake in cells treated with chemical 
inhibitors), solutions containing the inhibitor were diluted ten times in media with 
serum as they were added to the cells. To facilitate the experimental work stock 
solutions 1 were diluted in ultrapure water to produce stock solutions 2 (Table 3.1). 
Stock solutions 2 are 10 times concentrate solutions compared with the inhibitor 
concentration on well and were freshly prepared before each experiment. 
	   75	  
 
Inhibitor Stock solution 1 Stock solution 2 
Chlorpromazine 1 mM 
50 µM 
100 µM 
200 µM 
Monodansylcadaverine 1mM 250 µM 500 µM 
Filipin 1.5 mM 
10 µM 
50 µM 
100 µM 
Genistein 18.5 mM 
0.5 mM 
1 mM 
2 mM 
Dynasore 15 mM 
0.5 mM 
0.8 mM 
1 mM 
Sertraline 1mM 
50 µM 
200 µM 
500 µM 
Nocodazole 10 M 
3 µM 
30 µM 
333 µM 
Latrunculin B 2.5 mM 
10 µM 
50 µM 
100 µM 
Cytochalasin D 2 mM 
1 µM 
10 µM 
20 µM 
1,1′-Disulfanediyldinaphthalen-2-ol  (IPA-3) 1mM 
100 µM 
250 µM 
500 µM 
5-(N-ethyl-N-isopropyl) amiloride (EIPA) 1mM 250 µM 500 µM 
Bafilomycin A1 16 µM 
0.1 µM 
0.5 µM 
1 µM 
	  
Table	  3.2:	  Stock	  solutions	  prepared	  for	  different	  chemical	  inhibitors	  
	  
	  
AlexaFluor®647 conjugates of transferrin, cholera toxin subunit B and 10kDa dextran 
were purchased from InvitrogenTM (Life TechnologiesTM), diluted in ultrapure water or 
PBS according to manufacturer indications, and used as control cargoes for different 
endocytic pathways.  
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2.3.3.1.2 Screen 
 
Subconfluent HeLa cells growing in 6 well plates were pre-incubated with inhibitors 
(see table 6.3 for concentrations) for 15 minutes at 37°C and 5% CO2. Afterwards, 
rhodamine-labelled polymersomes, control cargoes (table 3.3 for concentrations), or 
PBS, were added to the cells, doubling the total volume of the wells and therefore 
reducing to half the concentration of inhibitors/well. Incubation under these conditions 
was maintained during 20 minutes at 37°C and 5% CO2. Finally, media was aspirated, 
cells were thoroughly washed three times with ice cold PBS, detached with the help of a 
cell scraper, and immediately processed for flow cytometry. Cells were analysed in a 
FacsArray (BD Biosciences) using the 532 nm laser and a 585-642 nm filter to capture 
the fluorescence emitted by cells treated with rhodamine-labelled polymersomes or a 
633nm laser and 661-716 nm filter in the case of cells treated with AlexaFluor®647 
conjugates. 	  
- Concentration/well (µg/ml) Amount/well (µg) 
Polymersomes 200 320 
Transferrin 5 8 
Cholera toxin subunit B 10 16 
10 kDa Dextran 100 160 
 
Table	  3.3:	  Experimental	  conditions	  for	  cells	  incubated	  with	  polymersomes	  or	  
control	  cargoes	  	  
 
3.3.3.2 Polymersome uptake in the presence of known ligands for 
scavenger receptors 
 
3.3.3.2.1 Ligands for scavenger receptors type A and B. Fucoidan and 
Polyinosinic acid 
 
Stock solutions, 10 times concentrated, of Fucoidan (from Fucus vesiculosus F5631, 
Sigma-Aldrich®) and Polyinosinic acid (P4154, Sigma-Aldrich®) were prepared in 
endotoxin free PBS, filtered and storage at -20°C until use.  
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Subconfluent cells growing in 24 well plates were incubated with Fucoidan (2 mg/ml) 
or Polyinosinic acid (0.25, mg/ml) for one hour.  Rhodamine-labelled polymersomes 
were then added to the cells at 1 mg/ml (final polymer concentration/well) and 
incubation was continued for another hour. Media was aspirated, cells were thoroughly 
washed with PBS and processed for flow cytometry. Cells incubated only with PBS and 
cells incubated with polymersomes in the absence of Fucoidan and Polyinosinic acid 
were used as negative and positive controls for uptake respectively.  	  
	  	  
Figure	  3.3:	  Chemical	  structures	  of	  Fucoidan	  and	  Polyinosinic	  acid.	  	  
a)	   Fucoidan	   from	   Fucus	   vesiculosus.	   Reproduced	   from	   Ale	   et	   al.,	   2011188.	   b)	  
Polyinosinic	   acid.	   Adapted	   from	   PubChem	   Compound	   database,	   unique	   chemical	  
structure	  identifier	  CID:	  8582.	  
 
3.3.3.2.2 SR-Bs antagonist ITX5061 
 
ITX5061 solution was a kind gift from Prof. McKeating (The University of 
Birmingham).  
HDF were seeded into 24 well plates and allowed to grow for two days until they were 
80% confluent. Cells were then incubated with different concentrations of ITX5061 (1-
20 µ mM) for 1 hour prior to incubation with rho-labelled polymersomes for another 
hour in the presence of the antagonist. Media was aspirated and cells were processed for 
flow cytometry.  
a) b) 
n 
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Figure	  3.4:	  Chemical	  structure	  of	  ITX5061.	  
Adapted	  from	  PubChem	  Compound	  database,	  unique	  chemical	  structure	  identifier	  CID:	  
56843466.	  
 
3.3.3.3 Polymersome uptake in the presence of blocking antibodies. 
Antibodies against scavenger receptors CD36 and SR-Bs, and tetraspanin 
CD81 
 
Subconfluent cells growing in 24 well plates were incubated with anti-SR-BI/SR-BII 
antibody (ab36970, 0.3 mg/ml or 0.5 mg/ml), anti-CD36 antibody (0.04 mg/ml or 0.02 
mg/ml), anti SR-BI/SR-BII plus anti CD36 (ab78054, 0.3 mg/ml) or anti-CD81 
antibody184 (kind gift form Prof. McKeating, The University of Birmingham, 0.006 
mg/ml). An unspecific IgG (ab37415) at the same concentration as the targeting 
antibodies was included as control. Rhodamine-labelled polymersomes (1 mg/ml final 
concentration per well) were added to the previous cells and incubation was maintained 
for another hour. Media was then aspirated and cells were processed and measured for 
flow cytometry. Cells incubated either with PBS, or polymersomes, in the absence of 
any antibody, were used as negative and positive controls for uptake respectively. 
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3.3.4 Cellular transfection 
 
3.3.4.1 Mutant K44A dynamin 
 
3.3.4.1.1 Flow cytometry 
 
Cells were seeded in 24 well plates and allowed to grow for 24 hours in antibiotic free 
DMEM media. The following morning the media was replaced with OPTI-MEM® 
media (Life TechnologiesTM). Transfection complexes were prepared using 
lipofectamine® 2000 (InvitrogenTM, Life TechnologiesTM) following the standard 
protocol supplied by the manufacturer. Ratio cDNA:lipofectamine was 1:2 and final 
cDNA concentration per well was 1 µg/ml for both wild type (WT) and mutant K44A 
dynamin constructs. Detailed preparation of WT and K44A constructs is described 
elsewhere72. Following incubation for 12 hours, transfection media was replaced with 
complete DMEM media and cells were incubated with rhodamine-labelled 
polymersomes (1 mg/ml final polymer concentration/well) for one hour. Afterwards the 
media was aspirated and cells were washed twice with ice cold PBS. Cells were then 
processed for flow cytometry and analysed in FacsAria analyser (BD Biosciences) using 
a 488 nm laser and a 575-626 nm filter to record red fluorescence associated with cells 
after incubation with fluorescent polymersomes. The expression of a cerulean blue 
fluorescent reporter gene included in the cDNA was used to identify transfected cells 
within the total cell population. Therefore, cells were also excited with a 405 nm laser 
and their fluorescence recorded between 450-550 nm. 
Control conditions included untransfected cells, treated or not with polymersomes, and 
WT and K44A transfected cells not treated with polymersomes.  
  
3.3.4.1.2 Fluorescence microscopy 
 
Cells growing in a 96 well plate were 70-80% confluent at the moment of the 
transfection with TurboFectTM  (Fermentas, Thermo Scientific). Transfection with either 
WT or K44A cDNA constructs was carried out according with the protocol supplied by 
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the manufacturer for a 96 well plate format. Ratio cDNA:TurbofectTM was 1:1 % (v/v) 
and 0.2 µg of cDNA were added per well. Transfection was prolonged for 8 hours.  
HeLa cells transfected with WT or K44A dynamin as well as non-transfected cells, 
were incubated in serum free media with either 25 µg/ml of AlexaFluor®647 transferrin 
(Ex/Em: 652/668 nm) for 20 minutes or 1 mg/ml of CelLuminate® (PMPC-PDPA 
polymersomes encapsulating rhodamine B octadecyl ester perchlorate, Ex/Em: 554/578 
approx.) during 1 hour.  Afterwards, media was aspirated and cells were washed twice 
with PBS and left in culture media without phenol red. Cells were immediately imaged 
in a Zeiss LSM510 Meta inverted confocal microscope using a 60X oil immersion lens. 
A 405 nm laser line was used to verify the presence of transfected cells while excitation 
with the 561 nm and the 633 lasers was used to investigate the cellular uptake of 
CelLuminate® and AlexaFluor®647 transferrin, respectively. Confocal images and Z-
stacks obtained were analysed using Image J software. 
 
3.3.4.2 siRNA knockdown  
 
3.3.4.2.1 siRNA knockdown by electroporation 
 
Cells were transfected either with On-TARGET plus Human SCARB1 siRNA pool or 
On-TARGET plus non-targeting siRNA pool (Darmacon, Thermo Scientific) by 
electroporation using the NeonTM Transfection System (InvitrogenTM, Life 
TechnologiesTM).  
 
FaDu cells were allowed to grow in a T75 flask with complete medium until they were 
70-90% confluent. On the day of the transfection cells were rinsed with PBS, detached 
form the flask, pelleted and counted. Different siRNA concentrations were tested with 
3x105 cells transfected per condition. Cells were electroporated with one pulse of 30 ms 
at 1350 V and immediately transferred to a 6 well plate with antibiotic free media. 
Transfection was prolonged for either 24, 36 or 48 hours. In any case, transfection 
media was replaced with fresh media without antibiotics 24 hours after transfection. 
Protein knockdown was investigated by western blotting.  
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3.3.4.2.2 siRNA knockdown screen in Drosophila cells 
 
Two 384 well plates, procured by the RNAi screening facilities at The University of 
Sheffield, were used for the screen. One contained siRNAs targeting genes of 
Caenorhabditis elegans (C.elegans), which have no homology with Drosophila genes 
(non-targeting siRNAs). The other plate comprised the siRNAs for the knockdown of 
the genes under study. Each well on the plate had 5 µL of a 0.05 µg/ml solution of 
siRNA in water (0.25 µg siRNA/well). Sealed plates were stored at -20°C or -80°C until 
their use.  
 
On the day of the transfection, plates containing the siRNAs were thawed at room 
temperature and centrifuged at 153 RCF for 1 minute before removing the seals. 20 µL 
of a suspension containing 6 x 105 SR2+ cells in serum free media were added to each 
well and incubated for 1 hour. Afterwards, 30 µL of complete Schneider’s media was 
added to the cells. Transfection under these premises was prolonged for 3 days in a 
CO2-free incubator at 25°C. To study polymersome internalisation in transfected cells, 
the media from the wells was aspirated and replaced with 50 µL of serum free media 
containing 5 µg of rhodamine labelled PMPC-PDPA polymersomes. Cells were 
incubated with polymersomes for 1 hour, afterwards the media was aspirated and cells 
were washed with PBS. Cells were fixed with 6 % formaldehyde and stained with 
Hoescht (InvitrogenTM, Life TechnologiesTM) during 10 minutes. Finally, the solution 
containing the fixative and the nuclear staining was aspirated and cells were washed 
with PBS. Cells in PBS were imaged in an ImageXpress Micro XLS Widefield High 
Content Screening System (Molecular Devices) using a 40x objective and two lasers 
lines configured to excite and record the fluorescence of DAPI and Cy3 dyes. The two 
fluorescent channels were used to generate a quantification mask for image analysis 
using MetaXpress® (Molecular Devices). 
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3.4 Statistics 
 
Unpaired T-test was used to test for statistical difference between two sets of data. One-
way ANOVA was employed when it was necessary to compare more than two sets of 
data. Bonferroni test was used after ANOVA if statistical significance was found 
between the groups. Statistical significance form either statistical test used was 
represented as follows: p< 0.05 (*), p<0.01 (**), p<0.001 (***). 
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Chapter 4: Uptake of PMPC-PDPA 
polymersomes in mammalian cells. Effect of 
nanoparticle size and nanoparticle shape in 
polymersome internalisation 
 
Part of this chapter has been published as: 	  
pH-Sensitive Tubular Polymersomes: Formation and Applications in Cellular Delivery. 
James D. Robertson, Guy Yealland, Milagros Avila-Olias, Luca Chierico, Oliver 
Bandman, Stephen A. Renshaw, Giuseppe Battaglia 	  
ACS Nano, 2014 
  
4.1 Introduction 
 
The cellular interactions and subsequent internalisation of a synthetic particle can be 
studied, similar to natural particles, by two complementary approaches. It is crucial to 
identify the cellular structures implicated in internalisation and at the same time it is 
essential to understand whether and how the inherent properties of the particle influence 
its uptake. Although traditionally the cellular internalisation of a biological cargo has 
been preferentially investigated on the basis of the first approach mentioned, and 
allocated to well-defined uptake pathways, it is nowadays becoming widely accepted 
and increasingly important that the cargo features are crucial in determining how it will 
be ultimately internalised, and therefore the uptake mechanism should be specifically 
characterised for each cargo with its set of defined properties135,189. According to this, 
the physicochemical properties of PMPC-PDPA polymersomes in relation to their 
uptake in mammalian cells, have started to be investigated. As presented in the 
introduction chapter, it has been demonstrated that the efficiency of PMPC-PDPA 
polymersome internalisation (polymersomes/cell) is strongly influenced by nanoparticle 
size and nanoparticle surface topology. To extend further our understanding of the 
effect that the physical properties of PMPC-PDPA polymersomes have in their 
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internalisation in mammalian cells, specifically polymersome shape and polymersome 
size below 100 nm, I carried out the studies presented in the next section of this chapter. 	  
 According to the experimental knowledge gained in recent years in our laboratory 
FaDu cells, an epithelial adherent cell line established from the pharynx of a patient 
with squamous cell carcinoma190, present a faster uptake of PMPC-PDPA 
polymersomes compared with other cell types. Hence I have used FaDu cells as a model 
cell type for further studies and most of the experiments presented in this thesis were 
conducted on them. In addition, FaDus are clinically relevant in the context of oral 
cancer and their enhanced uptake of PMPC-PDPA polymersomes could open new 
avenues for the treatment of this type of tumours, which remains very challenging191, 
adding an extra motivation for the study of polymersome internalisation in this cancer 
cell line. 
	  
4.2 Results 
 
4.2.1 General characteristics of the uptake of spherical PMPC-PDPA 
polymersomes in mammalian cells 
  
To validate whether PMPC-PDPA polymersomes are internalised by an energy-
dependent process I incubated primary human dermal fibroblasts (HDFs) with 
rhodamine-labelled polymersomes at either 37°C or 4°C for 20 minutes, and 
subsequently explored cellular uptake by confocal microscopy. As shown in figure 
4.1.a, cells that were incubated with fluorescent-labelled polymersomes at 37°C have 
become fluorescent. On the other hand, in cells that were incubated with the 
nanoparticles at 4°C, temperature at which the energy-dependent process of the cell are 
paused as a consequence of the reduced metabolic activity, there was no evident 
polymersome uptake and cells looked very similar to control cells, that were not 
incubated with the nanoparticles. Next, I measured the cellular uptake following 
incubation with increasing concentrations of polymersome dispersion. Cells were 
incubated with fluorescent-labelled polymersomes, up to 1.5 hours, and cellular uptake 
was investigated by flow cytometry. As expected, cellular internalisation increases as 
cells are incubated with increasing nanoparticle concentrations (figures 4.1.b-c) and, as 
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figure 4.1.b shows, at 1 mg/ml of polymersomes/well we are close to reaching 
saturation of the cellular uptake. 	  
Based on the experiments presented above together with the information derived from 
previous and current research in Prof. Battaglia group, it seems that the cellular uptake 
of PMPC-PDPA polymersomes in mammalian cells is a relatively fast process. In order 
to gain a qualitative insight into the internalisation kinetics of these nanoparticles I 
investigated the uptake of rhodamine-labelled polymersomes by confocal microscopy in 
FaDu cells. As figure 4.1.d shows, polymersomes were rapidly internalised. Cellular 
internalisation can start to be observed 5 minutes after incubation with fluorescent 
nanoparticles and it increases during the experimental time-course.  
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Figure	  4.1:	  Uptake	  of	  spherical	  polymersomes	  in	  mammalian	  cells	  
a)	   Confocal	   micrographs	   of	   HDFs	   following	   20	   minutes	   incubation	   with	   1	   mg/ml	   of	  
rhodamine-­‐labelled	  polymersomes	  at	  either	  37°C	  or	  4°C.	  Untreated	  cells	  are	  included	  
as	  control.	  Scale	  bars:	  20µm.	  b)	  Titration	  of	  polymersomes	  uptake	  in	  FaDu	  cells.	  Cells	  
were	   incubated	  with	   increasing	   concentrations	  of	   rhodamine-­‐labelled	  polymersomes	  
for	  90	  minutes.	  Chart	  shows	  median	  fluorescence	  intensity	  (MFI)	  values	  associate	  with	  
the	   cells	   as	   measured	   by	   flow	   cytometry.	   n=3	   experiments.	   Error	   bars:	   ±	   SD.	   c)	  
Representative	  histograms	  obtained	  by	   flow	  cytometry	   showing	   fluorescent	   intensity	  
associated	   with	   cells	   after	   incubation	   with	   increasing	   concentrations	   of	   fluorescent	  
polymersomes	   for	   90	  minutes.	   Untreated	   cells	   are	   represented	   in	   grey.	   d)	   Confocal	  
images	   of	   FaDu	   cells	   after	   incubation	   with	   0.5	   mg/ml	   of	   fluorescent-­‐labelled	  
polymersomes	   at	   the	   time	   points	   indicated.	  Micrographs	   display	   the	   FIRE	   LUT	   from	  
ImageJ	  software.	  Scale	  bars:	  25	  µm.	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4.2.2 Uptake kinetics of spherical PMPC-PDPA polymersomes with 
different diameters 
 
Once I had acquired information about the general characteristics of the uptake of 
PMPC-PDPA polymersomes in mammalian cells, I decided to move on into the 
investigation of the impact that the physical characteristics of these nanoparticles have 
in their cellular internalisation, I did so by exploring the effect of nanoparticle size in 
the first instance.  
 
Two main protocols are routinely conducted in the laboratory for the production of 
polymersomes, the pH switch method and the film rehydration method. On the former, 
we start from an acidic aqueous solution of copolymers chains and gradually raise the 
pH of the solution to physiological pH (7.4) by the dropwise addition of NaOH 1 M. 
We have usually observed in the laboratory that when polymersomes are produced in 
this way we end up with a dispersion of spherical nanoparticles with a heterogeneous 
size distribution (figures 4.2.b-c). We tried to purify this bulk dispersion to isolated 
aliquots of spherical nanoparticles, each of them containing particles within a different 
size range, for successive cellular internalisation studies.  
The purification process is represented in figure 4.2.a and consists of a combination of 
tangential flow filtration and successive cycles of centrifugation at increasing relative 
centrifugal force (RCF). First we removed the micelles, which constitute the fraction of 
smaller nanoparticles in suspension (fraction 6), by recirculating, for several hours, the 
bulk nanoparticle dispersion through a filtration module with a 50 nm pore threshold. 
The theoretical diameter of a micelle formed by PMPC25-PDPA70 block copolymers is 
approximately 33.4 nm. This value is the sum of two fully stretched MPC chains (brush 
conformation), each of them with a length of 6.25 nm, and two coiled coil DPA chains 
that form the hydrophobic core of the micelle, each of them circa 10.44 nm long192,193 
(specific lengths of the polymer chains are Prof. Battaglia personal comunications). 
Nanoparticles used for the experiments reported in this section were made using 
copolymers with slightly shorter DPA chains (PMPC25-PDPA65) hence, micelles formed 
by this polymer are expected to be less than 33.4 nm in diameter.  
The main dispersion, virtually free of micelles, underwent successive 20 minutes cycles 
of centrifugation at increasing RCF. After each cycle the nanoparticle pellet was 
carefully resuspended in sterile PBS and stored at 4°C for internalisation studies while 
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the supernatant was put through the next cycle of centrifugation. At the end of the 
purification process we have separated the starting nanoparticle dispersion into 6 
fractions, each of them enriched in nanoparticles of a certain size (figure 4.2.e). All 
fractions were characterised in terms of size and shape by dynamic light scattering 
(DLS) and transmission electron microscope 105 (figures 4.2.d, f). The combination of 
the hollow structure of the polymersomes and the drying process to which the 
polymersomes adsorbed onto the grids for TEM are exposed to, can lead to the collapse 
of the spherical architecture typical of hydrated polymersomes. This is more likely to 
happen with bigger polymersomes and can make them appear as non-spherical particles 
under the TEM microscope as shown for fraction 1 in figure 4.2.f. 
Following characterisation of the fractions, I investigated the uptake kinetics of 
polymersomes of different sizes (fractions 1-5) and polymeric micelles (fraction 6) in 
FaDu cells at different time points up to 24 hours using flow cytometry. The 
fluorescence intensity associated with the cells after nanoparticle incubation was 
normalised by the mass of polymer per particle, like this the uptake represented will be 
proportional to the number of particles internalised rather than to the amount of 
polymer. Normalising in this way I take into account that not all the cells were 
incubated with the same number of particles (figure 4.3a) and the difference in polymer 
per particle between particles of different sizes. As shown in figure 4.3.b nanoparticles 
of different sizes were not internalised with the same efficacy. If we plot the area under 
the curve for the uptake profiles in figure 4.3.b against the average nanoparticle size of 
each fraction, it seems to be an optimal particle diameter for polymersome 
internalisation, in terms of the relative number of nanoparticles internalised in a period 
of time, around 60 nm (figure 4.3.c). 
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Figure	   4.2:	   Polymersome	   fractions	   of	   different	   sizes	   and	   micelles	   obtained	   after	  
purification	  by	  centrifugation	  
a)	  Schematic	  representation	  of	  the	  purification	  process.	  A	  hollow	  fiber	  system	  is	  used	  
to	   remove	   the	  micelles	   from	   the	   bulk	   nanoparticle	   dispersion	   followed	   by	   cycles	   of	  
centrifugation	   at	   increasing	   centrifugal	   force;	   after	   each	   cycle	   a	   sample	   (fraction	   ♯)	  
enriched	  in	  polymersomes	  of	  a	  certain	  size	  is	  collected.	  b)	  Size	  distribution	  measured	  
by	   DLS	   of	   the	   bulk	   nanoparticle	   dispersion	   before	   purification.	   n=3	   batches	   of	  
nanoparticles.	   Errors	   bars:	   ±	   sem.	   c)	   TEM	  micrograph	   of	   the	   nanoparticle	   dispersion	  
before	  purification.	  Scale	  bar:	  200	  nm.	  d)	  DLS	   traces	  showing	   the	  size	  distribution	  of	  
the	   different	   fractions	   obtained	   after	   purification.	   n=3	   different	   batches	   of	  
nanoparticles.	  Errors	  bars:	  ±	  sem.	   	  e)	  Average	  size	  of	   the	   fractions	  measured	  by	  DLS.	  
n=3	  batches	  of	  nanoparticles.	  Errors	  bars:	  ±	  sem.	  f)	  TEM	  micrographs	  of	  the	  different	  
fractions	  obtained	  after	  purification.	  Scale	  bars:	  200	  nm	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Figure	  4.3:	  Uptake	  of	   spherical	  PMPC-­‐PDPA	  nanoparticles	  of	  different	  diameters	   in	  
FaDu	  cells	  
a)	   Table	  displaying	   the	  different	  nanoparticle	   fractions	   that	   the	   cells	  were	   incubated	  
with	   and	   the	   average	   nanoparticle	   diameter	   for	   each	   fraction.	   Cellular	   treatment	   is	  
presented	  as	  amount	  of	  polymer/well,	  concentration	  of	  polymer/well	  and	  number	  of	  
particles/well.	  b)	  Uptake	  kinetics	   for	  nanoparticles	  of	  different	  diameters.	  MFI	  values	  
measured	  by	  flow	  cytometry	  are	  normalised	  to	  the	  relative	  number	  of	  particles	  taken	  
up	  for	  each	  fraction	  at	  different	  time	  points	  up	  to	  24	  hours.	  Points	  on	  the	  graphs	  were	  
fitted	   to	   a	  one-­‐phase	  decay	  non-­‐linear	   regression	   curve	  using	  PRISM®	   software.	   n=3	  
experiments.	   Errors	   bars:	   ±	   sem.	   	   c)	   Cellular	   uptake	   as	   the	   relative	   number	   of	  
nanoparticles	  of	  a	  specific	  diameter	  internalised	  after	  24	  hours.	  The	  chart	  displays	  the	  
area	  under	   the	   curve	   for	   each	  plot	   in	  b	   against	   the	   average	  nanoparticle	   size	  of	   the	  
fraction.	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4.2.3 Uptake kinetics of tubular PMPC-PDPA polymersomes 
 
Polymersomes can be produced by the film rehydration method. Using this approach 
the copolymers are firstly dissolved in an organic solvent mixture in a glass vial and 
subsequently left under vacuum overnight to achieve solvent evaporation. The thin 
polymer film formed on the walls of the vial is then forced into solution by stirring it 
with PBS (pH 7.4) up to 4 weeks. Interestingly, polymersome dispersions obtained in 
this way mainly consist of tubular polymersomes. We have just started to understand 
how these tubular polymersomes are made, and the current knowledge of our group of 
the forces driving the formation of tubular structures from the polymer film is detailed 
in a recently published paper194. Briefly, it is a spinodal decomposition, where the 
thermal and mechanical fluctuations experienced by the polymeric film under stirring 
create pressure gradients across it, leading to film perforation and subsequent dewetting. 
The continuous hydration and swelling of the polymer, the balance between hydrophilic 
and hydrophobic forces and the shear stress, govern the successive transitions. The 
bicontinuous polymeric network comes into solution and forms a connected tubular 
network, from where branched tubular structures detach and finally break up into 
tubular polymersomes.  
For the purpose of the present research the opportunity to work with tubular 
polymersomes gave me the possibility to investigate the effect of nanoparticle shape in 
the internalisation of PMPC-PDPA polymersomes. In order to do that the nanoparticle 
dispersion obtained was first centrifuged at 2,000 RCF for 20 minutes to remove 
nanotubes and any membranous assemblies close to, or above the µm range. The 
remaining supernatant was then centrifuged at 15,000 RCF for another 20 minutes. The 
resuspended pellet in PBS resulting from the last centrifugation was characterised by 
TEM. A representative micrograph is displayed in figure 4.4.a, showing that this 
fraction is almost exclusively composed by tubular polymersomes, which are 
characterised by an average diameter of 60 nm and an average length of 240 nm. While 
the diameter is kept almost constant among all the tubular nanoparticles examined, the 
nanoparticles present a broad length distribution. The cellular uptake of these 
fluorescent-tubular nanoparticles was investigated by flow cytometry in FaDu cells, the 
resulting uptake profile is shown in figure 4.4.b. A biphasic uptake kinetic can be 
observed where a moderate increase in fluorescence signal up to 5 hours was followed a 
by a great and rapid increase in fluorescent signal. This seems different from the kinetic 
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profile previously observed for spherical particles. On figure 4.4.c the uptake profile of 
the tubular polymersomes under study is compared with spherical polymersomes with 
diameters that mimic the average tube diameter, 60 nm, or the average tube length, 240 
nm. Differences with the internalisation behaviour of the spherical counterparts are 
especially noticeable between tubular polymersomes and 60 nm spherical 
polymersomes where a rapid increase in fluorescence is followed by a single plateau.   
 
We believe that the two phases detected by flow cytometry in the uptake of tubular 
polymersomes could correspond to a first step of binding of the tubes to the cell surface 
followed by a slow internalisation of the elongated nanoparticles. Binding and final 
internalisation would be spaced enough in time so as to be detected separately. In order 
to test this hypothesis I tried to visualise the two phases looking under the microscope at 
cells that were incubated with fluorescent tubular polymersomes for either 5 or 9 hours. 
Representative confocal micrographs from these experiments are shown in figure 4.4.d 
where it is observed that after 9 hours incubation with rhodamine-labelled tubular 
polymersomes there is evident fluorescence inside of the cells while after 5 hours 
incubation the fluorescent signal is mainly observed at the cell periphery. 3D 
reconstructions from single cells in figure 4.4.e show in more detail the state of tubular 
polymersome internalisation at both time points. At 9 hours there is abundant 
fluorescence coming from different focal planes of the cell, as particularly observed in 
the bottom montage displaying all the successive slices from the Z-stack. Although at 5 
hours the fluorescent signal is, as expected, less intense and not so evident through the 
cell cytoplasm, some internalisation has already started to occur.  
 
To investigate the potential of these tubular polymersomes as intracellular drug delivery 
systems, tubular nanoparticles encapsulating fluorescent BSA were prepared, and 
thoroughly purified by gel permeation chromatography to remove any non-encapsulated 
protein from the nanoparticle dispersion. This is important, since BSA alone can be 
used as an endocytic probe195. Cells were incubated with purified polymersomes 
encapsulating fluorescent-BSA for 9 hours before exploring protein intracellular 
delivery by confocal microscopy (figure 4.5.b). 
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Figure	  4.4:	  Uptake	  of	  tubular	  PMPC-­‐PDPA	  polymersomes	  in	  FaDu	  cells	  
a)	  TEM	  micrograph	  of	  tubular	  polymersomes	  used	  for	   in	  vitro	  uptake.	  Reprinted	  with	  
permission	  from	  Robertson	  et	  al.,	  2014.	  Copyright	  2014	  American	  Chemical	  Society.	  b)	  
Uptake	  kinetics	  profile	  of	  tubular	  polymersomes	  (60	  nm	  x	  240	  nm).	  c)	  Uptake	  kinetics	  
profiles	  of	   tubular	  polymersomes	   (60	  nm	  x	  240	  nm),	  60	  nm	  spherical	  polymersomes	  
and	   240	   nm	   spherical	   polymersomes.	   b-­‐c	   Cellular	   uptake	   was	   analysed	   by	   flow	  
cytometry	   and	   normalised	   to	   number	   of	   particles	   internalised.	  d)	   Cellular	   uptake	   of	  
rhodamine-­‐labelled	   tubular	   polymersomes	   after	   5	   or	   9	   hours	   of	   incubation.	   Pictures	  
represent	   a	   single	   Z	   slice	   around	   the	   nuclear	   region	   of	   the	   cells.	   From	   left	   to	   right:	  
Rhodamine	   channel,	   merge	   rhodamine	   and	   DIC	   channels,	   rhodamine	   channel	   with	  
FIRE	  LUT	   from	   ImageJ	  software.	  Scale	  bar:	  30µm.	  e)	  3D	  study	  of	  confocal	  Z	  stacks	  of	  
single	  cells	  after	  5	  and	  9	  hours	  of	   incubation	  with	  tubular	  polymersomes.	  Left	  panels	  
represent	  top	  projection	  of	   the	  cell	   (scale	  bar:	  10	  µm)	  while	  middle	  panels	  show	  the	  
cell	  from	  the	  side.	  Right	  images	  are	  from	  a	  single	  Z	  slice	  through	  the	  nucleus	  of	  the	  cell.	  	  
Bottom	   panels	   are	   a	  montage	   showing	   the	   different	   Z	   slices	   through	   the	   cell.	   Scale	  
bars:	  5µm.	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Figure	   4.5:	   PMPC-­‐PDPA	   polymersome-­‐mediated	   intracellular	   delivery	   of	   different	  
compounds	  
a)	   Intracellular	   delivery	   of	   rhodamine	   B	   octadecyl	   ester	   perchlorate	   by	   spherical	  
polymersomes	   in	   HeLa.	   Cells	   were	   incubated	   with	   1	   mg/ml	   of	   polymersomes	   for	   1	  
hour.	  Scale	  bar:	  20	  µm	  b)	  Delivery	  of	  AlexaFluor®647-­‐BSA	  by	  tubular	  polymersomes	  in	  
FaDu	  cells.	  Cells	  were	   incubated	  with	  0.5	  mg/ml	  of	  polymersomes	   for	  9	  hours.	   Scale	  
bar:	  8	  µm.	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4.3 Discussion  
 
The investigation conducted in this chapter aimed to outline the main characteristics of 
the uptake of PMPC-PDPA polymersomes in mammalian cells and to improve our 
knowledge in the impact that the physical properties of these nanoparticles have in their 
cellular uptake.  
 
I have corroborated that the internalisation of polymersomes is a temperature-dependent 
process166 (figure 4.1.a) with a fast onset (< 5 min), at least in the cancer cell line FaDu 
(figure 4.1.d), which is in agreement with previously published results showing 
enhanced uptake of this formulation in cancer cells in comparison with healthy cells176. 
This information together with the fact that we have observed internalisation of this 
polymersome formulation in any cell type tested on the laboratory (more than 23 
different cell types) except red blood cells166, which are known for not undergoing 
endocytosis179,180, proves to a large extent that PMPC-PDPA polymersomes are 
internalised by an endocytic process in mammalian cells. It is important to consider that 
a diffusion or a fusion of these polymersomes with the plasma membrane would be 
quite unlikely taking into account their supramolecular structure and the high molecular 
weight of the polymers forming their entangled membranes196. As an example, a 200 
nm PMPC-PDPA polymersome would be disassembled into 1.7 x 103 copolymer 
chains, being the molecular weight of a standard PMPC25-PDPA70 block copolymer 
chain equal to 22,3 kDa. Glucose, one of the biggest molecules able to diffuse through 
the membrane is 180 Da. In addition, particles made up of high molecular weight 
polymers are related to slow chain exchange and therefore high colloidal stability.  
 
Taking maximum advantage of the knowledge acquired over the years working with 
polymersomes for biological applications and the tools at our disposal, I have studied 
the effect of polymersome size and shape in the nanoparticle internalisation. 
Nevertheless, to control polymersome production and to optimise nanoparticle 
purification in order to obtain polymersomes of a defined shape and a narrow size 
distribution is not a straightforward task. We have recently demonstrated how the 
physical characteristics of the polymersomes produced are affected by a complex 
combination of different parameters including the copolymers used and the degree of 
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polymerization of the polymers in their composition, the temperature, the pH and the 
ionic strength of the solution182; thus we are constantly monitoring and investigating 
polymersome production and purification in the laboratory in order to improve our 
control over these processes. Progress made in this sense during the course of the 
present research gave me the possibility to investigate the effect of polymersome size on 
nanoparticle internalisation at smaller nanoparticle sizes than it was done before and 
moreover, to study for the first time the effect of nanoparticle shape in PMPC-PDPA 
polymersomes uptake. We noticed that by using relatively mild cycles of centrifugation 
(from 5,000 RCF to 20,000 RCF, 20 minutes cycles) in a centrifuge with a fixed angle 
rotor we were able to separate fractions of nanoparticle dispersion enriched in different 
sizes, from 240 ± 30 nm polymersomes to 20 ± 4 nm polymeric micelles (figure 4.2.e-
f). Although we realise that the centrifugal forces used are one order of magnitude 
smaller than the average RCFs in differential force ultracentrifugation, the technique of 
choice in the biology laboratory for the routine fractionation of subcellular structures in 
the same range of sizes as our polymersomes, our methodology allowed us to achieve 
some degree of purification (figure 4.3.b vs. figure 4.3.d). Interestingly, Liang et al., 
pelleted 140 nm poly(γ-glutamic acid)-poly(lactide) (γPGA-PLA) nanoparticles  after 
20 minutes centrifugation at 20,000 RCF197 while Kakizawa et al., pulled down hybrid 
organic-inorganic nanoparticles, made up by poly(ethylene glycol)-block-poly(aspartic 
acid) (PEG-PAA) and calcium phosphate and diameters between 100-300 nm, by 
centrifugation at 15,000 rcf for 30 minutes198. These are just two examples of how by 
using sub-ultracentrifugation RCFs over relatively short period of time some groups 
have been able to spin down polymeric nanoparticles with sizes between 100 - 400 
nm199-202. These experimental observations seem to indicate that polymeric 
nanoparticles could be pelleted by milder centrifugation cycles than usually expected 
and they might be the starting point for a systematic study in the use of simple 
centrifugation for the purification of polymeric soft nanoparticles.  
 
Uptake experiments conducted with the aforementioned nanoparticle fractions led to the 
identification of the optimal diameter for the cellular internalisation of spherical PMPC-
PDPA polymersomes, around 60 nm. Polymersomes of this size were more efficiently 
internalised, in terms of the relative number of nanoparticles taken up, than bigger ones 
(figure 4.3.c). This value is slightly bigger than the one predicted by our theoretical 
model for the cellular uptake of nanoparticles (approx. 44 nm) 203. However, from that 
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work it was derived that the optimal nanoparticle size for endocytosis strongly depends 
on the number of receptors available at the cell surface. The total number of receptors 
expressed by a cell can vary between different cell types, and therefore the optimal 
polymersome size, experimentally obtained for PMPC-PDPA polymersome 
internalisation in FaDu cells could be slightly different from the one calculated using a 
standard approximation to that biological parameter.  
Finally, it is important to have in mind that for nanoparticles intended as intracellular 
delivery systems it is necessary to balance the optimal particle size for uptake with the 
optimal particle size for efficient encapsulation of the cargo. In this sense although we 
have observed that micelles present a favourable uptake kinetic, just below the optimal 
polymersome fraction (figure 4.3.d), they are not as versatile as polymersomes for the 
encapsulation and intracellular delivery of diverse compounds.  	  
It is now widely accepted that one of the features of nanoparticles that has a great 
influence over nanosystem-cellular interactions, apart from the size, is the particle 
shape. Studies looking at the biological performance of tubular soft polymeric 
nanoparticles have been mainly conducted in cylindrical micelles (also known as rod-
like, worn-like or filomicelles) and they have demonstrated that these nanoparticles 
present a different in vivo behavior compared with their spherical counterparts. 
Filomicelles remained in blood circulation up to 10 times longer than spherical 
micelles144, tended to accumulate less in healthy tissues than spherical ones204 and 
showed an enhanced drug-loading capacity205. According to this, elongated polymeric 
nanoparticles could offer different and interesting opportunities in comparison with 
their spherical counterparts to modulate the delivery of a cargo in vivo. To the best of 
our knowledge, there are no publications that specifically address the effects of tubular 
shape on the cellular internalisation of polymersomes. Nevertheless the production of 
stable tubular polymersomes in aqueous solutions with one of their dimensions in the 
nm range has been reported206-208. We have lately advanced in the knowledge of how to 
produce tubular PMPC-PDPA polymersomes with all their dimensions in the nanometer 
range194 (figure 4.4.a), opportunity that I have used to investigate the uptake of these 
nanoparticles in mammalian cells. I have observed that tubular polymersomes present 
an uptake profile with two phases where an initial slow onset is followed by a great 
increase, in terms of the relative number of tubes internalised, approximately 5 hours 
after incubation with the nanoparticles (figure 4.4.b). This uptake kinetic is different 
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from the one observed for spherical polymersomes of the same diameter as the tubes, 
which present a continuous polymersome endocytosis with a fast onset and a single 
plateau (figure 4.4.c). On the other hand, tubes appear to be internalised better than 
spherical polymersomes with a diameter that mimics the average tube length, 240 nm 
(figure 4.4.c). This situation could arise form the fact that the tubes investigated are 
characterised by a diameter of 60 nm, which according to our results is optimal for 
inducing the endocytosis of PMPC-PDPA polymersomes (figure 4.3.c). The curvature 
of the system is therefore ideal for stimulating deformation of the plasma membrane 
around the diameter of the tube; in contrast the length of the tube is not facilitating the 
internalisation of the tubular nanoparticle. Consequently the balance between the tube 
diameter and the tube length could be shaping the kinetic curve observed for tubular 
PMPC-PDPA polymersomes. Following cellular treatment, polymeric tubes would bind 
to the cell surface promoting a deformation of the plasma membrane around the 
diameter of the tube that subsequently would progress to wrap all the soft nanotube, a 
process that is likely to take more time than for a 60 nm spherical polymersome and that 
could be reflected in the initial slow onset for the internalisation of tubes observed by 
flow cytometry and confocal microscopy (figures 4.3.b,d).  
Finally, I have demonstrated that PMPC-PDPA tubular polymersomes are able, likewise 
spherical polymersomes (figure 4.5.a), to act as intracellular delivery vectors. Tubular 
polymersomes were able to deliver fluorescent BSA, previously encapsulated in them 
by electroporation, into cells (figure 4.5.b). Although the defined domains of high 
fluorescent intensity at the cell contours observed in figure 4.5.b could indicate 
frustrated tube endocytosis or unsuccessful cargo release, the diffuse fluorescence 
through the cell cytosol is an indication that some fluorescent protein was delivered 
inside the cells, and although early results, they are promising and reveal the potential 
of these tubular nanoparticles as intracellular delivery vectors. 
 
The information gathered in this chapter corroborates the strong influence that 
polymersome physical properties have in PMPC-PDPA polymersome internalisation in 
mammalian cells, and reveals the possibility to gain a new level of control over the 
temporal delivery of a encapsulated cargo through the fine tune of nanoparticle size and 
shape since it has been observed that tubular polymersomes present a slower cellular 
uptake than their spherical counterparts and they seem to able to act as intracellular 
delivery vectors.  
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Chapter 5: Receptor-mediated endocytosis of  
PMPC-PDPA polymersomes by scavenger 
receptors and tetraspanins 
 
Part of this chapter has been published as: 	  
Polymersome-mediated delivery of combination anti-cancer therapy to head and neck 
cancer cells: 2D and 3D in vitro evaluation. 	  
Helen E. Colley*, Vanessa Hearnden*, Milagros Avila-Olias*, Denis Cecchin, Irene 
Canton, Jeppe Madsen, Sheila MacNeil, Nicholas Warren, Ke Hu, Jane A. McKeating, 
Steven P. Armes, Craig Murdoch, Martin H. Thornhill, and Giuseppe Battaglia 	  
Molecular Pharmaceutics 2014 11 (4), 1176-1188 
* Authors contributed equally to this study 
 
5.1 Introduction 
 
PMPC-PDPA polymersomes have the ability to enter many different cell types 
including primary cells, STEM cells and cancer cell lines166. The enhanced uptake 
observed for this formulation is surprising given the properties of the polymer forming 
the external brush of the nanoparticles. The PMPC (poly(2-methacryloyloxyethyl 
phosphorylcholine)) is a biocompatible and fouling-resistant polymer. Due to this 
ability to avoid non-specific adsorption of proteins it is currently used for the coating of 
several medical devices/implants209,210. At the nanometer scale, polymeric nanoparticles 
with anti-fouling properties are often associated with increased blood circulation 
times211, this being  the reason for the usual coating of nanoparticles with polyethylene 
glycol (PEG), the most well known biocompatible and fouling-resistant polymer at the 
present. As a trade-off, nanosystems with such properties frequently have reduced 
cellular uptake. Therefore, PEGylated nanoparticles tend to be decorated with ligands 
on their surface for the targeting of specific cellular receptors. The attachment of 
ligands enhances nanoparticle cellular-recognition and promotes the endocytosis of the 
particle212. Nevertheless we have observed a high cellular uptake for PMPC-PDPA 
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polymersomes, and when PEG-PDPA polymersomes were compared with PMPC-
PDPA polymersomes, the cellular uptake for the PMPC formulation was more than 10 
times higher166. 
The fact that PMPC based polymersomes are easily taken up by different cell types 
could indicate a specific interaction with the cell through the targeting of specific 
membrane receptors. A literature search looking for potential receptors for PMPC based 
polymersomes was conducted and scavenger receptors (SCrs) emerged as the strongest 
candidates. SCrs are a large family of structurally unrelated transmembrane 
glycoproteins originally identified by Brown and Goldstein in 1979213,214. Eight classes 
have been defined so far, among them, SCrs classes A and B are the best characterised 
and different subtypes have been discovered within these two classes. While SCrs type 
B are almost ubiquitously found in mammalian cells215, with the exception of CD163 
which is only expressed by macrophages and monocytes, expression of SCrs type A is 
more restricted to myeloid cells and specific endothelial and epithelial cells216,217. These 
receptors recognise with high specificity many different types of ligands such as 
polyanionic ligands (i.e. polynucleotides and anionic phospholipids), viruses, bacteria, 
and endogenous nanoscopic particles (chylomicrons, HDL, oxidised LDL and 
acetylated LDL)216,218. Moreover, they have been implicated in the cellular uptake of 
some synthetic nanoparticles219-223. Interestingly, viruses and endogenous particles 
recognised by these receptors share with PMPC-PDPA polymersomes crucial physical 
characteristics for cellular uptake such as shape and a nanometer size. Additionally, the 
PMPC external brush of our polymersomes is enriched in phosphocholine groups, a 
specific recognition motif in ligands targeting some SCrs class B224.  
 
With the aim to investigate whether PMPC-PDPA polymersome internalisation is a 
receptor-mediated endocytic process in mammalian cells, facilitated at least to some 
extent by scavenger receptors, I conducted the experiments detailed below.  	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5.2 Results 
 
5.2.1 Effect of ligands for scavenger receptors A and B in PMPC-
PDPA polymersome uptake 
 
To test our hypothesis that SCrs might mediate polymersome uptake, I pre-incubated 
different cells types including primary HDFs, epithelial cancer cell-lines such as FaDus, 
HeLas and Huh7, and immune cells like LADMACs and macrophages (I-11.15 
macrophages) with Fucoidan and Polyinosinic acid, known ligands for SCrs. 
Polyinosinic acid is a single stranded polynucleotide of inosine that specifically targets 
SCrs type A225. Fucoidan is an anionic polysaccharide that binds to SCrs type A and 
SCrs type B226,227. It is important to specify that Fucoidan was considered a specific 
ligand for SCrs type A. Although some papers can be still found in which it is referred 
to as a specific ligand for SCrs type A, it has been demonstrated that Fucoidan binds 
also to SCrs type B and therefore it can be defined as a ligand for both scavenger 
receptors classes
226,227
. Following pre-incubation with SCrs ligands, cells were 
incubated with fluorescent-labelled polymersomes without removing the ligands from 
the media. Results are presented in figure 5.1. It can be observed how polymersome 
uptake was almost completely inhibited in the presence of Fucoidan, with fluorescence 
levels similar to cells that were not incubated with polymersomes. There was no 
statically significant difference between untreated cells and cells incubated with 
Fucoidan plus polymersomes for all the cell types with the exception of FaDus. 
Nonetheless, an inhibition around 80% in polymersome uptake was still observed on 
FaDu cells. On the other hand, pre-incubation with Polyinosinic acid did not produce a 
statistically significant inhibition in the cellular uptake of polymersomes except in the 
case of HeLas, where polymersome uptake was reduced by 40%. 
 
The results obtained are a proof-of-concept that SCrs are indeed implicated in PMPC-
PDPA polymersomes internalisation in mammalian cells, in addition, they point to SCrs 
type B as the ones associated with their cellular uptake. 
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Figure	   5.1:	   Effect	   of	   Fucoidan	   and	   Polyinosinic	   acid	   on	   polymersome	   uptake	   in	  
different	  cell	  types	  
Normalised	  MFI	  values	  obtained	  by	  flow	  cytometry	  for	  cells	  pre-­‐incubated	  with	  either	  
Fucoidan	   or	   Polyinosinic	   acid	   for	   1	   hour	   followed	   by	   incubation	   with	   1	   mg/ml	   of	  
fluorescent	  polymersomes	  for	  another	  hour.	  Negative	  control:	  cells	  incubated	  neither	  
with	   scavenger	   receptors	   ligands	   nor	  with	   polymersomes.	   Positive	   control:	   cells	   not	  
pre-­‐incubated	   with	   F	   or	   PI.	   n=3	   experiments.	   Error	   bars:	   ±	   sem.	   Statistical	   analysis:	  
one-­‐way	   ANOVA	   plus	   Bonferroni	   post-­‐test.	   ♯	   Represent	   statistically	   significant	  
difference	   compared	   with	   the	   negative	   control.	   *	   Represent	   statistically	   significant	  
difference	  compared	  with	  the	  positive	  control,	  p<0.01	  (**	  or	  ♯♯),	  p<0.001	  (***).	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5.2.2 Scavenger receptors type B: Role of SR-BI, SR-BII and CD36 in 
PMPC-PDPA polymersomes uptake	  
 
Four subtypes of scavenger receptors B expressed at the cell surface have been 
identified and characterised: CD36, SR-BI (also referred as CLA-1) and its isoform SR-
BII, and CD163 (5 isoforms). The narrow distribution of CD163, only expressed by 
monocytes and macrophages drove my attention towards the other two subtypes. CD36 
and SR-BI comprise a glycosylated extracellular domain, two transmembrane regions, 
and cytoplasmic amino- and carboxyl-terminus. SR-BI and SR-BII are splice variants of 
the same gene with the same extracellular loop and different C-terminus228. SCrs type B 
are widely expressed across different cell types comprising phagocytic immune cells 
such as macrophages, neutrophils, and monocytes, adipocytes, and diverse endothelial 
and epithelial cells including hepatocytes. FaDus and HDFs are positive for the 
expression of SCrs B229 (EMBL-EBI database). These receptors were first intensively 
studied in the uptake of modified lipoproteins, specially oxidised and acetylated 
LDL230. Since then, they have also been implicated in the removal of apoptotic cells and 
in the immune response by mediating the uptake of Plasmodium falciparum infected 
cells (CD36) and the cellular entry of different viruses and bacteria218,231. SR-BI and 
SR-BII are particularly recognised as the cellular receptors of HDL, being able to either 
mediate the internalisation of the particle, or the exchange of cholesterol between the 
HDL particle and the cell via their lipid exchange activity232-234. From a functional point 
of view, it appears that SR-BI and SR-BII accomplish the same functions although often 
they do it with different efficiency228. The experimental design for most of the 
experiments detailed in this section is based on the targeting of the extracellular loop of 
the SR-B receptors. According to the information just presented both SR-BI and SR-BII 
will be targeted by this means and consequently from now on I will refer to both of 
them as SR-Bs.  
 
To differentiate which subtype of SCr type B is responsible for the binding of PMPC-
PDPA polymersomes I tried to specifically block either the CD36 or the SR-Bs 
receptors and subsequently analyse polymersome internalisation under these conditions. 
The first study involved the use of the ketoamide ITX5061, a specific SR-Bs antagonist 
able to inhibit SR-Bs dependent uptake of HDL cholesterol esters and HCV 
infection235,236. 
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HDFs were pre-incubated with different ITX5061 concentrations (1 µM, 10 µM, 20 
µM) for one hour prior to incubation with rhodamine-labelled polymersomes for 
another hour in the presence of the antagonist. Flow cytometry results are shown in 
figure 5.2.a. Pre-incubation with ITX5061 produced a significant inhibition, close to 
50%, in PMPC-PDPA polymersome internalisation. There was no noticeable difference 
in the inhibition achieved by increasing concentrations of the antagonist suggesting that 
only 1 µM of the antagonist was enough to saturate SR-Bs receptors in HDFs.   
 
A specific antibody against the extracellular loop of CD36 was used to investigate 
polymersome internalisation under conditions where this receptor was blocked. Fadu 
cells were pre-incubated with the anti-CD36 antibody prior to the addition of 
fluorescent polymersomes to the cells. Cells were then incubated in the presence of both 
the antibody and polymersomes for a further hour and nanoparticle uptake was 
investigated by flow cytometry. As it can be observed in figure 5.2.d there was almost 
no difference in polymersome internalisation between cells incubated in the presence or 
absence of anti-CD36.  On the other hand, when an anti-SR-Bs antibody was used, a 
significant inhibition in polymersome internalisation, around 50%, was achieved. As 
observed in figure 5.2.e, this inhibition was further increased to 90% when the 
concentration of specific IgG was increased. It is important to point out that although a 
non-targeting IgG control produced an inhibition close to 50% this could be, at least to 
some extent, an artefact originating from the experimental procedure. The anti-SR-Bs 
antibody used on these studies is an antiserum preparation while the control IgG used is 
a pure IgG fraction with no other protein present in the commercial preparation, 
according to the information supplied by the manufacturer. Hence, for the same amount 
of IgG added to the cells the concentration of specific anti-SR-Bs IgG that the cells 
were incubated with is likely to be a low value, furthermore, this targeting IgG is 
surrounded by a heterogeneous protein mixture as it is characteristic for an antiserum 
preparation.  On the other hand, in the case of the IgG control, cells were incubated with 
a high concentration of pure IgG that under those conditions could be easily sticking to 
the cell surface and strongly contributing to the inhibition observed. In any case, at 
equal IgG concentrations, the inhibition in polymersome internalisation observed under 
specific blocking of SR-Bs was significantly stronger than the inhibition detected when 
the non-specific IgG was used (figure 5.2.e).  
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Even though blocking of CD36 did not produce an inhibition in polymersome uptake 
(figure 5.2.d), simultaneous blocking of CD36 and SR-Bs, using specific antibodies 
against each of them, resulted in significantly stronger inhibition than the one produced 
when only SR-Bs were neutralised. As it can be observed in figure 5.2.f, for the same 
concentration of specific IgG/well, inhibition of polymersome internalisation is close to 
50% when only SR-Bs was blocked compared to more than 80% inhibition when the 
binding to both receptors was hindered. This result suggests that a role for CD36 in the 
uptake of PMPC-PDPA polymersomes should not be totally discarded at this stage. 
 
The strong inhibition in PMPC-PDPA polymersome uptake observed under SR-Bs 
neutralising conditions either by the presence of a receptor antagonist or by a specific 
antibody led me to investigate the uptake of nanoparticles in SR-Bs knockdown cells. 
Knockdown of the scavenger receptors type B SR-Bs in FaDu cells was performed by 
electroporation using the NEONTM transfection system (Invitrogen). Effective 
knockdown of SR-Bs was accomplished after a process of optimization where different 
siRNA concentrations from 40 nM up to 160 nM were tested. Knockdown was 
investigated after 24, 36 and 48 hours post-transfection. Although knockdown levels 
were encouraging, there were still residual SR-Bs 24 hours after transfection (data not 
shown). By contrast, after 36 hours transfection with either 130 or 160 nM of siRNA, 
SR-Bs levels were almost zero as investigated by western blotting (figure 5.3.a); at 48 
hours post-transfection proteins levels started to be recovered (figure 5.3.b). Therefore, 
transfection with 130 nM of siRNA during 36 hours was chosen as the ideal 
experimental set-up to study polymersome uptake in the absence of scavenger receptor 
SR-Bs.  
Uptake of PMPC-PDPA polymersome in SR-Bs knockdown cells is shown in figure 
5.3.c. Surprisingly, there was no significant inhibition of polymersome uptake when 
SR-Bs was knocked down, which contrasts with the results obtained when SR-Bs were 
present but blocked with an antibody. Nevertheless, although the inhibition was not 
significant, it was observed a tendency towards a reduced uptake (> 20%) in cells where 
the knockdown effectiveness was close to 100% (almost no detectable protein 
expression by western blotting, experiments 2 and 3) (figure 5.3.d-e). 	  
The information derived from the inhibitory experiments performed, the blocking 
studies and the SR-Bs knockdown, points out a role for SR-Bs in PMPC-PDPA 
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polymersome uptake and at the same time it also highlights that it could be another 
receptor rather than SR-Bs and CD36 mediating polymersome internalisation in 
mammalian cells. 	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Figure	   5.2:	   Scavenger	   receptors	   type	   B:	   SR-­‐BI,	   SR-­‐BII	   and	   CD36	   in	   polymersome	  
uptake	  
a)	   Inhibition	  of	  polymersome	   internalisation	   in	   the	  presence	  of	   the	  SR-­‐Bs	  antagonist	  
ITX5061	   in	   HDFs.	   b)	   %	   Fluorescent	   cells	   after	   incubation	   with	   fluorescent	  
polymersomes	   in	   the	   presence	   or	   absence	   of	   serum.	   c)	   Normalised	   MFI	   values	  
associated	  with	  cells	  after	  incubation	  with	  fluorescent	  polymersomes	  in	  the	  presence	  
or	   absence	   of	   serum.	   d)	   Uptake	   of	   polymersomes	   in	   cells	   pre-­‐incubated	   with	   an	  
antibody	   against	   SR-­‐Bs	   (whole	   antiserum)	   or	   a	   non-­‐specific	   IgG	   (pure	   IgG	   fraction).	  
Cells	   incubated	   with	   polymersomes	   in	   the	   absence	   of	   antibody	   and	   cells	   incubated	  
neither	  with	  antibody	  nor	  with	  polymersomes	  are	   included	  as	  controls.	  e)	  Uptake	  of	  
polymersomes	   in	  cells	  pre-­‐incubated	  with	  an	  antibody	  against	  CD36.	  Control	  wells	  as	  
in	  d.	  f)	  Comparison	  of	  polymersomes	  uptake	  in	  cells	  pre-­‐incubated	  with	  either	  an	  anti-­‐
SR-­‐Bs	  or	  with	  a	  combination	  of	  anti-­‐SR-­‐Bs	  plus	  anti-­‐CD36	  antibodies;	  controls	  as	  in	  d.	  
All	   experiments	   in	   the	   figure	   were	   analysed	   by	   flow	   cytometry;	   graphs	   display	  
normalised	  MFI	   values	   except	   b)	  which	   shows	  %	   fluorescent	   cells.	   n=3	   experiments.	  
Error	   bars:	   ±	   sem.	   Statistical	   analysis:	   one-­‐way	   ANOVA	   plus	   Bonferroni.	   p<	   0.05	   (*),	  
p<0.01	  (**),	  p<0.001	  (***).	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Figure	  5.3:	  Uptake	  of	  PMPC-­‐PDPA	  polymersome	  in	  SR-­‐Bs	  knockdown	  FaDu	  cells	  
a-­‐b)	  SR-­‐Bs	  cellular	  levels	  by	  western	  blotting	  at	  36	  a)	  or	  48	  b)	  hours	  after	  transfection	  
with	   two	   different	   concentrations	   of	   non-­‐targeting	   or	   targeting	   siRNA.	   c)	   Flow	  
cytometry	   results	   showing	   uptake	   of	   polymersomes	   in	   non-­‐transfected	   cells,	   non-­‐
targeting	   siRNA	   transfected	   cells	   and	   SR-­‐Bs	   knockdown	   cells.	   n=2experiments	  
(experiments	  2	  and	  3),	   ±	   sem.	  d)	   Combined	  graphs	   showing	  uptake	  of	  polymersome	  
(bar	  chart)	  and	  SR-­‐Bs	  expression	  levels	  measured	  by	  western	  blotting	  (grey	  traces)	  for	  
four	   individual	   knockdown	   experiments	   performed.	   e)	   Western	   blots	   from	  
experiments	   in	  d.	   	   nt:	   non	   transfected	   cells.	  NT:	   cells	   transfected	  with	  non-­‐targeting	  
siRNA.	  *	  100-­‐150	  kDa	  band	  instead	  of	  75	  kDa.	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5.2.3 Tetraspanin CD81 in PMPC-PDPA polymersome uptake 
 
Tetraspanins are a family of transmembrane proteins discovered in 1990
237,238
. 
Members of this family present four transmembrane domains defining a small and a 
large extracellular loop with cytoplasmic N- and C-terminus. As many as thirty-three 
tetraspanins have been identified in mammals being in most of the cases widely 
expressed across all the spectra of mammalian cells, both intracellularly and at the 
plasma membrane. Tetraspanins often interact among themselves or with other proteins 
(i.e. integrins) forming tetraspanin-enriched domains 105 at the cell membrane, which 
are different to lipid rafts239. Nowadays tetraspanins attract great interest in two major 
biomedical areas, cancer and infection, with different viruses and bacteria targeting 
tetraspanins to enter host cells240. One example is the tetraspanin CD81, which is 
expressed by all mammalian cells investigated except red blood cells, platelets and 
neutrophils. CD81 is one of the best-studied tetraspanins due to its involvement in the 
internalisation of hepatitis C virus (HCV), where it is one of the main receptors 
implicated, together with the scavenger receptor SR-BI. Interestingly, this is not the 
only situation where CD81 and SR-BI have been identified as co-receptors of a specific 
ligand, both are also involved in the internalisation of Plasmodium sporozoites240,241. 
 
The fact that scavenger receptor SR-BI and tetraspanin CD81 work together in the 
internalisation of some natural cargoes, which in turn are exogenous particles, one of 
them with all its dimensions in the nanometer range, and taking into account the results 
previously described in this chapter, we propose that CD81 is a good candidate for 
being a receptor implicated in PMPC-PDPA polymersome internalisation in 
mammalian cells.  
To investigate a possible role for the tetraspanin CD81 in polymersome internalisation I 
studied the cellular uptake of PMPC-PDPA polymersomes in HDF, FaDu and Huh7 
cells previously incubated with a neutralising antibody anti-CD81. The results presented 
in figure 5.4 show a strong and significant inhibition of polymersome uptake in all the 
three cell types under study, 88%, 70% and 75% respectively, when CD81 was blocked 
highlighting a role for CD81 in the cellular uptake of the nanoparticle formulation. 
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Three receptors have been investigated in this chapter in relation with PMPC-PDPA 
polymersome uptake in mammalian cells: the scavenger receptors type B CD36 and SR-
Bs, and the tetraspanin CD81. The same global effect, an inhibition in the cellular 
uptake of polymersome internalisation was observed across different cell types upon 
blocking of either scavenger receptors type B (figure 5.1) or tetraspanin CD81 (figure 
5.4). On the other hand, I have often observed that PMPC-PDPA polymersomes are not 
taken up to the same degree, or with the same rate, by different cells types. Figure 5.2.c 
shows uptake of fluorescent-labelled polymersomes as measured by flow cytometry 
after 90 minutes incubation of HDF, FaDu and Huh7 cells. I believe that diverse cellular 
expression levels of the receptors investigated in here across the cell types could 
explain, at least in part, the differences in polymersome internalisation kinetics 
observed. In order to test this hypothesis the levels of CD36, SR-BI and CD81 at the 
plasma membrane of live HDF, FaDu and Huh7 cells were investigated by indirect 
immunofluorescence and flow cytometry. Results in figure 5.5.a shows how expression 
levels of CD36 among the different cells under study is almost equal while in the case 
of the tetraspanin CD81, it seems to be a higher concentration of receptor on the plasma 
membrane of primary HDF, compared with the cancer cells lines. Finally, the highest 
difference in receptor expression was observed with the scavenger receptors SR-Bs that 
appears to be enriched in the plasma membrane of Huh7 compared to FaDu (almost two 
fold increase) while HDFs express very low levels of this scavenger receptor at the cell 
surface. Therefore, the hepatocytes are the cell type under study, which present 
altogether higher expression of the receptors that seem to be regulating the endocytosis 
of PMPC-PDPA polymersomes. As a result, it could be expected a high avidity for 
polymersomes in Huh7 with a consequent enhanced uptake compared with HDF and 
FaDu cells. However as it can be seen in figure 5.2.c FaDu cells and not Huh7, are the 
ones showing an enhanced uptake of this formulation. A high expression at the plasma 
membrane of CD81 and SR-Bs does not therefore directly correlate with a higher 
uptake of PMPC-PDPA polymersomes. 
 
The cellular expression of the tetraspanin and the scavenger receptors was further 
studied in FaDu cells by confocal microscopy. In order to obtain information not only 
of the expression of the receptors at the cell surface but also to learn whether there are 
intracellular pools of this receptors and how they are distributed inside the cell FaDu 
cells were fixed and permeabilised prior to performing indirect immunolabeling of the 
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receptors. Images in figure 5.5.b are Z projections from Z-stacks in a group of cells 
displaying the distribution of each receptor. The first thing that can be observed is that 
all cells within the group express the receptors, there are not subpopulations of cells that 
do not express a certain receptor, although in the case of CD36 the expression in some 
cells is very low. The second important point is that expression of the receptors seems 
enhanced in dividing cells compared with non dividing cells, this was specially 
noticeable for SR-Bs. This point was further verified by quantification of the 
fluorescence associated with dividing and non-dividing cells across different pictures. In 
the case of the SR-Bs expression of the receptors was significantly higher in dividing 
cells. Dividing cells also present enhanced expression of CD81 protein. On the contrary, 
there was no overall difference in expression levels in dividing vs. non-dividing cells in 
the case of CD36.  
A detailed 3D analysis of the expression of each receptor in a single cell is shown in 
figures 5.5.c and 5.5.d. Comparing the single Z-slice montages in figure 5.5.d it can be 
seen how expression of the tetraspanin CD81 is almost restricted to the periphery of the 
cell while SR-Bs is evenly distributed through all the cell volume. The scavenger 
receptor CD36 is present both intracellularly and at the cell surface but it seems to be 
slightly more expressed at the plasma membrane. SR-Bs expression through the cell 
appears to be quite homogeneous and more diffuse compared with the other two 
receptors. In the case of CD81, it specially seems to be arranged into clusters or 
domains while CD36 distribution from this perspective would be a case in between the 
two expression patterns observed for SR-Bs and CD81.  	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Figure	  5.4:	  Uptake	  of	  polymersomes	   in	  the	  presence	  of	  a	  blocking	  antibody	  against	  
CD81	  
Normalised	  flow	  cytometry	  results	  comparing	  polymersome	  uptake	  in	  cells	   incubated	  
with	   an	   antibody	   targeting	   the	   extracellular	   loop	   of	   CD81	   vs.	   uptake	   in	   normal	  
conditions	  (absence	  of	  antibody)	  or	  the	  presence	  of	  a	  control	  IgG	  (non-­‐targeting	  IgG).	  
n=3	   experiments.	   Erros	   bars:	   ±	   sem.	   Statistical	   analysis:	   one-­‐way	   ANOVA	   plus	  
Bonferroni	  post-­‐test	  p<0.001	  (***).	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Figure	   5.5:	   Cellular	   expression	  of	   the	   scavenger	   receptors	   SR-­‐Bs	   and	  CD36	   and	   the	  
tetraspanin	  CD81	  in	  mammalian	  cells	  
a)	  Plasma	  membrane	  levels	  of	  SR-­‐Bs,	  CD36	  and	  CD81	  receptors	  in	  live	  HDFs,	  FaDu	  and	  
Huh7	  cells	  measured	  by	  flow	  cytometry.	  b-­‐d)	  Cellular	  distribution	  of	  SR-­‐Bs,	  CD36	  and	  
CD81	  receptors	  by	  immunofluorescence	  in	  fixed	  FaDu	  cells.	  b)	  Confocal	  micrographs	  of	  
the	  distribution	  of	   each	   receptor	   in	   a	   group	  of	   cells.	   Scale	  bars:	   4	  µm.	  Right	   graphs:	  
receptor	   expression	   (MFI	  per	   cell)	   in	  dividing	   cells	  vs.	   non-­‐dividing	   cells.	  Mean	  ±	   SD.	  
Statistical	   significant	   difference	   (student’s	   t-­‐test,	   **	   p<0.01,	   *	   p<0.05).	   c)	   Single	   cell	  
detail	  of	  the	  distribution	  of	  each	  receptor	  by	  confocal	  microscopy.	  3D	  reconstructions	  
across	  the	  Z	  planes	  of	  the	  cells	  are	  shown	  from	  two	  perspectives:	  top	  projections	  (left	  
panels)	   and	   side	  projections	   (central	   panels).	   	   Right	   panels	   represent	   a	   single	   Z	   slice	  
through	  the	  nucleus	  of	  the	  cell.	  Scale	  bars:	  5	  µm.	  d)	  Montage	  pictures	  of	  Z	  stacks	  in	  c	  
displaying	  the	  single	  Z	  slices.	  Slice	  width:	  0.28	  µm	  (SR-­‐Bs),	  0.22	  µm	  (CD36)	  and	  0.28	  µm	  
(CD81).	  Scale	  bars:	  5	  µm.	  	  
	   124	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   125	  
5.3 Discussion 
 
The aim of the present research, motivated by the favourable internalisation of PMPC-
PDPA polymersomes observed in mammalian cells, was to investigate whether PMPC-
PDPA polymersome uptake is a receptor-mediated endocytic process and whether this 
endocytosis is mediated by scavenger receptors in mammalian cells. With this in mind, I 
investigated uptake of polymersomes in serum free conditions and in cells where 
scavenger receptors were blocked or inhibited by different means. 
 
I observed that polymersome uptake is enhanced in serum free conditions (figures 5.2.b 
and 5.2.c), which is in line with a role for SCrs in PMPC-PDPA polymersome 
internalisation. Although the exact composition of FCS (fetal calf serum) is not known, 
it is expected to be rich in lipoproteins that are natural ligands of SCrs. Therefore, it is 
reasonable to think that these lipoproteins could compete with polymersomes for the 
SCrs with a consequent higher nanoparticle uptake in serum free conditions. 
Interestingly, Patel et al., have recently reported 150% higher uptake of their 
biofuntionalised nanoparticles in serum free conditions while investigating the SCrs 
mediated uptake of the nanoparticles. These results are agreement with my own 
observations.  
A different interpretation of the results obtained would imply the adsorption of serum 
proteins to the polymersome surface, to form a protein corona. The protein corona will 
control the interactions of the nanoparticle with the surroundings, including the rate and 
the mechanism of cellular internalisation of the protein-polymersome aggregate242. 
Nonetheless, results recently generated in our laboratory have shown, using isothermal 
titration calorimetry, that serum albumin, the most abundant protein in mammals 
blood243, as well as a standard IgG, does not interact with PMPC-PDPA polymersome 
surface (Prof. Battaglia unpublished data). 
 
The fact that polymersome internalisation was almost completely abolished in the 
presence of Fucoidan, a ligand for SCrs type A and B (figure 5.1), in the six different 
cell types under study support receptor-mediated endocytosis as a common uptake 
mechanism for PMPC-PDPA polymersomes in mammalian cells. Additionally, the fact 
that nanoparticle endocytosis was inhibited in the presence of a ligand for SCrs type A 
and B but not in the presence of a specific ligand for SCrs type A led me to look into the 
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specific target receptor for the nanoparticles among three types of SCrs B expressed at 
the plasma membrane: SR-BI, SR-BII and CD36. SCrs type A have therefore not being 
further investigated in this thesis in relation with PMPC-PDPA polymersome 
internalisation although I realise that the inhibition observed in cells incubated with 
Fucoidan could be the result of the simultaneous blocking of both types of receptors. In 
any case, we found important evidence that SR-Bs receptors (SR-BI and SR-BII) are 
participating in the internalisation of this polymersome formulation since nanoparticle 
uptake is reduced to 50% in cells pre-incubated with ITX5061 (figure 5.2.a), an 
antagonist of SR-Bs receptors. Moreover blocking of SR-Bs using a specific antibody 
against the extracellular loop of these receptors inhibited polymersome uptake up to 
80% in a concentration dependent manner (figure 5.2.d). The use of an antibody to 
block CD36 did not result in a significant inhibition of polymersome internalisation 
(figure 5.2.d). However, simultaneous blocking of SR-Bs and CD36 produced a 
stronger inhibition than the inhibition observed when only SR-Bs was blocked (figure 
5.f), suggesting that CD36 could still have a role in PMPC-PDPA polymersome 
internalisation. 
Surprisingly, the uptake of polymersomes in SR-Bs knockdown cells was not 
significantly perturbed. Nevertheless, we should not exclude a role for these receptors in 
PMPC-PDPA polymersome internalisation based on knockdown studies alone. It is not 
the first case reported where siRNA-mediated inhibition of SCrs did not result in the 
inhibition of the cellular uptake of an exogenous ligand otherwise strongly inhibited 
using another experimental approach. In 2006 Saleh et al., were the first to link the 
uptake of exogenous double stranded RNA (dsRNA) with SCrs in Drosophila S2 cells. 
They observed a strong inhibition in dsRNA endocytosis using a pharmacological 
approach but failed to replicate the inhibition by knocking down as many as 19 genes 
coding for SCrs. Neither the individual knockdown nor the simultaneous knockdown of 
the genes inhibited the cellular uptake of dsRNA244. More recently, in 2010, Patel et al., 
discovered that specific biofunctionalised nanoparticles were taken up by SCrs in 
mammalian cells. Internalisation of oligonucleotide-funtionalised gold nanoparticles 
was reduced >60% in cells incubated with either Fucoidan or Polyinosinic acid. On the 
other hand knockdown of SCrs type A, SCrs type B or simultaneous knockdown of both 
types did not inhibit nanoparticle uptake219. In both cases, they concluded that 
simultaneous knockdown of different receptors was probably not enough to impair the 
uptake through remaining receptors at the cell surface, or that unidentified family 
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members were responsible for the effective cellular uptake. In line with this, Fucoidan 
and Polyinosinic acid could present a boarder targeting ability as traditionally accepted 
being able to target other members of the scavenger family or even other receptors at 
the cell surface. It is known that Fucoidan can block selectins on the cell surface of 
leukocytes, platelets and red blood cells245. In addition, it has been recently discovered 
to be an agonist to C-type lectin-like receptor 2 (CLEC-2), present in platelets 
neutrophils and dendritic cells246. Although the cells used by Saleh and Patel in their 
studies do not fall into the range of cells expressing selectins or CLEC-2 receptor, it 
illustrates the possibility that the high inhibition observed upon pharmacological 
treatment could be strongly influenced by the blocking of unidentified cellular partners.  
 
The use of different approaches to test the same hypothesis is part of a good scientific 
practice. Nonetheless, it can sometimes lead to apparently opposed results as it has 
happened to other groups before us. In our case the use of a neutralising antibody 
directed against SR-Bs receptors produced the strongest inhibition observed in PMPC-
PDPA polymersome internalisation under neutralising conditions for a specific receptor, 
while the knockdown of SR-Bs did not produce a significant inhibition in polymersome 
uptake. The use of a blocking antibody against a specific SCr represents a fast and 
overall non-cell-disruptive way to specifically assess the implication of a receptor in 
polymersome internalisation. On the other hand, knocking down the protein under study 
offers the possibility to investigate polymersome uptake in the complete absence of the 
candidate receptor, in contrast with the previous approach where the receptor is present 
but blocked. However, to knockdown the expression of one of the constitutive elements 
of a cell can lead to off-target effects. A protein such a membrane receptor is often 
implicated in different functional networks and therefore it could be expected that the 
cell will try to compensate this absence by regulating the expression of other genes or 
the functions of other proteins. These off-targets effects will acquire more importance as 
the time that the cell remains in the absence of the protein increases and could dilute or 
mask the true effect of the receptor under study. The antibody approach is not exempt of 
possible off-target effects either. Sometimes antiserum preparations can contain 
together with the specific IgGs against the receptor under study, another non-reported 
IgGs targeting other surface molecules. Another possibility is that by specifically 
blocking the SR-Bs we are producing a non-specific block of another surface molecule 
working in partnership with the SR-Bs towards the internalisation of the nanoparticles. 
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In either case, the total inhibition achieved would be the result of the simultaneous 
blocking of a receptor complex and the knockdown of only one of the receptors 
implicated might be not enough to effectively inhibit polymersome internalisation. In 
agreement with this possibility I have found evidence that another receptor, tetraspanin 
CD81, is also implicated in PMPC-PDPA polymersome internalisation in mammalian 
cells (figure 5.4). Interestingly both SR-Bs and CD81 receptors seem to be upregulated, 
in terms of cellular protein levels, in dividing cells (figure 5.3.b), an observation that 
could shed some light into the reasons behind the enhanced uptake noticed for this 
formulation in cells with high dividing rates176.  	  
 One of the main characteristics of the tetraspanin family is their ability to physically 
interact with other proteins. Interestingly, the tetraspanin CD9 has been found to 
interact with the scavenger receptor CD5 in the plasma membrane of B cells247. 
Although a direct interaction between the tetraspanin CD81 and the scavenger receptors 
SR-BI/SR-BII has not been identified, CD81 and SR-BI have been found mediating the 
endocytosis of the same exogenous biological particles in the cases of HCV and the 
Plasmodium sporozite. To the best of our knowledge, this is the first time that a 
scavenger receptor and a tetraspanin are implicated together in the endocytosis of man-
made nanoparticles. It is important to highlight that PMPC-PDPA polymersomes are 
completely synthetic nanoparticles that according to the results presented here are 
actively targeting biological receptors without been intentionally biofuntionalised for 
that purpose, as it has been the case for other nanoparticles taken up by SCrs248-250. 
Nonetheless, it is important to highlight that the phosphocholine groups repeated in the 
external brush of PMPC polymersomes are a common chemical group within natural 
systems, and we believe that these groups could be responsible, at least in part, for the 
biological targeting observed. In line with this, PMPC polymersomes targeting of SCrs 
and tetraspanin CD81 could be revealing a novel functionality of the PMPC polymer. 
Like PEG, PMPC is currently used in biomedical applications for its biocompatibility 
and non-fouling properties. This resistance to interact with biomolecules can get in 
conflict with any PMPC responsibility in specific molecular interactions with cellular 
receptors. Nonetheless, it might be possible that the special arrangement of the polymer 
in the surface of highly curved nanovesicles favours its interactions with specific 
receptors in the plasma membrane. Probably guided by a similar  thought Choi et al., 
have recently shown that the cellular uptake, through SCrs, of oligonucleotide-
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funtionalised gold nanoparticles seems to derive from the specific arrangement of the 
nucleotides in 3D structures251. In addition, our own previous results have shown that 
when PMPC distribution at the surface of the polymersomes is not continuous but 
patched, 25% PMPC-PDPA polymersomes vs. 100% PMPC-PDPA polymersomes, 
bigger patched particles can be taken up with the same efficiency as non-patched 
particles half in size
165,166
. With the identification of the specific receptors mediating 
the uptake of PMPC polymersomes this results could be indeed an indication that the 
specific targeting ability of the nanoparticles resides in the combination between the 
physical and the chemical properties of the formulation. This is just one of the 
interesting new lines of work derived from the results presented on this chapter where I 
have shown that PMPC-PDPA polymersome internalisation in mammalian cells is a 
receptor-mediated endocytic process regulated by two different transmembrane family 
proteins, with tetraspanin CD81 and SCrs type B identified as the specific molecular 
targets for this nanoparticle formulation.  
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Chapter 6: Characterising the mechanism of 
receptor-mediated endocytosis of PMPC-PDPA 
polymersomes  
 
6.1 Introduction 
 
From a simple point of view, receptor-mediated endocytosis of cargo comprises a 
specific binding at the cell surface often followed by a local plasma membrane re-
arrangement, and in any case, by a membrane deformation, with the consecutive 
pinching off, and subcellular trafficking, of the endocytic vesicle containing the cargo.  
Having identified at least some of the receptors involved in the first stage of PMPC-
PDPA polymersome endocytosis, I aimed to characterise the subsequent mechanism of 
internalisation of this nanoparticle formulation.  
 
In the previous chapter I have shown that the tetraspanin CD81 and the scavenger 
receptors SR-Bs facilitate the uptake of PMPC-PDPA polymersomes in mammalian 
cells. To gather information about the potential cellular structures defining the 
mechanism of polymersome endocytosis, we could consider the characteristics of the 
endocytic pathways triggered upon binding of recognised ligands of these two 
receptors. The best example is HCV, which directly interacts with the receptors SR-BI 
and CD81 at the cell surface. Bound HCV particles are then translocated to tight 
junctions, in a process that seems to be regulated by claudin 1 and occludin, where they 
are finally internalised by clathrin-mediated endocytosis (CME). Following 
internalisation, the decrease of the pH in the early endosomes triggers the fusion of the 
viral particle with the endosomal membrane and the subsequent release of nucleocapsid 
into the cell cytosol252.  
When considering the possible endocytic pathways that a cargo interacting with CD81 
and SR-BI could follow, it is also worth noticing that both transmembrane proteins have 
being found to bind cholesterol at the plasma membrane253,254, and that SR-BI has been 
shown to be associated with caveolae255, while CD81 is part of tetraspanin enriched 
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domains at the plasma membrane240. Therefore, a cargo using this set of receptors to 
gain cellular entry may use various endocytic routes to achieve this goal. 
 
The ultimate role of PMPC-PDPA polymersomes is to be internalised by the cell and to 
release its cargo at a subcellular level. Nanoparticle endocytosis and its consequent 
subcellular sorting is a complex process to elucidate, with multiple cellular pathways 
often playing interconnecting roles. However, a full understanding of polymersome 
endocytosis will allow the rational improvement of the nanovector features and the 
establishment of the complete toxicological profile of the system. In order to 
characterise the pathway/s of PMPC-PDPA polymersome internalisation I have 
explored several experimental approaches whose results are detailed below.   
 
6.2 Results 
 
6.2.1 Investigation of PMPC-PDPA polymersome endocytosis using 
chemical inhibitors 
 
Chemical inhibitors are compounds that once in contact with the cell will stop or hinder 
endocytosis, either by removing essential structures from the plasma membrane (i.e. 
cholesterol) or by interfering with the normal activity of certain molecules (i.e. 
dynamin). They have been used to study the internalisation mechanisms of different 
nanoparticles. The fact that these experiments are usually considered straightforward to 
perform and interpret, as well as economical, is behind their widespread usage. 
However, in the last few years, the awareness about the extra care needed when 
planning, performing and interpreting studies involving chemical inhibitors has grown 
considerably256,257. These concerns arise in part, from the fact that chemical inhibitors 
can easily induce cellular toxicity256. It is reasonable to think that the normal 
endocytosis of a cargo will be strongly affected if mechanisms of cellular stress and 
death are activated, with the consequent risk of achieving misleading results. Therefore, 
it is crucial to carefully select the concentrations of the chemicals and the time that the 
cells will be exposed to them. It is also clear that these compounds have cell specific 
effects256,258,259; in consequence, treatment conditions should be specifically determined 
for each cell type. Finally, chemical inhibitors have been always associated with a 
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certain lack of specificity256,257 that is has been aggravated, as it has become clear that 
the boundaries between different endocytic routes are less rigid than it was thought a 
decade ago. 
 
Taking into account the considerations mentioned above, the use of chemical inhibitors 
can be still a useful technique to first approach the characterisation of an endocytic 
pathway, especially as a way to narrow down the list of candidates mediating the 
internalisation. Accordingly, we decided to employ inhibitors to start characterising 
PMPC-PDPA polymersome uptake.  
 
6.2.1.1 Prescreen. Selection of chemical inhibitors to map different 
endocytic routes and definition of their treatment window 
 
The range of available inhibitors to study the endocytosis of a system is large, as well as 
the experimental protocols and conditions at which they are used in some cases. To be 
able to investigate different endocytic routes I shortlisted 12 inhibitors, presented in 
table 6.1, together with their inhibitory effect on endocytosis and examples of the 
concentrations and the incubation times previously used in HeLa cells. 
 
6.2.1.1.1 MTT assays 
 
As mentioned before, chemical inhibitors are potentially cytotoxic; as a first step to be 
able to use them to investigate polymersome endocytosis, I screened the shortlisted 
agents for induced cellular toxicity. Based on reported treatments in the literature three 
concentrations were selected for each compound to be tested (table 6.1). In addition, 
each concentration was investigated at three different incubation times: 10, 30, and 60 
minutes. Cellular viability levels after incubation with the inhibitors was explored using 
a MTT assay. Results are presented in figure 6.1.  
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Inhibitor Effect 
Reported 
incubation 
in HeLa (37oC) 
Concentrations 
to be tested 
Chlorpromazine 
(CPZ) 
Prevents the 
assembly of coated 
pits at the plasma 
membrane. Promotes 
reversible 
translocation of 
clathrin and its 
adaptor protein from 
the plasma 
membrane to 
intracellular vesicles. 
14µM 30 min260 
5 µM 
10 µM 
20 µM 
20 µM 65 min 
(30 min pre-i+35 
min t.)261 
Monodansylcadaverine 
(MDC) 
Competitive 
inhibitor of the 
enzyme 
transglutaminase. 
Transglutaminase is 
involved in the 
cross-linking of 
proteins during 
coated pit formation. 
100 µM up to 1 
h*262 
25 µM 
50 µM 
100 µM 
400 µM 1 hr 
(30 min pre-i.+30 
min t.)*263 
Filipin 
(FLP) 
Sequesters 
cholesterol at the 
plasma membrane. 
7,5 µM 30 min260 1 µM 
5 µM 
10 µM 
5µg/ml 50 min 
(30 min pre-i.+20 
min t.)264 
Genistein 
(GNT) 
Inhibits tyrosine 
protein kinase 
impairing actin and 
dynamin 2 
recruitment to the 
endocytic site. 
100 µg/ml 
(30 min pre-i.+20 
min t.)264 
50 µM 
100 µM 
200 µM 
Dynasore 
(DNY) 
Inhibits dynamin 1 
and dynamin 2 
GTPase activity. 
50-80 µM 5 hrs265 
50 µM 
80 µM 
100 µM 
80 µM 45 min 
(30 min pre-i.+15 
min t.)*266 
90µM 30 min260 
Sertraline 
(SRT) 
Inhibits dynamin 1 
and dynamin 2 
GTPase activity. 
20 µM 65 min 
(30 min pre-i.+35 
min t.)261 
5 µM 
20 µM 
50 µM 
Nocodazole 
(NCDZ) 
Disrupts 
cytoskeleton by 
promoting 
microtubule 
depolymerisation. 
33 µM 70 min 
(10 min,4 oC pre-
i+1h t.)*267 
0.3 µM 
3 µM 
33 µM 33 µM 2 hrs 
(1hr pre-i+1h t.)166 	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Inhibitor Effect 
Reported 
incubation 
in HeLa (37oC) 
Concentrations 
to be tested 
Latrunculin B 
(LatB) 
Disruption of 
cytoskeleton by 
inhibiting actin 
filament assembly. 
0.5 µM 15 
min268 1 µM 
5 µM 
10 µM 
2 µM 1.7 hrs 
(40 min pre-
i+1h t.)*267 
Cytochalasin D 
(Cyto-D) 
Disrupts cytoskeleton 
by inhibiting further 
actin polymerisation. 
0.1 µM 30 
min269 
0.1µM 
1 µM 
2 µM 
0.2-4 µM 60 
min pre-i.270 
1-5 µM 1.5 hrs 
(30 min pre-
i+1hr t.)*271 
2 µM 30 min260 
1,1′-
Disulfanediyldinaphthalen-
2-ol (IPA-3) 
Allosteric inhibitor of 
the serine/threonine 
kinase Pak1. 
Pak 1 is a regulator of 
the cytoskeleton 
dynamics through 
effectors such as 
BAR domain 
proteins. 
5-25 µM 1.5 
hrs 
(30 min pre-
i+1hr t.)*271 
10 µM 
25 µM 
50 µM 
5-(N-ethyl-N-isopropyl) 
amiloride (EIPA) 
Blocks the Na+/H+ 
exchangers leading to 
mild acidification of 
the cytosol. 
Decreases plasma 
membrane ruffling 
often associated with 
macropinocytosis. 
25,50 µM 1.5 
hrs 
(30 min pre-
i+1hr t.)*271 25 µM 50 µM 
100 µM 100 µM 10 
min260 
Bafilomycin A1 
(Baf-A) 
Inhibits the vacuolar 
ATPase hampering 
the acidification of 
the endosomal lumen. 
2-100 mM 1.5 
hrs 
(30 min pre-
i+1hr t.)*271 
10 nM 
50 nM 
100 nM 8-200 nM, 60 
min pre-i.270 
	  
Table	  6.1:	  Chemical	  inhibitors	  of	  endocytosis	  	  Mechanisms	  of	  different	  inhibitors	  to	  perturb	  endocytosis,	  examples	  of	  inhibitory	  treatments	   (concentrations	   and	   incubation	   times)	   reported	   in	   the	   literature	   to	  investigate	   endocytosis	   in	  HeLa	   cells,	   and	   concentrations	   of	   each	   inhibitor	   to	   be	  tested	  in	  our	  laboratory.	  Legend:	  pre-­‐incubation	  (pre-­‐i.),	  treatment	  (t.),	  incubation	  with	   inhibitors	   was	   carried	   out	   in	   serum	   free	   media	   (*).
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Figure	  6.1:	  Cell	  viability	  levels	  after	  incubation	  with	  inhibitors	  (MTT	  assays)	  
HeLa	  cells	  were	  incubated	  with	  three	  different	  concentrations	  of	  each	  inhibitor	  for	  10	  
minutes,	  30	  minutes	  or	  1	  hour.	  Cell	  viability	  was	  investigated	  by	  MTT.	  Cells	  incubated	  
only	  with	  ultrapure	  water	  (main	  diluent	  added	  to	  the	  cells	  together	  with	  the	  inhibitors)	  
were	  used	  as	  a	  control,	  and	  were	  set	  to	  represent	  100%	  cellular	  viability	  (dashed	  line).	  
n=3	   experiments.	   Error	   bars:	   ±	   sem.	   Statistical	   analysis:	   one-­‐way	   ANOVA	   plus	  
Bonferroni	   post-­‐test.	   *	   Represents	   statistically	   significant	   difference	   compared	   with	  
control	  cells,	  p<0.05	  (*),	  p<0.01	  (**),	  p<0.001	  (***).	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6.2.1.1.2 Live-Dead cell viability assays: flow cytometry and fluorescence 
microscopy	  
 
Based on the MTT results I decided not to consider monodansylcadaverine, sertraline, 
latrunculin B and EIPA for further studies. On the other hand, the inhibitors and 
concentrations selected for the next screen are listed in table 6.2. 
To verify further that the chosen compounds do not cause cell death or compromise the 
plasma membrane integrity, live/dead assays were performed. Propidium iodide (PI) is a 
red fluorescent intercalating agent (Em: 617 nm) that will not permeate intact cell 
membranes. Therefore, it is usually used to distinguish cells with a compromised 
membrane within a cell population. Using PI, and taking advantage of the possibility to 
analyse large cell populations by flow cytometry, I investigated the percentage of dead 
cells after 30 minutes incubation with the inhibitors at the concentrations listed in table 
6.2. As figure 6.2 shows, the percentage of positive cells for PI staining after inhibitor 
treatment was always ≤ 3% (1.8% for untreated cells), in contrast with the nearly 30% 
observed when cells were incubated with 10% DMSO, a highly cytotoxic organic 
solvent at that percentage. Moreover, the cell population profile in terms of physical 
properties (cell size and granularity), was greatly altered in cells incubated with 10% 
DMSO, while it remained similar to untreated cells in the rest of the conditions.   
In a parallel study, following inhibitor treatment, the cells were incubated with PI and 
SYTO®9, a cell-permeable green fluorescent nucleic acid stain (Em: 500 nm). In this 
case, the cells were analysed by fluorescence microscopy to be able to visualise in detail 
any morphological change induced by the inhibitors. After incubation with both dyes, 
viable cells should be only stained by green SYTO®9, while dead cells or cells with a 
compromised plasma membrane will be simultaneously stained in red by PI. Pictures 
displayed in figure 6.3 demonstrate the low occurrence of cells with compromised 
plasma membrane, and the maintenance of normal cell morphology, in cells incubated 
with chemical inhibitors of endocytosis. On the other hand, cells incubated with 10% 
DMSO appeared as a homogenous cell mass where the nuclear membrane has 
disappeared. The percentage of damaged cells seems higher than the one obtained by 
flow cytometry. At 1% DMSO the previous damaging and drastic effects over cell 
morphology were not observed.  
 
	   139	  
The results derived from the live/dead experiments show that for the proposed 
inhibitors, concentrations and incubation times, cell viability and plasma membrane 
integrity are maintained as normal. 
 
Inhibitor Concentration (µM) 
Incubation 
time (min) 
Chlorpromazine 10 30 
Filipin 5 30 
Genistein 50 30 
Dynasore 50 30 
Nocodazole 33 30 
Cytochalasin D 1 30 
1,1′-Disulfanediyldinaphthalen-2-ol  (IPA-3) 10 30 
Bafilomycin A1 0.01 30 
	  	  	  
Table	   6.2:	   Selected	   inhibitors	   and	   their	   associated	   incubation	   conditions	  
(concentration	  and	  time)	  for	  live/dead	  assays	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Figure	  6.2:	  Live-­‐Dead	  experiments	  I.	  Flow	  cytometry	  
The	  plasma	  membrane	  integrity	  of	  HeLa	  cells	  incubated	  with	  endocytic	  inhibitors	  was	  
investigated	  using	  propidium	   iodide.	   	  Following	   incubation	  with	   inhibitors,	  cells	  were	  
incubated	  with	   the	   red-­‐fluorescent	  dye	  and	   the	  percentage	  of	   fluorescent	  cells	   (cells	  
with	   a	   compromised	   plasma	   membrane)	   was	   explored	   by	   flow	   cytometry.	   Cells	  
incubated	  with	  DMSO	  or	  ultrapure	  water	  were	  used	  as	  positive	  and	  negative	  controls	  
for	  membrane	  damage.	  Dot	  plots	  on	   the	   left	   represent	   the	  cell	  population	  analysed,	  
for	  each	  treatment,	  in	  terms	  of	  size	  (forward	  scatter)	  and	  granularity	  (side	  scatter).	  Dot	  
plots	  on	  the	  right	  display	  cells	  with	  fluorescence	  over	  the	  threshold	  (red	  dots).	  Graphs	  
correspond	  to	  1	  (of	  3)	  experiment	  performed.	  The	  percentage	  shown	  in	  the	  graphs	  is	  
the	  average	  fluorescent	  cell	  population	  from	  3	  independent	  experiments.	  Bar	  chart	  on	  
the	   bottom	   summarises	   the	   data	   from	   the	   3	   experiments	   performed	   for	   each	  
condition.	  Error	  bars:	  ±	  sem.	  Statistical	  analysis:	  one-­‐way	  ANOVA	  plus	  Bonferroni.	  p<	  
0.001	  (***).	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Figure	  6.3:	  Live-­‐Dead	  experiments	  II.	  Fluorescence	  microscopy	  
The	  plasma	  membrane	  integrity	  of	  HeLa	  cells	  incubated	  with	  endocytic	  inhibitors	  was	  
investigated	  using	  propidium	  iodide	  and	  SYTO®9.	  	  Following	  incubation	  with	  inhibitors,	  
cells	  were	  incubated	  with	  the	  nucleic	  acids	  stain	  for	  10	  minutes	  before	  being	  imaged	  in	  
a	  BD	  Pathway	  855	  spinning	  disk	  confocal	  using	  a	  20X	  lens.	  Cells	  incubated	  with	  DMSO	  
or	  ultrapure	  water	  were	  used	  as	  positive	  and	  negative	  controls	  for	  membrane	  damage.	  
Representative	   images	  from	  1	  of	  the	  3	  experiments	  performed	  for	  each	   inhibitor	  are	  
shown.	  Scale	  bars:	  100	  µM.	  	  
SYTO®9 PI Merge 
DYNASORE 
SYTO®9 PI Merge 
CYTOCHALASIN D 
SYTO®9 PI Merge 
IPA-3 
SYTO®9 PI Merge 
Bafilomycin A1 
	   145	  
	  
6.2.1.2. Final screen 
 
The final incubation conditions for the use of each chemical inhibitor were sometimes 
milder than the ones reported in the literature, since the practice to check the toxicity 
induced by these compounds, before using them to inhibit the endocytosis of a cargo, 
has not been very common in the past. Because of the inhibition produced by most of 
these agents is reversible256,266,272,273, they should be also present in the media during the 
incubation with polymersomes. The final layout of the screen, including inhibitors 
concentrations and incubation times is shown in table 6.3.   
Control molecules, representative of different endocytic pathways, were selected to 
analyse their uptake, in parallel to polymersomes, in the presence of the inhibitors. 
Transferrin is considered a specific marker for clathrin-mediated endocytosis274. On the 
other hand, cholera toxin (CTxB) has been traditionally considered a marker for 
caveolae-mediated endocytosis275. However, recent studies suggest that this toxin may 
not be internalised by a canonical caveolae route. The internalisation path followed by 
CTxB could be more accurately defined as dependent on lipid rafts at the surface of the 
plasma membrane276,277, cholesterol dependent276,278	   and caveolae-independent but 
caveolin-1 regulated278,279. Finally, dextrans of the correct molecular weight are suitable 
markers for macropinocytosis the other major ubiquitous endocytic pathway identified 
to date. Dextrans are also considered markers for fluid phase endocytosis. Therefore, 
AlexaFluor®647 conjugates of transferrin (5µg/ml), cholera toxin subunit B (10 µg/ml) 
and 10kDa dextran (0.1 mg/ml) were used as control molecules in the present study.  
 
The results from the screen are shown in figure 6.4. Briefly, the cells were pre-
incubated during 15 minutes with the inhibitors before addition of either rhodamine-
labelled PMPC-PDPA polymersomes (0.2 mg/ml) or control molecules. Incubation was 
maintained for another 20 minutes without removing the inhibitors from the media. 
Afterwards, the media was aspirated and cells were thoroughly washed twice with PBS 
before being processed for flow cytometry. 	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Inhibitor Pre-incubation (15 minutes) 
Incubation 
(20 minutes) 
Chlorpromazine 20 µM 10 µM 
Filipin 10 µM 5 µM 
Genistein 100 µM 50 µM 
Dynasore 100 µM 50 µM 
Nocodazole 66 µM 33 µM 
Cytochalasin D 2 µM 1 µM 
1,1′-Disulfanediyldinaphthalen-2-ol  (IPA-3) 20 µM 10 µM 
Bafilomycin A1 0.02 µM 0.01 µM 
	  
Table	   6.3:	   Selected	   inhibitors	   and	   their	   associated	   incubation	   conditions	  
(concentration	   and	   time)	   to	   investigate	   the	   mechanism	   of	   PMPC-­‐PDPA	  
polymersome	  endocytosis	  in	  HeLa	  cells	  	  	  Cells	   will	   be	   pre-­‐incubated	   with	   the	   indicated	   inhibitor	   concentrations	   for	   15	  minutes	   before	   the	   addition	   of	   polymersomes	   or	   control	   cargoes	   for	   different	  endocytic	   pathways.	   Incubation	  with	   polymersomes	   or	   controls	   was	  maintained	  for	  20	  minutes,	  in	  the	  presence	  of	  the	  inhibitors,	  at	  the	  listed	  concentrations.	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Figure	  6.4:	  Uptake	  of	  PMPC-­‐PDPA	  polymersomes,	  transferrin,	  cholera	  toxin	  subunit	  B	  
and	  dextran	  in	  the	  presence	  of	  inhibitors	  of	  endocytosis	  in	  HeLa	  cells	  
Fluorescent	   intensity	   values	   normalised	   to	   control	   cells	   (cells	   incubated	   with	   PBS	  
instead	  of	   inhibitors)	  of	  HeLa	  cells	   incubated	  with	   rhodamine-­‐labelled	  polymersomes	  
(200	  µg,	  a),	  or	  AlexaFluor®647	  conjugates	  of	  transferrin	  (8	  µg,	  b),	  cholera	  toxin	  subunit	  
b	  (16	  µg,	  c)	  and	  10	  kDa	  dextran	  (100	  µg,	  d)	  in	  the	  presence	  of	  inhibitors	  of	  endocytosis.	  	  
Cells	   were	   pre-­‐incubated	  with	   the	   inhibitors	   for	   15	  minutes	   before	   being	   incubated	  
with	   polymersomes	   or	   control	   cargoes	   for	   20	   minutes	   (in	   the	   presence	   of	   the	  
inhibitors).	  Cells	  were	  analysed	  by	  flow	  cytometry.	  n=3	  experiments.	  Error	  bars:	  ±sem.	  
Control	   cells	   are	   represented	   by	   a	   black	   continuous	   line	   with	   its	   associated	   errors	  
(dashed	   lines).	   Statistical	   analysis:	   one-­‐way	   ANOVA	   plus	   Bonferroni.	   p<	   0.05	   (*),p<	  
0.001	  (***).	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6.2.2 Role of dynamin in PMPC-PDPA polymersome internalisation 
  
According to the results presented in the previous section, none of the endocytic 
inhibitors used produced a statistically significant difference in polymersome uptake. 
Nonetheless, impairing the normal function of dynamin using the inhibitor dynasore 
showed a trend towards reduced polymersome uptake in HeLa cells. Consequently, I 
decided to investigate further the role of dynamin in PMPC-PDPA polymersome 
internalisation. In order to do that, I examined polymersome uptake in cells transiently 
transfected with a dominant negative dynamin. Dynamin K44A is a mutant form of the 
protein dynamin (dynamin 1) impaired in its ability to bind GTP. The mutation is 
localised in the Lysine 44 of the G1 region, in the GTPase domain. It has been 
demonstrated that efficient binding and hydrolysis of GTP are essential for dynamin-
dependent endocytosis280. 
HeLa cells were transfected with either wild type dynamin (WT) or mutant K44A 
dynamin (K44A) cDNA constructs inserted in a cytomegalovirus expression vector, 
using TurboFectTM for 8 hours. Afterwards, transfected cells were incubated with 
CelLuminate® (PMPC-PDPA polymersomes encapsulating rhodamine B octadecyl ester 
perchlorate) for one hour and imaged by confocal microscopy. In a parallel experiment 
transfected cells were incubated for 20 minutes with AlexaFluor®647 transferrin. 
Transferrin endocytosis is dynamin-dependent and the use of dynamin K44A has been 
previously demonstrated to reduce transferrin internalisation
72,281
. Due to the presence 
of a reporter gene encoded in the cDNA used for the transfection, transfected cells are 
fluorescent in blue and therefore, they can be identified under the microscope. Confocal 
micrographs displaying the extent of polymersome and transferrin internalisation in 
transfected cells are presented in figure 6.5. 
 
The effect of the expression of a dominant negative dynamin in polymersome 
endocytosis was also investigated in FaDu cells. Following overnight transfection with 
Lipofectamine®2000, cells were incubated with rhodamine-labelled polymersomes for 1 
hour and analysed by flow cytometry.  In figure 6.6.a representative dot plots obtained 
by flow cytometry are shown. Using the appropriate gating I could segregate transfected 
cells (blue fluorescent cells) from untransfected ones, and investigate polymersome 
internalisation only in the former group. As figure 6.5.b shows there was no reduced 
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polymersome uptake in cells expressing dynamin K44A compared with WT cells. 
Unfortunately, it was not possible to verify the flow cytometry results by using 
fluorescence microscopy in FaDu cells due to technical difficulties. As noticed by flow 
cytometry, the transfection efficiency in FaDu cells was generally low (16 ± 3.9 for WT 
cells and 12 ± 2.4 for K44A mutant cells), even though I tried to improve it by using 
two different vectors, Lipofectamine®2000 and TurboFectTM, and a range of diverse 
experimental settings for each of them. In addition, I noticed that FaDu cells adhered 
with difficulty to dishes or slides for microscopy following transfection with 
Lipofectamine®2000 and TurboFectTM. While FaDus grew very well in polystyrene 
tissue cultured 24 well plates, they did not attach to Ibidi® untreated glass bottom µ-
dishes neither to Ibidi®µ-slides with plastic bottom. I then coated the surface of these 
dishes to improve cellular attachment but FaDus grew with an unusual morphology 
when cultured in poly-L-Lysine incubated µ-dishes and collagen incubated µ-dishes. 
Finally, I discovered that they attach to, and grow normally in Ibidi® tissue culture 
incubated µ-dishes, which are compatible with high-resolution microscopy. 
Nevertheless, transfected FaDu were extremely photosensitive and developed very fast 
and intense phototoxicity after excitation with the 405 laser, which ultimately made it 
impossible to obtain quality confocal micrographs during the course of this thesis.  
 
To summarise, the experiments conducted in this section showed that polymersome 
uptake was not significantly inhibited in cells where dynamin-dependent endocytosis 
was severely impaired due to the overexpression of the mutant K44A dynamin (K44A) 
compared with cells where dynamin-assisted internalisation was almost 100% operative 
(WT dynamin). This was more evident for FaDu cells (figure 6.5) than for HeLa cells. 
Although there was a reduction in polymersome uptake between WT and K44A 
dynamin HeLa cells (figure 6.4.a), the quantitative analysis of the micrographs 
indicated that it was minimal (figure 6.4.d). A more noticeable reduction was observed 
between dynamin K44A cells and non-transfected HeLas (figures 6.4.b-d). Nonetheless, 
it has been previously reported that cells overexpressing wild type dynamin present a 
reduced transferrin endocytosis compared to non-transfected cells281, something that we 
also qualitatively perceived (figure 6.4.a).  
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INTENSITY PARAMETERS FROM MICROSCOPY ANALYSIS 
(POLYMERSOMES CHANNEL) 
Cell type N Min. Max. Median Mode Integrated density 
Non-transfected 5 
123 
± 67 
596 
± 163 
147 
± 72 
139 
± 73 
428.870 
WT dynamin 3 
115 
± 4 
360 
± 130 
146 
± 8.5 
133 
± 4 
152.289 
K44A dynamin 5 
73 
± 98 
329 
± 43 
98 
± 95 
91 
± 99 
107.896 
	  
Figure	  6.5:	  Polymersomes	  and	  transferrin	  uptake	  in	  mutant	  K44A	  dynamin	  HeLa	  cells	  
Cells	  expressing	  a	  dominant	  negative	   form	  of	  dynamin	   (K44A)	  were	   incubated	  either	  
with	   PMPC-­‐PDPA	   polymersomes	   encapsulating	   rhodamine	   B	   octadecyl	   ester	  
perchlorate	   (CelLuminate®)	   (1	  mg/ml,	  1	  hour)	  or	  with	  AlexaFluor®647	   transferrin	   (25	  
µg/ml,	  20	  minutes).	  Non-­‐transfected	  cells	  and	  cells	  transfected	  with	  wild	  type	  dynamin	  
were	   also	   incubated	  with	   the	   cargoes	   and	   used	   as	   controls.	   Cells	   were	   imaged	   in	   a	  
Zeiss	   LSM510	   Meta	   inverted	   confocal	   microscope	   using	   a	   60X	   oil	   immersion	   lens.	  
Transfected	  cells,	   encoding	  a	  blue	   fluorescent	   reporter	  gene,	  were	   identified	  using	  a	  
405	  nm	  laser.	  a)	  Confocal	  micrographs	  displaying	  uptake	  of	  transferrin	  (left	  column)	  or	  
polymersomes	  encapsulating	  a	  fluorescent	  dye	  (right	  column)	  in	  non-­‐transfected	  cells,	  
cells	   transfected	  with	  WT	  dynamin	  and	  cells	   transfected	  with	  mutant	  K44A	  dynamin.	  
All	   cells	   shown	   in	   the	  wild	   type	   and	  dynamin	   K44A	  mutant	   panels	  were	   positive	   for	  
expression	   of	   the	   blue	   fluorescent	   reporter.	   The	   blue	   channel	   has	   been	   omitted	   for	  
clarity.	   	   Scales	   bars:	   10	   µM.	   b-­‐c)	   Confocal	   pictures	   showing	   uptake	   of	   rhodamine-­‐
encapsulated	   polymersomes	   in	   adjacent	   cells.	   In	   both	   pictures,	   cells	   represented	   in	  
blue	   are	   cells	   that	   express	   K44A	   dynamin.	   In	   both	   pictures,	   cells	   that	   are	   not	  
represented	  in	  blue	  correspond	  to	  non-­‐transfected	  cells.	  Non-­‐transfected	  cells	  express	  
only	  endogenous	  dynamin.	  Scale	  bars:	  10	  µM.	  d)	   Intensity	  parameters	  obtained	  from	  
the	  analysis	  of	  confocal	  micrographs	  using	  ImageJ	  1.48q	  software.	  N:	  number	  of	  cells	  
analysed	   in	   each	   group.	   Min.&Max.:	   minimum	   and	   maximum	   grey	   values.	   Median:	  
median	   grey	   value.	  Mode	   (mode	   grey	   value):	  most	   frequently	   occurring	   grey	   value.	  
Integrated	  density:	  the	  sum	  of	  the	  values	  of	  the	  pixels.	  
d 
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Figure	  6.6:	  Polymersome	  uptake	  in	  FaDu	  cells	  expressing	  mutant	  K44A	  dynamin	  
FaDus	  transfected	  with	  mutant	  K44A	  dynamin	  cDNA	  were	  incubated	  with	  rhodamine-­‐
labelled	  PMPC-­‐PDPA	  polymersomes	  (1mg/ml,	  1	  hour).	  Non-­‐transfected	  cells	  and	  cells	  
transfected	  with	  wild	  type	  dynamin	  were	  used	  as	  controls.	  Following	  treatment,	  cells	  
were	   analysed	   by	   flow	   cytometry	   using	   a	   405	   laser	   to	   investigate	   the	   presence	   of	  
transfected	  cells	  (fluorescent	  blue	  reporter	  gene	  encoded	  in	  the	  cDNA)	  and	  a	  488	  nm	  
laser	   to	   assess	   cellular	   uptake	   of	   fluorescent	   polymersomes.	   a)	   Examples	   of	   flow	  
cytometry	   plots	   obtained.	   Transfected	   cells	   are	   fluorescent	   in	   blue	   (X	   axis),	   cells	  
positive	   for	   polymersome	   internalisation	   are	   fluorescent	   in	   red	   (Y	   axis).	   Therefore,	  
transfected	   cells	   that	   have	   interacted	   with	   polymersomes	   are	   displayed	   in	   Q2,	  
transfected	   cells	   that	   do	   not	   uptake	   polymersomes	   fall	   within	   Q4,	   and	   uptake	   of	  
polymersome	   in	   non-­‐transfected	   cells	   is	   represented	   in	   Q1.	   b)	   Median	   fluorescent	  
intensities	   normalized	   to	   control	   cells	   (cells	   not	   incubated	   with	   polymersomes)	  
obtained	   by	   flow	   cytometry	   for	   transfected	   FaDus	   after	   incubation	  with	   fluorescent	  
polymersomes.	  n=3	  experiments.	  Error	  bars:	  ±	  sem.	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5.2.3 BAR domain proteins in PMPC-PDPA polymersome 
internalisation. siRNA screening in Drosophila cells 
 
BAR domain proteins currently attract great attention in the field of endocytosis. 
Proteins belonging to this super family contain a BAR domain within their structure that 
allow them to sense and/or induce membrane curvature and therefore we were very 
interested to study them in relation with PMPC-PDPA polymersome internalisation. 
Since polymersomes are highly curved nanoparticles and the curvature of the system 
influences its uptake, as previously shown in chapter 4, we hypothesise that BAR 
domain proteins could play an important role in PMPC-PDPA polymersome 
endocytosis. To test this hypothesis we took advantage of the Drosophila siRNA 
screening facilities at The University of Sheffield. A small screen, comprising 19 
Drosophila genes that are homologues of human genes coding for BAR domain proteins 
implicated in endocytosis and cellular trafficking, was designed.  The screen was 
completed with another 13 genes coding for diverse proteins related to endocytosis in 
mammalian cells such as clathrin, protein kinase D, epsin, actin, and the identified 
PMPC-PDPA polymersomes receptors CD81 and SR-BI. All the Drosophila genes 
screened, their human homologues and associated human proteins are listed in table 6.4.  
Our aim with this experimental set up was to exploit the high susceptibility of SR2+ 
Drosophila cells to gene inhibition by siRNA, to investigate polymersome uptake in 
Drosophila cells defective in a specific protein related to cellular trafficking, as a way to 
identify potential proteins regulating polymersome endocytosis in mammalian cells. 
Any hits from this screen would be further verified in a secondary screen in mammalian 
cells.   
According to the standard protocol in the screening facility, SR2+ cells were seeded in 
multiwell plates containing 0.25 µg of siRNA per well that is passively incorporated 
into the cells and depletes the expression of the targeted protein over a period of 3 days. 
Transfected cells were then incubated with 5 µg of rhodamine-labelled polymersomes 
for 1 hour before being fixed and imaged in a widefield high-content screening 
microscope (example of images obtained in figure 6.7). A high-content cellular imaging 
software (MetaXpress®) was used to process the images obtained. The software was set 
up to recognise individual cells within a micrograph and to quantify the rhodamine 
fluorescence associated with them. 
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The percentage of fluorescent cells and the fluorescent intensity values retrieved by the 
software were first used to investigate whether the transfection by itself has an effect on 
polymersome uptake. As figure 6.8 shows, around 50% of the cells in both groups, non-
transfected and transfected with non-targeting siRNA, have become fluorescent after 1 
hour incubation with polymersomes, although mean fluorescent intensity associated 
with transfected cells was slightly higher.   
I next examined polymersome uptake in knockdown cells. The average cellular 
fluorescent intensity (± SD) for each transfection condition compared to control cells 
(cells transfected with non-targeting siRNA) is plotted in figure 6.9.a. Knockdown cells 
falling within the variability range of control cells were considered not to present a 
distorted polymersome uptake. As a consequence, cells above or below this threshold 
presented an enhanced/inhibited polymersome endocytosis. A secondary threshold, 
arbitrarily defined as control cells SD ± 5, was implemented in order to differentiate 
between genes that affect polymersomes endocytosis at a low extent and those that 
influence polymersome internalisation at a higher level.  
The same data (average fluorescent intensity) was re-analysed and represented 
according to published methods for hit selection in RNAi high-throughput screens282 
(figures 6.9.b-c). A dual-flashlight chart was used to present at the same time, biological 
meaningful data (difference between the mean fluorescent intensity obtained for 
knockdown and control cells) and statistical information (SSDM). According to the 
guidelines provided in the literature282, and taking into account that my experimental 
design includes an average of 9 technical replicates for each gene,  I use the following 
formula to calculate the strictly standarised mean difference (SSDM): 
Equation 4 
	  
Where Xi is the mean fluorescent intensity from the replicates of the genes and XN is 
the mean fluorescent intensity from the replicates of the control cells. Si and SN 
correspond to the standard deviations of the genes and the control replicates, 
respectively.  
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Genes with a fold change larger than ± 10 and a SSDM superior to ± 1 would be 
considered to code for proteins that are implicated in polymersome uptake in 
Drosophila cells (figure 6.9.b-c).  
 
In general, polymersome uptake was reduced in cells lacking any of the genes studied 
except for Sar1 knockdown cells (gene 25), where the high variability across the 
repeated measurements was big enough to overshadow a biological effect. 
Polymersome uptake was specially reduced in cells missing Lfq (gene 21) and 
CG42388 (gene 19) genes, which correspond to the human proteins epsin and nostrin, 
respectively. Epsin is a protein with membrane-bending capacity that facilitates the 
formation of clathrin-coated invaginations through direct interaction with clathrin283. 
Nostrin is a peripheral cytoplasmic protein that functions as an adaptor of caveolin-1 
and directly interacts with dynamin284. In addition, according to the strong inhibition 
observed after knockdown, the following proteins could be also assisting polymersome 
endocytosis in mammalian cells: Rho GTPase activating protein 10 (gene 13), which 
activates RhoA and Cdc42 (related to clathrin and caveolae-independent endocytosis), 
tetraspanin CD81 (gene 18), protein kinase D (gene 11) that is involved in many 
receptor-mediated signal transduction pathways285, sortin nexins 1, 2, 5 and 6 (gene 9) 
BAR domain proteins facilitating protein sorting,  centaurin-γ-2 (gene15) a GTPase 
activating protein of ARF1, which in turn is related to dynamin-independent 
endocytosis and the endo-lysosomal traffic of proteins through CME, and finally 
centaurin 1 (gene20) that interacts with protein kinase D. 
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Gene 
Number 
Drosophila 
Gene 
Human 
Homologue Gene Human Protein 
1 emp (CG2727) SCARB1 SR-BI 
2* CG8176 FCHo1, FCHo2 
FCH domain only, 
proteins 1 and 2 
3* H3PX1/SH3PX1 (CG6757) 
SNX 9, 
SNX 18 Sortin Nexins 
4 Chc (CG9012) CLTC Clathrin 
5* CG32082 IRSp53/BAIAP2L2 BAI1-associated protein 2-like 2 
6 Arf79F (CG8385) ARF1 ADP-ribosylation factor 1 (ARF1) 
7 nwk (CG43479) FCHSD2/NWK, FCHSD1/NWK2 
FCH and double SH3 domains 
proteins 1 and 2 
8* Cip4 (CG15015) FNBP1L/TOCA-1 Formin-binding protein 1-like 
9* Snx6 (CG8282) 
SNX 1 
SNX 2 
SNX 5 
SNX 6 
Sortin Nexins 
10* Appl (CG7727) APPL2 
Adaptor protein, 
phosphotyrosine interaction, 
PH domain and leucine zipper 
containing 2 
11 PKD (CG7125) PRKD1 Protein Kinase D 
12* Asap1 (CG30372) ASAP2 
Arf-GAP with SH3 domain, 
ANK repeat and PH domain 
containing-protein 2 
13* Graf (CG8948) GRAF2 Rho GTPase activating protein 10 
14* CG17184 ARFIP1 ARFIP2 
Arfaptin 1 
(ADP-ribosylation factor 
interacting proteins 1 and 2) 
15 cenG1A (CG31811) AGAP1 
Centaurin gamma 2 
(Arf-GAP with GTPase, ANK 
repeat and PH domain-
containing protein 1) 
16 santa-maria (CG12789) SCARB1 SR-BI 
17* mim (CG33558) MTSS1L/ ABBA-1 
Metastasis suppressor 1-like 
protein 
18 Tsp96F (CG6120) CD81 CD81 
19* CG42388 NOSTRIN Nostrin 
20* CG8243 ADAP1 
Centaurin 1 
(Arf-GAP with dual PH domains 
containing protein 1) 
21 Lfq (CG8532) EPN1 Epsin 
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Gene 
Number 
Drosophila 
Gene 
Human 
Homologue Gene Human Protein 
22* endoA (CG14296) 
SH3GL2 
SH3GL1 
SH3GL3 
Endophilins 1,2,3 
23* cenB1A (CG6742) ACAP3 
Arf-GAP with coiled-coil, ANK 
repeat and PH domains 3 
24* Amph (CG8604) AMPH/BIN1 Amphiphysin 
25* Sar1 (CG7073) Sar1A GTP-binding protein SAR1a 
26* alphaTub84B (CG1913) 
DNMBP/ 
TUBA Dynamin binding protein 
27 Act5C (CG4027) ACTC1 Actin 
28* Synd (CG33094) PACSIN1 Pacsin/ Syndapin 
29 CG6120 CD81 CD81 
30* CG6167 PICK1 
PRKCA-binding protein 
(protein interacting with C 
kinase 1) 
31 lap (CG2520) SNAP91 Clathrin coat assembly protein AP180 
32 Act42A (CG12051) ACTC1 Actin 
	  
Table	  6.4:	  Genes	  related	  to	  endocytosis	  and	  cellular	  trafficking	  investigated	  
in	  a	  siRNA	  screening	  in	  SR2+	  Drosophila	  cells	  	  Drosophila	  genes	  knocked	  down,	  together	  with	  the	  identification	  number	  used	  in	  the	  screen,	  the	  human	  homologue	  gene	  and	  the	  corresponding	  human	  protein	  for	  each	  of	  them.	  *	  Denotes	  BAR	  domain	  protein.	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Figure	   6.7:	   Uptake	   of	   PMPC-­‐PDPA	   polymersomes	   in	   knockdown	   SR2+	   Drosophila	  
cells.	  Fluorescent	  micrographs	  examples	  
Interaction	  of	  rhodamine-­‐labelled	  polymersomes	  with	  Drosophila	  cells	  where	  gene	  32	  
and	  gene	  5	  were	  depleted	  is	  shown	  in	  the	  bottom	  panels.	  Uptake	  of	  polymersomes	  in	  
cells	  transfected	  with	  non-­‐targeting	  siRNA,	  and	  non-­‐transfected	  cells	  are	   included	  for	  
comparison.	   Cells	   non-­‐incubated	   with	   polymersomes	   are	   shown	   as	   control.	   Images	  
were	  acquired	   in	  an	   ImageXpress	  Micro	  XLS	  widefield	  high	  content	  screening	  system	  
using	  a	  40X	  objective	  and	  analysed	  using	  MetaXpress®	  and	  imageJ	  software	  packages.	  
Scale	  bars:	  20	  µm.	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Figure	   6.8:	   Uptake	   of	   rhodamine-­‐labelled	   PMPC-­‐PDPA	   polymersomes	   in	   non-­‐
transfected,	  or	  transfected	  with	  non-­‐targeting	  siRNA,	  SR2+	  Drosophila	  cells	  
Graph	   displays	   cellular	   uptake,	   in	   terms	   of	   %	   fluorescent	   cells	   and	   fluorescent	  
intensity,	  after	  incubation	  with	  rhodamine-­‐labelled	  polymersomes	  in	  cells	  transfected	  
with	  non-­‐targeting	   siRNA	   compared	  with	   cells	   that	  were	  not	   transfected.	  Rectangles	  
represent	   max.	   and	   min.	   values	   (upper	   and	   lower	   lines)	   and	   mean	   value	   (midline).	  
Non-­‐transfected:	  28	  technical	  replicates.	  Non-­‐targeting	  siRNA:	  63	  technical	  replicates.	               
% Fluorescent
 cells
Fluorescence
 intensity
0
50
100
150
200
0.0
0.2
0.4
0.6
0.8
1.0
%
 F
lu
or
es
ce
nt
 c
el
ls
Non transfected Non targeting siRNA
Fluorescent intensity a.u.
	   163	  
NT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
100
110
120
130
140
Av
er
ag
e 
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 (a
.u
.)
a 
-20 -10 10 20 30 40 50
-4
-3
-2
-1
1
X= FI siRNAi - FI nt control
Y
= 
SS
D
M
b 
	   164	  
	  
-15 -10
-3
-2
-1
X= FI siRNAi - FI nt control
Y
= 
SS
D
M
1
2
34
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22 23
24
26
27
28
29
30
31
32
33
c 
	   165	  
Figure	   6.9:	   Uptake	   of	   PMPC-­‐PDPA	   polymersomes	   in	   knockdown	   SR2+	   Drosophila	  
cells.	  Fluorescent	  intensity	  measurements	  
32	   genes	   coding	   for	   proteins	   related	   to	   endocytosis	   and	   cellular	   trafficking	   were	  
knocked	  down	  in	  SR2+	  cells	  using	  siRNA.	  Transfected	  cells	  were	  incubated	  with	  5µg	  of	  
rhodamine-­‐labelled	   polymersomes	   for	   1	   hour	   before	   being	   qualitatively	   and	  
quantitatively	   analysed	   by	   high	   throughput	   microscopy.	   	   a)	   Average	   cellular	  
fluorescent	  intensity	  for	  each	  transfection	  condition.	  Graph	  displays	  mean	  values	  ±	  SD.	  
An	   average	   of	   9	   technical	   repetitions	   for	   each	   gene	   was	   performed.	   The	   green	   dot	  
represents	  cells	  transfected	  with	  non-­‐targeting	  siRNA	  (control	  cells).	  Knockdown	  genes	  
falling	  within	  the	  variability	   range	  of	   the	  control	   (thick	  dashed	   lines)	  are	  represented	  
by	   black	   dots	   and	   do	   not	   present	   a	   distorted	   polymersome	   endocytosis.	   Narrow	  
dashed	  lines	  denote	  control	  cells	  SD	  ±	  5.	  Genes	  overlapping	  with	  this	  interval,	  but	  not	  
with	   the	   previous	   one,	   present	   a	   decreased	   polymersome	   internalisation	   (dark	   blue	  
dots).	  Knockdown	  genes	  that	  do	  not	  overlap	  with	  any	  of	  the	  thresholds	  mentioned	  are	  
represented	  as	   light	  blue	  dots.	  A	  decreased	  polymersome	   internalisation	   is	  observed	  
under	  these	  conditions,	  and	  the	  inhibition	  is	  stronger	  that	  the	  one	  observed	  after	  the	  
knockdown	  of	  genes	  represent	  in	  dark	  blue.	  Note:	  Gene	  25	  is	  not	  represented	  as	  its	  SD	  
exceeded	  the	  Y-­‐axis.	  b)	  Dual-­‐flashlight	  representation	  of	  SSDM	  vs.	  fold	  change.	  Strictly	  
standardised	   mean	   difference	   (SSDM)	   is	   represented	   in	   the	   Y-­‐axis.	   Mean	   cellular	  
fluorescent	   intensity	   obtained	   for	   each	   gene	   minus	   the	   mean	   fluorescent	   intensity	  
value	   for	   control	   cells	   (non-­‐targeting	   siRNA)	   is	   represented	   in	   the	   X-­‐axis.	   Vertical	  
dashed	  lines	  represent	  average	  fold	  change	  ±	  10.	  Horizontal	  dashed	  lines	  denote	  SSDM	  
±	  1.	  Genes	  (empty	  circles)	  falling	  between	  the	  dashed	  lines	  and	  the	  axis	  are	  considered	  
not	   to	   affect	   the	   normal	   endocytosis	   of	   polymersomes.	   c)	   Genes	   considered	   to	  
facilitate	  polymersome	  endocytosis.	  The	  bottom	  left	  quadrant	  from	  graph	  b	  has	  been	  
zoomed	   to	   visualise	   the	   genes	   distribution.	   The	   influence,	   in	   polymersome	  
endocytosis,	  of	  the	  protein	  codified	  by	  each	  gene	  is	  higher	  as	  the	  gene	  appears	  more	  
distant	  from	  the	  axis	  and	  the	  threshold	  lines.	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6.3 Discussion 
 
Following the identification, in the previous chapter, of two specific receptors 
facilitating polymersome uptake in mammalian cells, I aimed to further characterise the 
endocytic pathway/s followed by the nanoparticles, with emphasis on the identification 
of the intracellular cell factors required for particle uptake. In order to do that, I 
perturbed endocytosis and assessed polymersome uptake, using different experimental 
approaches with increasing level of specificity towards a particular endocytic 
mechanism.  
 
6.3.1 Investigation of PMPC-PDPA polymersome endocytosis through 
chemical inhibitors 
 
In the first instance, chemical compounds were used to inhibit/perturb different 
endocytic molecules. According to the extra care needed when using these agents to 
avoid misleading results, I performed an exhaustive pre-screen to select the inhibitors to 
use and their incubation conditions (figures 6.1-6.3, table 6.3). Consequently it was 
possible to explore polymersome uptake in cells incubated with inhibitors under 
conditions that resemble controls cells in terms of general cellular viability level and 
integrity of the plasma membrane. Surprisingly, a reduction in polymersome 
internalisation in cells pre-incubated with bafilomycin or nocodazole was not observed 
(figure 6.4). In the former case, the compound hinders the acidification of the 
endosomal lumen, which should prevent PMPC-PDPA polymersomes disassembly 
since they are pH responsive nanoparticles. However, it might be possible that 20 
minutes incubation with fluorescent polymersomes is not enough to appreciate a 
difference in fluorescent intensity levels between control cells and cells where 
nanoparticle disassembly is reduced or inhibited. Following polymersome break up in 
endosomes and cytosol release, single amphiphilic copolymers chains are likely to be 
integrated within cellular membranes, staining them over time. Therefore, although the 
cell will get eventually stained, the fluorescence of the nanoparticles confined in 
endosomes will be initially diluted as they escape from the endocytic compartment. 
Providing bafilomycin did work, there is the possibility that cells containing non-
acidified endocytic vesicles loaded with fluorescent polymersomes could have similar 
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overall fluorescent intensity to cells undergoing normal polymersome endocytosis and 
endosomal release for only 20 minutes. In the case of nocodazole, the present results 
contrast with results previously obtained in our group, where endocytosis of 
polymersomes was inhibited by 60% in HDFs after incubation with this microtubules 
depolymerising agent166. Apart from any cell type-dependent sensitivity to this 
compound, on that occasion cells were pre-incubated with nocodazole for 1 hour, 
compared with the 15 minutes pre-incubation protocol followed for the experiments 
reported in this chapter. Additionally, the argument put forward for bafilomycin could 
also apply here.  
 
In the interest of avoiding cytotoxicity induced by chemical inhibitors I might have been 
too conservative with the pre-incubation times and the concentrations used (table 6.3). 
Judging from the inhibition observed for the control cargoes (figure 6.3), slightly longer 
pre-incubation times would probably have been necessary to allow the chemicals to 
exert their full inhibitory effect. For example, it could be expected that a reduction in Tf 
uptake would have been observed in cells incubated with cytochalasin D, since actin 
plays an important role in CME endocytosis286. However, it has also been reported that 
the effectiveness of this inhibitor to prevent Tf endocytosis is very cell type-
dependent102. The introduction of a final acid wash step before flow cytometry analysis 
would have possibly amplified any difference in fluorescent intensity, between control 
cells and cells where endocytosis was partially inhibited, particularly if polymersomes 
were stacked at the plasma membrane or in invaginations connected with it. Finally, the 
experiments were conducted in the presence of serum, while in some experimental 
protocols involving the use of these inhibitors pre-incubation is carried out in serum 
free conditions (table 6.1), possibly to avoid any aggregation/precipitation of the 
chemicals that could diminish their effect.  
In the case of cholera toxin it is difficult to discern whether the results obtained could 
include artefacts derived form the experimental protocol or not. According to the 
information presented in the results section, CTxB is very promiscuous regarding the 
endocytic mechanisms used. The significant reduction in toxin uptake in cells incubated 
with chlorpromazine is in agreement with reports showing CME endocytosis of 
CTxB275. Nevertheless CTxB has also been related to caveolae-mediated endocytosis287, 
in which case an effect in toxin uptake in cells incubated with filipin and/or genistein 
should have been observed. There are also contradictory reports showing dynamin-
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dependent278 and dynamin-independent275 uptake of the toxin. According to the results 
presented, CTxB seems to be using CME endocytosis. However it would be 
recommended to repeat the experiments with the amendments to the experimental 
protocol mentioned above. CTxB was used as a control to compare its uptake to that of 
PMPC-PDPA polymersomes under the same inhibitory conditions. Figures 6.4.b,c 
shows that their endocytosis is not affected in the same way by the inhibition of the 
same cell factors. A comparison between the uptake profiles obtained for polymersomes 
and dextran in inhibited cells is more difficult. Little dextran internalisation was 
observed in control cells, and cells incubated with inhibitors. In addition, the results 
were highly variable (figure 6.4.d). A reason for this could be that macropinocytosis is a 
transient process in most cell types which gets commonly activated after growth factors 
stimulation288. Unstimulated HeLa cells were used and so, macropinocytosis could be 
not occurring at a significant level in them. Therefore, to be able to compare the uptake 
profile of polymersomes with that of dextran in inhibited cells I should have used 
stimulated cells (i.e. using epidermal growth factor). 
 
This discussion illustrates the high number of variables to have in mind while designing 
and performing these experiments. Similarly, it highlights the fragile balance between 
effective inhibition of a certain endocytic route and promoting cytotoxic and off-target 
effects while working with chemical inhibitors. 
 
6.3.2 Implication of dynamin in PMPC-PDPA polymersome 
internalisation 
 
Over the years dynamin has emerged as a very important molecule in endocytosis. It is 
the main force driving the pinching off the invaginated endocytic vesicles from the 
plasma membrane in some of the best-characterised endocytic mechanisms in 
mammalian cells such as CME and caveolae-mediated endocytosis, as well as in 
recently described endocytic pathways like RhoA and interleukin-2-mediated 
endocytosis15. Therefore, it was surprising to find out that dynamin seems not to be 
essential, or to be strongly implicated, in PMPC-PDPA polymersome endocytosis. I 
arrived to this conclusion after noticing similar nanoparticle uptake in cells 
overexpressing the mutant K44A dynamin (not able to bind GTP and therefore to 
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mediate the pinching off of vesicles from the plasma membrane) and a wild type 
dynamin. The same conclusion was obtained in two different cell lines using different 
experimental settings (CelLuminate® vs. rhodamine-labelled polymersomes and 
microscopy vs. flow cytometry).  Nonetheless, in the case of HeLa cells I have drawn 
my conclusion from a very small number of observations and therefore it would be 
advisable to repeat the experiment looking at a larger population in order to investigate 
whether the small reduction observed is diluted or it becomes significant. It is also 
important to consider that the inhibition of dynamin-dependent process could up-
regulate dynamin-independent process, as it has been previously observed289. This 
would mask the true level of dynamin implication in PMPC-PDPA polymersome 
endocytosis providing the nanoparticles can use both, dynamin-dependent and dynamin-
independent internalisation routes. PMPC-PDPA polymersome could be using one of 
the dynamin-independent pathways described to date, such as Cdc42 and Arf6-mediated 
endocytosis15. Macropinocytosis and flotillin-mediated endocytosis, where there is 
some controversy about their dependence on dynamin, could be also possible routes for 
the cellular internalisation of these polymersomes. The involvement of these pathways 
in polymersome uptake could be investigated under the microscope, looking for the 
early localisation of fluorescent polymersomes in cells transfected to express 
fluorescent-labelled markers, such as Cdc42, Arf6, or flotillin.  
 
The experiments performed in this section raise the interesting question of which 
molecules, rather than dynamin, could be mediating the detachment of the endocytic 
vesicle containing the nanoparticles from the plasma membrane. The actin cytoskeleton 
and BAR domain proteins are potential candidates. They play a main role in dynamin-
independent endocytosis as well as being normally implicated in dynamin-dependent 
processes74,93,96. Their implication in PMPC-PDPA polymersome uptake has been 
investigated to some extent in this chapter by means of the actin inhibitor cytochalasin 
D, which did not affect polymersome internalisation, and by siRNA knockdown of actin 
and BAR domain proteins, discussed below.  
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6.3.3 BAR domain proteins in PMPC-PDPA polymersome 
internalisation. siRNA screening in Drosophila cells 
 
The possibility to test almost simultaneously, and in a comparable manner, the impact 
that different single proteins have in polymersome endocytosis, drove the design of a 
screen with chemical inhibitors. Unfortunately, I did not obtain as much information as 
I was expecting from it, possibly influenced by the experimental considerations 
previously mentioned. Nevertheless, a screen is one of the most interesting ways to 
explore polymersome internalisation. In this sense, the possibilities offered by high-
throughput screening are exceptional. The opportunity to automate almost every step of 
the protocol marks it as a high reproducible methodology. In addition, the amount of 
biological information both, at a single cell level and at a population level, provided by 
this kind of screen is outstanding. Therefore, I decided to take advantage of the 
screening facilities for genome wide screens in Drosophila cells at The University of 
Sheffield to study polymersome endocytosis. Due to the time limit of this thesis I had 
just enough time to start exploring the suitability of this technique to characterise 
polymersome uptake, and to set up a small preliminary screen. Surprisingly, almost all 
the genes investigated came out as positive hits (figure 6.9), meaning that the proteins 
that they code for would be implicated in PMPC-PDPA polymersome internalisation or 
subcellular trafficking (figure 6.9). This is not usual. Although SR2+ cells are easily 
transfectable it is unlikely that the knockdown was 100% effective in all the cases. 
Moreover, the high number of hits raises the question of whether the control could be an 
outlier. This is probably the weakest point of the screen. Although the use of cells 
transfected with siRNA for Caenorhabditis elegans genes with no homology with 
Drosophila cells is adequate, the presence of more controls would have been necessary. 
The screen could be further optimised in the future by including scramble siRNA and 
siRNA coding for housekeeping genes not related to endocytosis or subcellular 
trafficking. Besides siRNA controls, it would be suitable to include cells incubated with 
a cytotoxic agent at a toxic dose, to be able to compare fluorescent signal associated 
with dead cells or cells with a compromised membrane to that of healthy transfected 
cells undergoing endocytosis. This control would be useful to rule out not optimal 
transfected cells from the final results.  
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Having pointed out the main limitations of the screen and how they could be overcome 
in the future, there is also the possibility that the high number of hits is a natural 
consequence, or highly influenced by redundant functions among the group of genes 
comprising the screen. Most of the genes investigated code for proteins able to sense 
and induce membrane curvature. If our hypothesis is true, and polymersome 
endocytosis is strongly driven by the curvature of the particle, it is reasonable to expect 
that the knockdown of proteins able to sense plasma membrane deformation would, in 
most of the cases, have an effect in polymersome uptake. 
  
Actin, another candidate to mediate the detachment of the endocytic vesicle containing 
the polymersomes from the plasma membrane, is represented in the screen by two genes 
(32, 27), while one of them came out as a relative strong hit, the other one did not, 
leaving very much unresolved actin implication in PMPC-PDPA polymersome uptake. 
On the other hand, the tetraspanin CD81 (genes 18 and 29) emerged as strong hit, in 
agreement with the results previously obtained in mammalian cells. Intriguingly, none 
of the two genes coding for SR-BI (genes 16 and 1) were strong hits on the screen.  This 
could be due to different receptor requirements in mammal and insect cells and 
highlights the necessity to characterise in detail PMPC-PDPA polymersome uptake in 
Drosophila cells. It would be advisable to repeat Fucoidan and Polyinosinic acid 
experiments in SR2+ cells, to investigate further the implication of scavenger receptors 
in nanoparticle internalisation in this cell type. It also raises the question of whether it 
would be better to continue with the screen in mammalian cells rather than in 
Drosophila cells, if there are such important differences in PMPC-PDPA polymersome 
endocytosis between the two cell types.  
 
6.3.4 Final remarks 
 
Although some of the experiments presented in this chapter have clear limitations and 
would require additional optimisation, I believe that the overall picture indicates that 
PMPC-PDPA polymersomes exhibit a high level of plasticity in their mechanism of 
cellular entry. In addition, polymersome endocytosis is a dynamin-independent process 
in FaDu cells, and most likely in HeLa cells, which often defines very unique endocytic 
routes where the cargo features play a central role. Consequently, I propose a cargo-
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driven endocytic mechanism for PMPC-PDPA polymersomes where the nanoparticle 
high curvature and the specific nanoparticle binding to the cell surface are crucial. The 
model for the endocytosis of PMPC-PDPA polymersomes, based on the information 
gathered by the experiments conducted in this thesis, would be described and discussed 
in detail in the following chapter. 
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Chapter 7: Conclusions, final discussion and 
future perspectives 
 
The aim of this thesis was to extend our knowledge of the internalisation mechanism 
followed by PMPC-PDPA polymersomes in mammalian cells, which was minimal at 
the beginning of the present research. This has been fulfilled with the acquisition of 
important pieces of information that have made us understand the reason behind the 
enhanced uptake of this formulation, and how to properly balance key polymersome 
properties in order to better control their internalisation, opening new and interesting 
lines of work to be developed in the future.  
 
7.1 Summary of findings  
 
7.1.1 Effects of polymersome size and shape in PMPC-PDPA 
polymersome uptake  
 
Taking advantage of the specific physical properties that different production methods 
imprint in PMPC-PDPA polymersomes, and exploring sequential centrifugation as a 
technique for the purification of bulk polymersome dispersion, the important effect of 
particle size on polymersome uptake kinetics has been corroborated and extended. 
Moreover, the impact of nanoparticle shape in PMPC-PDPA polymersome uptake has 
been investigated for the first time. Importantly, we have discovered that a diameter of 
approximately 60 nm corresponds to the optimal nanoparticle size for the uptake of 
spherical PMPC-PDPA polymersomes (relative number of particles taken up) in 
mammalian cells. This result, obtained in the cancer cell line FaDu (presented in this 
thesis), and in a parallel study conducted by another PhD student in primary 
neutrophils, is in agreement with the optimum particle diameter for the receptor-
mediated endocytosis of nanoparticles reported by different groups142,290-293. 
Complementing this finding, we have demonstrated that polymersome uptake is highly 
influenced by nanoparticle shape. Uptake profiles are different for spherical and tubular 
nanoparticles. Elongated particles show a biphasic uptake and a delayed internalisation 
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when compared to spherical polymersomes of the same diameter. This, together with 
the discovery that tubular PMPC-PDPA polymersomes present higher encapsulation 
ability than their spherical counterparts194, and are able to act as intracellular delivery 
vectors, could be translated into new possibilities to modulate the temporal delivery of a 
cargo in vivo. Therefore, the next step will be to compare the uptake profiles of 
spherical and tubular PMPC-PDPA polymersomes in vivo animal models. Polymeric 
filomicelles present enhanced circulation times in vivo144, and we would like to 
investigate if this is also the case for tubular polymersomes. In addition, it would be 
quite interesting to compare the biodistribution profiles of spherical and tubular 
polymersomes, in order to explore whether some level of control over polymersomes 
sites of action in vivo could be achieved by fine-tuning of the nanoparticle shape.  
 
7.1.2 Identification of the cellular receptors targeted by PMPC-PDPA 
polymersomes 
 
One of the most important contributions of this thesis to the understanding of cell-
PMPC-PDPA polymersome interactions has been the identification of receptor-
mediated endocytosis as a common pathway for the internalisation of these 
nanoparticles in mammalian cells. Using different molecules, from antagonists to 
neutralising antibodies, to impair/block endocytosis through specific receptors, I have 
found strong evidence that tetraspanin CD81 and scavenger receptors SR-BI/SR-BII 
(the methodology followed did not allow us to distinguish between them) are mediating 
PMPC-PDPA polymersome uptake in mammalian cells. A role for scavenger receptor 
CD36 in polymersome internalisation is also possible following consideration of the 
results obtained. This could be investigated further in CD36 knockdown cells. It would 
be also important to verify, in knockdown cells, the strong polymersome inhibition 
observed when a neutralising antibody anti-CD81 was used, and most interesting would 
be to study polymersome uptake in cells simultaneously deprived of the expression of 
all three receptors. Moreover, we would like to learn about the interactions established 
among these receptors in the context of PMPC-PDPA polymersome endocytosis, and 
the specific role that each one plays in polymersome uptake. In the case of HCV 
endocytosis, the sequential involvement of the different receptors (SR-BI, and CD81) 
and other cell surface factors mediating viral internalisation has been determined by 
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incubating the cells with specific neutralising antibodies at different time points, before 
and after viral binding. It has been demonstrated that SR-BI acts both in early viral 
binding to the cell, and at later stages of viral infection181,294,295. We could adapt the 
experimental procedure followed in those studies to explore at what time the different 
receptors are being used in PMPC-PDPA polymersome endocytosis. In addition, we 
could investigate the existence of direct interactions between CD81, SR-BI, SR-BII and 
CD36 before and after polymersome incubation using immunoprecipitation protocols. 
It is exciting to discover the ability of PMPC-PDPA polymersomes to target specific 
receptors at the cell surface, mimicking the interactions established by natural 
nanoparticles with the cells. The finding that the endocytosis of this formulation is 
greatly enhanced in serum free conditions is an additional indication that the targeting 
of the receptors is directly mediated by polymersome surface and not through 
nanoparticle association with the proteins present in the media.  
 
7.1.3 Dynamin-independent internalisation of PMPC-PDPA 
polymersomes 
 
Another important aspect of the cellular uptake of PMPC-PDPA polymersomes 
revealed by the research presented in here, is that receptor-mediated endocytosis of 
these nanoparticles could be a dynamin-independent process in mammalian cells. This 
conclusion was achieved after investigating, by flow cytometry, the uptake of 
rhodamine-labelled polymersomes in FaDu cells expressing a dominant negative 
dynamin. The same result although less convincing than in the previous cell line due to 
the reduced sample size, was obtained in K44A mutant HeLa cells incubated with 
unlabelled-polymersomes encapsulating a fluorescent dye and analysed by confocal 
fluorescence microscopy. The slightly different experiment setups and the different 
detection techniques used strengthen the common observation. It would be important to 
complement these observations by studying the participation of dynamin in 
polymersome uptake in primary cells. In addition, it would be interesting to repeat these 
experiments using tubular polymersomes instead of spherical ones, since we have 
already noticed a difference between their internalisation kinetics.  
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Finally, the involvement of specific endocytic pathways such as CME, caveolae-
mediated endocytosis and macropinocytosis, in PMPC-PDPA polymersome uptake, as 
well as the participation of BAR domains proteins in nanoparticle internalisation has 
been investigated to some extent in this thesis. Although, as discussed on the previous 
chapter, these experiments would require further optimisation and therefore are not fully 
conclusive at this stage, we believe that, so far, the emerging picture points to the 
possibility that PMPC-PDPA polymersomes use multiple endocytic pathways to enter 
the cells.  
 
7.2 Final discussion and future perspectives 
 
Taking into account the findings summarised above and acknowledging the limitations 
of some of the results presented, I propose that the endocytic uptake of PMPC-PDPA 
polymersomes is characterised by: 
 
a) A high level of promiscuity. Polymersomes would be able to take advantage of 
any endocytic process operating at the cell surface at a given time. For example, it is 
known that caveolae are constantly present at the cell surface where they help to 
counteract membrane tension through different mechanisms including their 
endocytosis296. In addition, it has been demonstrated that clathrin coated pits starts to 
assemble at the plasma membrane in the absence of any cargo, rapidly aborting the 
nucleation after a short period of time or committing to the next endocytic step only 
after cargo stimulation297,298. The ability of PMPC-PDPA polymersome to enter a high 
number of heterogeneous cell types could be a consequence of their promiscuous 
behaviour. Most endocytic routes are ubiquitous in mammalian cells, but interestingly 
we have reported here, high polymersome uptake in Huh7 cells, which present very low 
levels of caveolins and are negative for caveolae expression299. Additionally, 
experimental data generated in the laboratory, although not by this thesis, has revealed 
that polymersomes could enter the cells via phagocytosis in neutrophils. These 
observations nourish my hypothesis of polymersome endocytosis being chracaterised by 
a high level of promiscuity, for which there are also biological precedents. Some 
pathogens have been proven to enter the cell following a wide range of different 
endocytic routes. One of the best examples is cholera toxin (CTxB). As previously 
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pointed out in this thesis, CTxB can enter the cell via caveolae-mediated endocytosis, 
CME, and caveolae and clathrin-independent endocytosis300. Likewise Shiga toxin 
(STx) and simian virus 40 (SV40) have been shown to gain cellular access through 
different endocytic routes301-303. Furthermore, the research conducted by Prof. Ludger 
Johannes group (Institut Curie, Paris) has demonstrated the ability of all these 
exogenous particles to induce their own endocytosis, without the help of any cytosolic 
endocytic machinery304,305. They have shown that CTxB, STx and SV40 bind to specific 
glycolipids receptors (GM1, Gb3, GM1 respectively) through pentameric protein 
scaffolds, leading to lipid reorganisation and membrane clustering, which in turn is 
translated into cellular membrane invagination and formation of tight tubular 
invaginations containing the toxins or the viral particles. Based on experiments 
conducted in model (giant unilamelar vesicles, GUVs) and cellular membranes Prof. 
Johannes group proposed that the kinetics of the tubule nucleation is controlled by a 
free energy barrier, which is strongly influenced by the cost of membrane deformation 
at the invagination neck. The intrinsic high curvature of the viral particles (SV40, 45 nm 
in diameter) is enough to trigger tubule nucleation at the membrane within seconds of 
incubation with the virus. This process is delayed (minutes) in the case of small toxins 
(STx, CTxB), which lack the ability of simultaneously imposing membrane deformation 
as they adhere to the cell surface305. Finally, they have shown that detachment of the 
endocytic vesicle from the plasma membrane is dynamin and actin-dependent in the 
case of STx304 and actin-dependent but dynamin-independent for SV40305. Nonetheless, 
there are also reports demonstrating a dynamin-independent internalisation for all three 
particles 300,302,303.  
 
b) The ability of PMPC-PDPA polymersomes to induce their own endocytosis. 
Similarly to the natural particles just presented, the promiscuous behaviour of this 
nanoparticle formulation could be also the reflection of their inherent facility to promote 
their endocytosis. In order to do that, a first step of docking to the plasma membrane 
seems to be a logical prerequisite. In the case of PMPC-PDPA polymersomes it is 
fulfilled with the binding to tetraspanin CD81 and specific scavenger receptors B. The 
capacity to induce an inward membrane deformation as the nanoparticle binds to the 
plasma membrane, or shortly after it, seems to be also essential. This thesis has 
produced evidence of the importance of nanoparticle curvature in PMPC-PDPA 
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endocytosis. Spherical polymersomes 60 nm in diameter, the ones with the optimal 
curvature at the contact point with the cell investigated, were the most effectively and 
rapidly internalised. Therefore, the ability of PMPC-PDPA polymersome to induce their 
endocytosis would be the result of the balance between polymersome-receptors 
interactions and the energy necessary to deform the membrane. Such balance would be 
strongly dependent on the inherent polymersome curvature and influenced by 
polymersome shape. In fact, tubular PMPC-PDPA polymersomes show a slower 
cellular uptake than their spherical counterparts.  In order to directly test the ability of 
PMPC-PDPA polymersome to induce membrane invagination and the physico-chemical 
characteristics of those invaginations (shape of the bud and lipid composition) we could 
replicate the work done by Prof. Johannes group in model membranes. Using GUVs we 
could study the potential of these polymersome formulation to induce local 
rearrangement of the membrane and lipid clustering. The direct observation of the type 
of invaginations at which polymersomes are found at the cellular plasma membrane 
would be a milestone. During the course of this thesis, we have unsuccessfully tried to 
visualise these early events using transmission electron microscopy and resin-embedded 
cellular samples. Recent developments in microscopy have made it possible to combine 
fluorescence microscopy and electron microscopy to visualise the same area of a sample 
on a grid by both techniques, with a total resolution below 100 nm306,307. Such powerful 
systems would be ideal to investigate the molecular architecture of the membrane 
invaginations associated with polymersomes of different sizes and shapes. Moreover, 
combining it with immunolabelling we could assess the participation of specific cell 
factors, from clathrin to BAR domain proteins and actin, at different stages of 
polymersome endocytosis. Until these techniques become more readily available and 
we can have access to them, we could attempt to directly visualise polymersomes 
attachment to the plasma membrane, invaginations containing the nanoparticles and 
subcellular sorting of the endocytic vesicles using cryogenic electron microscopy 
(CryoEM).  
An interesting question arising from the work presented in here, is related to the 
molecular force driven the detachment of the endocytic vesicle containing the 
nanoparticles from the plasma membrane, since PMPC-PDPA polymersome 
internalisation seems to be a dynamin-independent process, consistent with our current 
results. Apart from dynamin, there are other proteins that could assist this process such 
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as actin96, epsin93, Eps15 homology (EH)-domain (EHD)-containing proteins308, even 
BAR domain proteins93. In fact, according to the preliminary data obtained from the 
siRNA screening conducted in drosophila cells, it seems that epsin, actin, and BAR 
domain proteins are implicated in the internalisation of this nanoparticle formulation. 
The involvement of these molecules in polymersome endocytosis could be explored 
further by investigating nanoparticle uptake in knockdown cells, cells transfected with 
dominant negative versions of these proteins or transfected to express a fluorescent 
version of these molecules, ideally using high-throughput imaging. In addition to 
proteins, the biophysical properties of the plasma membrane also play an important role 
in vesicle fission67,113. Research conducted by Prof. Aurelien Roux (University of 
Geneva) has shown that phase separation of membrane lipids, either by specific lipid 
clustering or by induced membrane tubulation, promotes the local fission of membranes 
in vitro309. As mentioned above, cargo binding can directly induce membrane 
rearrangement, lipid clustering, even membrane tubulation. In addition, it has been 
observed that the interaction of some nanoparticles with phospholipid models 
membranes, and more recently with cellular membranes in live cells, resulted in 
effective vesicle severing and nanoparticle endocytosis310,311. It would be interesting to 
investigate if membrane invaginations containing PMPC-PDPA polymersomes could be 
detached from parent membranes without the need of any cell factor. This could be 
studied in GUVs. A totally cargo-driven membrane scission in cells would be a priori 
more difficult, since the cortical actin meshwork and the highly crowded and viscous 
cytoplasm would present a high resistance to it, nonetheless it is a stimulating scenario 
for further research.  
 
 
According to the findings and the conclusions presented, PMPC-PDPA polymersomes 
seem to mimic the ability of pathogens to guarantee their cellular uptake by taking 
maximum advantage of cellular endocytosis. The similarity is especially interesting in 
the case of PMPC-PDPA polymersomes and HCV, as both nanoparticles target the 
scavenger receptor SR-BI and the tetraspanin CD81. Accordingly, PMPC-PDPA 
polymersomes could compete with HCV for their common receptors, with the 
possibility of observing a reduced viral uptake in the presence of these polymersomes. 
We have already started to test this hypothesis, in collaboration with Prof. McKeating 
(The Univeristy of Birmingham), with promising results so far. Viral infection, 
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measured by cellular luciferase expression 72 hours after treatment with HCV 
pseudoparticles encoding a luciferase reporter gene, was reduced by approximately 50% 
in cells simultaneous incubated with viral particles and empty PMPC-PDPA 
polymersomes (2 independent experiments performed by Mrs. Ke Hu at The University 
of Birmingham). It is important to remember that we have previously investigated the 
toxicological profile of PMPC-PDPA polymersomes in cell cultures, without finding 
any indication of significant cellular toxicity induced by these nanoparticles166,173. 
Moreover, we have recently explored the expression of genes involved in the interferon-
α and interferon-β immune responses, which are normally activated in cells after viral 
exposure and that are critical for host defense, finding out that incubation with empty 
PMPC-PDPA polymersomes induce a non-specific antiviral state on the cells (Dr. 
Patikarnmonthon and Prof. Battaglia unpublished data). This is very interesting, since 
one of the tricks that virus, such as HCV, play on their hosts to avoid their clearance is 
to switch off this antiviral cellular state312. According to these results, polymersomes 
could prevent HCV infection, to some extent, using multiple mechanisms, competition 
for plasma membrane receptors and induction of an antiviral state on the cells. We are 
currently continuing this line of work, that ascribed a possible antiviral activity to 
PMPC-PDPA polymersomes, and we will soon be repeating the competition studies for 
the third time. If the data shows again an inhibition of viral infection in cells 
simultaneously incubated with polymersomes, it is our intention to repeat this study in 
vivo, to investigate whether these nanoparticles are able to significantly reduce HCV 
infection in animal models. At the same time, it would be important, to monitor the 
health profile of the animal after different polymersome administration regimes. This is 
definitely one the most exciting lines of work derived from this thesis due to the high 
clinical impact of the possible outcome. Hepatitis C virus infection is a major global 
health problem with 150 million people chronically infected, and more than 350.000 
deaths per year from hepatitis C-related liver diseases (WHO 2013). There is not a 
preventive vaccine available and the mainstay of standard-of-care for HCV, interferon-α 
plus ribavirin, is effective only in approximately 50% of the patients313,314, highlighting 
the necessity to improve current HCV treatments.  
In addition, if our hypothesis were true, it would be revealing a novel and revolutionary 
property of PMPC-PDPA polymersomes. From being the intracellular delivery vector 
encapsulating the prophylactic/therapeutic molecule, the polymersome itself could also 
be an active compound with prophylactic/therapeutic activity. One cannot but get 
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excited imagining the long-term possibilities that such a finding could bring, for 
example, HCV patients could be treated with PMPC-PDPA polymersomes loaded with 
an antiviral drug, reducing the chances of cellular re-infection and cell-to-cell viral 
spread (extracellular action) and treating the cells (intracellular action) at the same time, 
with the same nanoparticle. This research could be also extended to test the capacity of 
PMPC-PDPA polymersomes to effectively reduce other viral infections, in this sense, it 
is our intention to investigate in the near future whether human immunodeficiency 
virus283 infection is affected by the presence of PMPC-PDPA polymersomes 
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